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Polyols, such as carbohydrates and other compounds containing multiple hydroxyl groups, 
represent an important class of molecules. The selective transformations of polyol-containing 
compounds are of great importance as relatively easily accessible polyol building blocks can be 
transformed into more synthetic useful compounds. Accomplishing selective transformations of 
polyols is challenging due to intrinsic complexity of these molecules and unpredictable inherent 
selectivity of primary and secondary alcohols in the structure. These challenges can be addressed 
by employing asymmetric catalysis. This dissertation describes the use of chiral phosphoric acids 
(CPAs) to address the challenges associated with polyol functionalization in carbohydrate system. 
The described in this dissertation methods, hence, streamline the selective modification of 
carbohydrates and the carbohydrate synthesis. In addition to the selective functionalization of 
carbohydrates, this thesis describes the development and use of asymmetric catalysis to address 
other existing synthetic challenges such as biomimetic Michael reactions.    
Chapter 1 describes the development of a new single-pot copper(II)-catalyzed 
decarboxylative Michael reaction between β-ketoacids and enones, followed by in situ aldol 
condensation. This reaction results in highly functionalized chiral and achiral cyclohexenones 
containing all carbon quaternary stereocenter.  
Chapter 2 provides an overview of regioselective functionalization of polyols by chiral 
Brønsted acids and other catalysts. The utility of these transformations as well as the discussion of 
the various catalyst-controlled regioselective reactions of polyols including acylation, silylation, 
acetalization and glycosylation reactions is provided. 
xix 
 
Chapter 3 describes CPA-catalyzed desymmetrizative glycosylation of a functionalized 
meso-diol derived from 2-deoxystreptamine. The chirality of CPA dictates the outcome of the 
glycosylation reactions, and the use of enantiomeric CPAs results in either C4-glycosylated or C6-
glycosylated 2-deoxystreptamines. These glycosylated products can be converted to 
aminoglycosides, and the application of this strategy to the synthesis of protected iso-neamine and 
iso-kanamycin B with inverted connection at the C4 and C6 positions is described. 
Chapter 4 summarizes CPA-catalyzed regioselective and stereoselective glycosylation 
reactions in carbohydrate‐derived 2,3‐diols. These studies describe evaluation and optimization of 
CPA-catalyzed glycosylation reactions that helped to identify the most promising catalysts in 
terms of their ability to control regio- and stereoselectivity. In addition to the structure of the CPA-
based catalysts, other factors that can affect stereoselectivity and regioselectivity of glycosylation 
were investigated. These studies included evaluating the effect of the stereochemistry of the 
anomeric position of the donor, type and chirality of the sugar donors as well as acidity in the 
reaction mixture. 
Chapter 5 illustrates the development of a regioselective single-pot functionalization of 
monosaccharides. A single-pot regioselective functionalization of the C2- and C3- hydroxyl 
groups in monosaccharides (e.g. D-glucose, D-galactose, and D-mannose) was accomplished using 
CPA-catalyzed regioselective acetalization as the initial step to differentiate the diol moieties in 
monosaccharides. From this, a single-pot regioselective protection and regioselective 




Chapter 1  
Copper(II)-Catalyzed Tandem Decarboxylative Michael/Aldol Reactions Leading to the 
Formation of Functionalized Cyclohexenones 
(This chapter was partially published in: Lee, J.; Wang, S.; Callahan, M.; Nagorny, P., Org. Lett. 
2018, 20 (7), 2067.) 
1.1 Introduction of biomimetic decarboxylative addition reactions 
In recent years, carbon-carbon (C-C) bond formation from carbon−hydrogen (C-H) bond 
functionalization has flourished as a front-line research theme in the field of catalysis. Among 
many methods, a decarboxylative coupling reaction has attracted considerable attention as a way 
to construct new C-C bond. Compared to conventional C-C bonding methods, the decarboxylative 
coupling reaction has four major benefits1: 1) carboxylic acid derivatives are inexpensive and 
abundant in different forms, 2) the decarboxylation reaction uses mild conditions to generate the 
reactive intermediates, 3) the only byproduct of the decarboxylation reaction is CO2, which is non-
hazardous, non-flammable, and is easily removed from the reaction mixture, 4) the 
decarboxylation reaction results in selective functionalization of the site next to the carboxylate, 
whereas more traditional enolyzation methods are often not as selective..2 
By elucidating the polyketides synthase, an essential enzyme for biosynthesis of fatty acids 
and polyketides, enzymatic mechanism, researchers found that nature already performs 
decarboxylative coupling reactions under mild conditions (Scheme 1.1). Polyketides synthases 
utilize malonic acid half-thioesters (MAHTs) as a thioester enolate3 to carry out biosynthesis of 
polyketides under physiological conditions without need of strong bases.4 Polyketides synthases, 
2 
 
firstly, promote decarboxylation of MAHT through hydrogen bonding with asparagine (Asn) and 
histidine (His) to convert MAHT to a thioester enolate. The resulting thioester enolate performs a 
nucleophilic attack to the acyl group of cysteine (Cys) to afford the Claisen condensation product.5 
Decarboxylation enhances the nucleophilicity of the carbon, which is the driving force of the 
Claisen condensation reaction. 
 




Inspired by polyketides synthases, several groups utilized MAHTs and their derivatives as 
coupling donors for decarboxylative addition reactions. The very first example of decarboxylative 
addition of MAHTs was reported by the Kobuke group.6 The decarboxylative Claisen 
condensation of MAHT 1-1a was successfully catalyzed by Mg(OAc)2 to provide synthetically 
useful products (Scheme 1.2a). The authors proposed two possible mechanisms for the 
decarboxylative Claisen condensation reactions, (Scheme 1.2b) the first mechanism is based on 
decarboxylation followed by the enolate addition, while second mechanism is based on 
nucleophilic addition of enolate followed by decarboxylation. From the subsequent mechanistic 





Scheme 1. 2. a) Kobuke’s first example of decarboxylative addition of MAHTs to thioestates. b) 
Two potential mechanisms for decarboxylative acylation reactions. 
 
Following Kobuke’s pioneering biomimetic Claisen condensation reaction with MAHT, 
the Shair group illustrated the first example of a biomimetic decarboxylative aldol reaction in 2003 
(Scheme 1.3a).8 This reaction was performed by a Cu(2-ethylhexanoate)2 under remarkably mild 
conditions (i.e. open air condition with wet solvent at room temperature). Due to its mild reaction 
condition, both aromatic and aliphatic aldehydes such as 1-4a were converted to the corresponding 
aldol adducts such as 1-5a without any enolization or self-condensation side reactions. 
Subsequently, Shair group described an enantioselective version of decarboxylative aldol reaction 
of MAHT 1-1b to aldehydes 1-4 (Scheme 1.3b).9 In this work, the authors employed chiral 
copper(II)/ bis(oxazoline) catalyst 1A to carry out decarboxylative aldol reactions, which resulted 
in the desired aldol adducts 1-6 in high enantioselectivities and good yields (Scheme 1.3). Like 




Scheme 1. 3. Shair’s decarboxylative aldol reaction of MAHTs to aldehydes. a) Racemic Cu(II)-




After the Shair group’s pioneering work on Cu(II)-catalyzed enantioselective 
decarboxylative aldol reactions, numerous research groups have developed different metal-based 
catalyst-controlled decarboxylative addition of MAHTs to various electrophiles.10 However, the 
decarboxylative addition reactions have been catalyzed not only by the metal-catalysts, but also 
by the metal-free organocatalysts. In 2007, the Ricci group demonstrated the first example of 
organocatalyst-controlled asymmetric decarboxylative Mannich reactions of MAHT 1-1c to imine 
1-7. 11 They used a Cinchona-derived organocatalyst 1B to catalyze the decarboxylative reaction 
affording the β-amino thioester 1-8 which can be converted to chiral β-amino acids. From this 
study, O-methylthioester maolnate and the α-dimethyl substituted diketone of MAHT were also 
subjected to the same condition. The reaction of the ester was sluggish, and the reaction of the 
substituted acid did not afford the desired product, but only unreactive decarboxylation happened. 
This result suggested first that the decarboxylation is vital for the reactivity of the reaction, and 
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second that there is a severe limitation by the high sensitivity of the decarboxylative reaction due 
to steric effects exhibited by the substitution pattern. 
 
Scheme 1. 4. Ricci’s first example of organocatalyzed enantioselective decarboxylative Mannich 
reaction of MAHTs to imines.  
 
 
Subsequently, the Song group developed an organocatalyzed enantioselective aldol 
reaction with a variety of aromatic and α,β-unsaturated aldehydes,12 which were not previously 
described by the Shair group. The Song group demonstrated that the metal-free sulfonamide-based 
organocatalyst 1C could catalyze the enantioselective decarboxylative aldol reaction of MAHT 1-
1a with aldehyde 1-4b. The resulting aldol products such as 1-5b were valuable as they could be 
utilized as the synthetic precursors to valuable drugs, such as paroxetine, duloxetine, tomoxetine. 
 




In addition to MAHTs, malonic acid half oxyester (MAHO)13, β-ketoesters14, β-ketoacids15, 
and regular aliphatic16 and aromatic carboxylic acids16 can also be involved in the decarboxylative 
coupling reactions. This means that the decarboxylative coupling reactions could be used for 
carboxylic acid derivatives in general. The carboxylic acid functionality acts as a traceless 
activating groups (similar to cuprates, boronic acids, halides, and Grignards reagents in cross-
coupling reactions).17 Unlike many related transformations that are based on metal activation, 
decarboxylative reactions produce primarily CO2 as the nontoxic side-product. Upon 
decarboxylation, the reactive nucleophilic carbon is generated, and then trapped with carbon-based 
electrophiles to form C-C bonds efficiently. For these and many other beneficial features, 
decarboxylative methods have been widely employed in various asymmetric transformations.  
1.2 Overview of decarboxylative Michael reactions 
From the discovery of the Michael reaction in 188718, 1,4-conjugated additions have been 
indispensable for C-C bond formation in organic synthesis.17 In Michael reactions, either 
nucleophiles or SOMO-activated donors are added to the electrophilic olefin acceptors in a 
regioselective1,4-addition manner.17 Among various ways of performing Michael reactions, the 
decarboxylative strategy was applied to Michael reaction substrates. Due to carboxylate acting as 
a traceless activating group, such reactions can be promoted under very mild conditions using 
catalysts that otherwise would not be compatible with strongly basic nucleophilic Michael donors.  
In 2007, the Evans group reported the first enantioselective decarboxylative Michael 
reaction (Scheme 1.6).15d In this study, they used a Ni(II) complex 1D  to perform the Michael 
reaction of 1,3-dicarbonyl compounds, such as β-ketoacid 1-9, to nitroalkene acceptor 1-10 in a 
good yields with high enantioselectivities. Similar to Shair’s decarboxylative aldol reaction, 8-9 the 
conditions of Evans’ Michael reaction were very mild, and a wide range of Michael acceptors and 
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donors were tolerated. The chiral diamine ligands did not only provide the chiral environment for 
the asymmetric transformation, but also promoted the substrate enolization as a base. 
 
Scheme 1. 6. Evan’s enantioselective decarboxylative Michael reaction. 
 
 
Following the Evans’ pioneering work of the chiral Lewis acid complex-catalyzed 
enantioselective decarboxylative Michael reactions, the potential of enantioselective 
decarboxylative Michael additions has been unraveled over past decades. Up to date, three 
different categories of catalysts have been employed to accomplish enantioselective 
decarboxylative Michael reactions.  
First, the asymmetric decarboxylative Michael addition has been accomplished by using 
Lewis acid catalysts, including Evans’ example.15d, 19 Subsequent to Evans’ study, the Shibasaki 
group reported a Ni/La complex (Ni/La/1Di/1Dii) catalyzed decarboxylative Michael reaction of 
MAHT 1-1d to nitroolefin 1-10 (Scheme 1.7a).19a To achieve the enantioselectivity, the 
dinucleating salan-type ligand 1Di was used to coordinate to both nickel and lanthanum. As a 
result, high yields and enantioselectivities were obtained with aryl nitroolefins, but the Michael 
reaction with alkyl nitroolefins provided moderated yields and enantioselectivities. The Shibasaki 
group was able to convert the Michael adduct to the optically active antidepressant (S)-rolipram in 
2 steps in 83% yield. In addition to the nickel and lanthanum complex, rhodium complexes have 
been employed in the decarboxylative Michael reactions. For instance, the Kang group 
demonstrated rhodium(III)-complex 1E catalyzed 1,4-additions of β-ketoacid 1-9 to α,β-
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unsaturated 2-acyl imidazole 1-13 (Scheme 1.7b). 19b,19c Unlike the previous examples where 
asymmetric induction relied on the chiral ligand in the Lewis acid catalyst, this work achieved the 
enantioselectivity through the chirality at the actual metal rhodium. The concept of chiral-at-metal 
complexes was firstly introduced by the Meggers group,20 and the Kang group successfully 
employed the chiral-at-metal Rh(III) complex 1E in an asymmetric decarboxylative addition 
reaction. The reaction was very efficient with only 1 mol% of Rh(III)-catalysts 1E to generate the 
desired Michael adduct 1-4 in 97% yield with 93% enantioselectivity. 
 
Scheme 1. 7. Lewis-acid catalyzed enantioselective decarboxylative Michael addition. a) 
Shibasaki’s example of Ni/La complex catalyzed MAHT to nitroolefins. b) Kang’s example of 
Rh complex catalyzed β-ketoacid to α,β-unsaturated imidazoles or pyridines. 
 
 
Next, the decarboxylative Michael reactions have been achieved using photoredox 
catalysis.21 The representative example of photo-catalyzed Michael reaction was carried out by the 
MacMillan group by using a Ir(III)-catalyst 1F as the photoredox catalyst (Scheme 1.8a).17  The 
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authors proposed that the acidic proton gets deprotonated by the base and the subsequent single-
electron oxidation of formed carboxylates is promoted by the visible-light excited photocatalyst. 
The resulting carboxyl radical fragments to lose CO2 to provide active SOMO species, which 
readily undergo conjugate addition with an electron-deficient olefin to form a new C-C bond. 
Inspired by these decarboxylative radical conjugate addition reactions, a carboxylic acid 1-15 and 
Michael acceptor 1-16 were coupled together to afford desired Michael products 1-17 in high 
yields. By utilizing the Michael adduct from these studies, MacMillan group was able to synthesize 
optically active pregabalin (Lyrica), an anticonvulsant discovered by Pfizer, in three steps.   
Inspired by Mariano’s and Wang’s work of photoredox catalyzed decarboxylative coupling 
of glyoxylic acid acetal to aryl and alkenyl electrophiles,21a Xu and coworkers developed another 
example of iridium-catalyzed photoredox decarboxylative Michael reaction.21b The Xu group 
employed the same Ir(III)-catalyst 1F as the MacMillan group, 17 and demonstrated that the 
catalyst was able to catalyze decarboxylative 1,4-additions of glyoxylic acid acetal 1-18 to the 
Michael acceptor 1-19 with irradiation to afford Michael adduct 1-20 in high yields (Scheme 1.8b). 
Lastly, a decarboxylative Michael reaction can also be carried out by chiral 
organocatalysts,3a, 22which resemble polyketide synthases. The organocatalysts have key diamine 
functionality in their structure, which mimics the active sites of a polyketide synthase. Among the 
examples of such organocatalyzed decarboxylative Michael reactions, the representative work is 
exemplified by the Wennemers group who developed the first chiral organocatalyzed 
enantioselective decarboxylative 1,4-addition of MAHT 1-1e to nitroalkene 1-10 (Scheme 1.9). 3a 
Wennemers employed the chiral Cinchona alkaloid-derived urea 1G as the catalyst to improve the 
reactivity and selectivity of these reactions. The bifunctional catalyst 1G can hydrogen-bond 
nitroolefin and deprotonated MAHT by the tertiary amine at the same time. 
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Scheme 1. 8. Photoredox Ir(III)-catalyst catalyzed decarboxylative Michael reaction. a) 
MacMillan’s decarboxylative radical conjugate addition. b) Xu’s decarboxylative 1,4 additions 










Following the Wennemers’ pioneering work, various chiral organocatalysts were designed 
for the enantioselective decarboxylative Michael reaction. For example, Kim group developed 
cinchonidine-derived chiral primary amine organocatalysts 1H, to promote enantioselective 1,4-
addition of β-ketoacid 1-9 to α,β-unsaturated ketones 1-21 (Scheme 1.10a).22a As a result, 
corresponding chiral 6-aryl-2,6-hexanedione 1-22 was generated efficiently. Subsequently, the Ma 
group described a glucose-derived chiral thiourea catalyst 1I catalyzed decarboxylative Michael 
addition of β-ketoacid 1-9 to dicyanoolefins 1-23a and disulfonylolefins 1-23b (Scheme 1.10b).22f 
The reaction featured wide substrate scope, and afforded the Michael adducts with high yields and 
enantioselectivities for both the dicyano substrates and the disufonyl substrates. One chiral adduct 
was converted to a synthetically valuable optically active fluorine-containing building blocks in 4 
steps (68% yield with 85% ee).  
Scheme 1. 10. Example of organocatalyzed enantioselective decarboxylative Michael reaction. 




These studies demonstrated the synthetic utility of decarboxylative Michael reactions. 
Different kinds of catalysts were successfully employed to perform 1,4-addition of carboxylic 
acid-containing compounds to various electrophilic olefin containing substrates. These reactions 
do, however, suffer from severe limitations posed by the high sensitivity of Michael reactions to 
the steric effects exhibited by the substituents on the enones and β-ketoacids. For example, the 
studies discussed above do not include examples of sterically hindered substrates, such as β,β′-
substituted Michael acceptors, due to their low reactivity. Intermolecular addition to β,β′-
substituted Michael acceptors is extremely rare23 and encountered mostly for the Mukaiyama 
Michael reactions.24 To address this problem, a new, more powerful, catalyst for the 
decarboxylative Michael reactions is needed. 
1.3 Cu(II)-catalyzed Michael reaction of β-ketoesters and enones 
Recently, our group demonstrated that Cu(II) complexes are among the most active 
catalysts for the Michael reaction of β-ketoesters and enones under solvent-free conditions. 25 This 
catalytic Cu(II) protocol26, 27, 28 enabled the unprecedented formation of highly strained Michael 
addition products containing vicinal quaternary/tertiary and quaternary /quaternary stereocenters23 
under atmospheric pressure (Scheme 1.11).25b A Cu(II)/ bis-oxazoline complex 1J efficiently 
promoted 1,4-additions of  β-ketoesters 1-26 to mono-β-substituted enone substrates 1-25 to afford 
the desired Michael adducts 1-27 with high yields, diastereoselectivies and enantioselectivities. 
The reaction was general in that different ring sizes of β-ketoesters and the wide range of 
substituents of β-position of enones were tolerated. Interestingly, Cu(II)-catalyst allowed 
successful addition of a β-ketoester to sterically hindered β,β′-substituted enones 1-27e and 1-27f 
in decent yield. Although low enantioselectivities were observed for these reactions (10 to 15% 
ee), this result was still remarkable considering how difficulty is the intermolecular addition to  
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Scheme 1. 11. Nagorny’s Cu(II)-complexes-catalyzed enantioselective Michael reaction.  
 
 
β,β′-enones. This indicated that Cu(II)-catalysts are exceptional promoters of the Michael reactions, 
and therefore, further development of Cu(II)-catalysts may improve the Michael reactions of 
sterically hindered substrates. 
Based on the enantioselective Cu(II)-catalyzed Michael reactions of β-ketoesters 1-26 and 
enones 1-25, the total synthesis of a cardiatonic steroid was carried out (Scheme 1.12). The 
Michael adducts 1-27 underwent intramolecular aldol reactions to form the cardiotonic steroid 
cores 1-28. The oxygenated steroid core 1-28 was further functionalized to afford several natural 






Scheme 1. 12. Nagorny’s enantioselective synthesis of oxygenated steroids via sequential 
copper(II)-catalyzed Michael addition/intramolecular aldol cyclization reactions. 
 
Based on these prior results, we envisioned that Cu(II) salts could promote decarboxylative 
Michael reactions of unreactive substrates to provide products that are typically inaccessible 
through the previously reported reactions of β-ketoacids. This chapter summarizes out studies that 
demonstrates for the first time that Cu(II) salts are unique catalysts for promoting the 
decarboxylative Michael reactions between β-ketoacids and enones, and the Michael adducts are 
directly cyclized to form functionalized cyclohexenones in situ. The enantioselective variant of 
this Robinson annulation reaction may also provide chiral cyclohexenones with vicinal tertiary 
centers. These aforementioned motifs are frequently present in natural products, but are 
challenging to construct as only few existing Robinson annulation methods could be used to 
efficiently and selectively install quaternary stereocenters.29 The utility of this protocol in natural 
product synthesis has been successfully demonstrated by accomplishing an expedient synthesis of 
the oxygenated 10-nor cardiotonic steroid skeleton in excellent yield and selectivity. 
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1.4 Initial optimization for decarboxylative Robinson annulation 
Our studies commenced with an investigation of the reaction between β-ketoacid 1-28a 
and mesityl oxide 1-29a (Table 1.1). Considering that the intermolecular addition to β,β′-enones 
such as 1-29a is not typical,23 we investigated various catalytic and stoichiometric promoters.26c 
Monitoring these reactions represents a challenge as multiple products are often observed. 
Interestingly, the preliminary screen identified that the Robinson annulation product 1-30a rather 
than the direct Michael addition product prevailed in the cases when productive reactions were 
observed. The Cu(OTf)2-catalyzed reaction resulted in the cleanest formation of 1-30a in 45% 
yield (entry 1). This yield was further improved by adding a solution of p-TSA in THF at the end 
of the reaction to facilitate the cyclization and dehydration of cyclic and acyclic products arising 
from the Michael reaction of 1-28a and 1-29a. Re-evaluation of the Lewis acid-catalyzed reactions 
under these modified conditions (entries 1-3, 7-13, Table 1.1) further allowed us to conclude that 
Cu(OTf)2 is an excellent and unique catalyst for the formation of 1-30a (entry 1, 83% yield). In 
addition, Fe(OTf)2 and Yb(OTf)3 were found to possess some activity, but this was significantly 
lower than for the Cu(OTf)2-catalyzed case (entries 10 and 11). The catalytic activity of Cu(OTf)2  
cannot be attributed solely to the in situ generation of triflic acid as it alone did not promote the 









Table 1. 1. Evaluation of the Catalysts for Decarboxylative Robinson Annulation. 
 
 
1.5 Decarboxylative Michael/aldol reaction with β,β′-enones to generate cyclohexenones 
with quaternary stereocenters 
With the catalyst and conditions developed, the scope of the decarboxylative Robinson 
annulation of β,β′-disubstituted enones to give cyclohexenones with quaternary stereocenters was 
next explored (Table 1.2, 1.3, and Scheme 1.4). Consistent with the observations made for the 
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reaction of 1-28a and 1-29a (vide supra), all of the reactions with β,β′-disubstituted enones 
provided mixtures of Michael adducts and cyclized products when treated with Cu(OTf)2 (20 
mol%) alone. However, clean formation of the cyclohexenones was observed if the Cu(II)-
catalyzed reactions were followed by in situ treatment with p-TSA (50 mol %) in THF. Thus, in 
accord with the results. 
 
Table 1. 2. Substrate scope 1 for the decarboxylative Michael reaction leading to formation of 
cyclohexenones with quaternary carbon.a 
 
 
obtained for mesityl oxide 1-29a, the reaction of (R)-(+)-pulegone 1-29b and 1-28a resulted in the 
unsaturated 2-decalone 1-30b in 57% yield (Table 1.2, entry 2). This transformation could tolerate 
modifications in the β-ketoacid, and in addition to 1-28a, β-ketoacids 1-28b (Table 1.3) and 1-28c 
(Scheme 1.3) were successfully employed to provide cyclohexenes 1-30c−1-30k in good to 
excellent yields. Finally, the reactions of 1-28b with a variety of β,β′-disubstituted enones (1-
29c−1-29j) indicated that this method tolerated changes in the β,β′-substitution pattern without a 
significant drop in the overall yield. In addition to β,β′-substitution pattern, this method also  
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Table 1. 3. Substrate scope 2 for the decarboxylative Michael reaction leading to formation of 




tolerated the steric hinderance for alpha to the ketone as 3-oxo-3-phenylpropanoic acid 1-28c gave 
the desired cyclohexene 1-30k (Scheme1.3). Importantly, this method provides quick, 
straightforward, and selective access to highly functionalized cyclohexenones that are not always 
readily accessible through other transformations such as metal-catalyzed alkyne insertion into 
cyclobutanones.30 
 
Scheme 1. 13. Decarboxylative Robinson annulation reaction of 1-28c and 1-29a. 
 
 
1.6 Enantioselective formation of cyclohexenones  
Our initial attempts to accomplish the enantioselective formation of cyclohexenones 1-30 
containing quaternary stereocenters by using the chiral bis(oxazoline)-based Cu(II) complexes 
such as 1J25a-d, 27, 28  (Scheme 1.4) were met with limited success as the reactions of β,β′-substituted 
2-en-1-ones 1-29 suffered from low conversion and enantioselectivity. However, the reactions of 
β-monosubstituted enones such as 1-32a proceeded with excellent yields and enantioselectivities 
(Table 1.4). Both racemic and enantioselective reactions of decarboxylative Robinson annulation 
of β-ketoacid 1-31 and enone 1-32a successfully carried out with Cu(OTf)2 and bis(oxazoline)-
based Cu(II) complexes 1J (Table 1.4a)  Thus, the annulation of 1-32a with reactive β-ketoacids 
1-31 lacking the C2-substitution resulted in the formation of chiral cyclohexenones 1-33a−1-33c 
in good yields and excellent enantioselectivities. In addition, the reaction of C2-substituted β-
ketoester 1-31d and 1-32a led to the formation of the synthetically valuable functionalized decalin 
1-33d (Table 1.4b). From the optimization studies, we found that the catalyst 1J at -10 oC provided  
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Table 1. 4. Reaction optimization of Cu(II)-catalyzed enantioselective decarboxylative Robinson 






the best result of a 4:1 mixture of diastereomers at C4 in 75% yield and 94% ee for both 
diastereomers (entry 5).  The formed diastereomers were found to be epimeric at the C4 position 
as a result of decarboxylation followed by a moderately selective protonation of the resultant enol. 
The summarized result of enantioselective copper-catalyzed decarboxylative robinson annulation 
of β-ketoacid 1-31 and enone 1-32a was described in scheme 1.14. 
Scheme 1. 14. Enantioselective copper-catalyzed decarboxylative Robinson annulation.a 
 
 
1.7 Synthesis of 10-nor-steroid core 
To further demonstrate the utility of this chemistry, the enantioselective decarboxylative 
Robinson annulation method was also successfully applied to the synthesis of 10-nor-steroid 1-
33e (Table 1.5). Based on our previous study,25a-d enone 1-32b was generated in two steps from 
the readily available starting materials. The achiral catalyst Cu(OTf)2 efficiently catalyze 
decarboxylative Robinson annulation of 1-32b with β-ketoacids 1-31d, resulting in formation of 
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10-nor-steroid 1-33e  in 80% yield with 7:1 d.r (entry 1). After the screening of various conditions 
of enantioselective decarboxylative Robinson annulation, catalyst 1J at -10 oC again was found to 
be the best condition for this reaction (entry 8). With this condition, upon decarboxylative 
Robinson annulation of 1-32b with β-ketoacids 1-31d, 10-nor-steroid 1-33e was directly obtained 
in 85% yield with 93% ee and 8:1 dr (1 g scale). The diastereomers arise at the C10 position as a 
result of decarboxylation/enol protonation, and the stereochemistry of the major diastereomer 1-
33e was assigned via X-ray crystallographic analysis. (Scheme 1.15) It is noteworthy that the 
skeleton present in 1-33e is commonly found in various natural 10-nor-cardiotonic steroids. 31 
 
Table 1. 5. Reaction optimization of Cu(II)-catalyzed enantioselective decarboxylative Robinson 







Scheme 1. 15. Synthesis of 10-nor-steroid core 1-33e. 
 
 
1.8 Plausible mechanism 
The plausible mechanism for the copper(II)-catalyzed decarboxylative Michael reaction is 
proposed in Figure 1.1. The enol form of β-ketoacids 1-31 is proposed to undergo chelation with 
Cu(II) complex 1J. The complexation to Cu(II) results in enhanced acidity of carboxylate, which 
is important for the activation of the enones 1-33 either by protonation or through hydrogen 
bonding. The activated enone 1-33 then undergoes a Michael reaction followed by a proton transfer 
with the enolized β-ketoacid. The Michael reaction is then followed by decarboxylation and aldol 
condensation leading to 1-33. This proposal is consistent with the mechanism for decarboxylative 
aldol addition by Shair and co-workers who proposed that the decarboxylation takes place after 
the reaction with electrophile.8-9 In the absence of enone, β-ketoacids were found to be stable when 
exposed to Cu(II) salts. This observation further confirms that decarboxylation takes place after 
the Michael addition step. It is also consistent with the observation that both diastereomers of 1-
33d are formed with identical enantiopurity, which implies that the enantiodetermining step 




Figure 1. 1. Proposed mechanisms of Cu(II)-catalyzed enantioselective decarboxylative 




In summary, a new single-pot protocol involving copper(II)-catalyzed decarboxylative 
Michael reaction between β-ketoacids and enones followed by in situ aldolization has been 
developed to achieve an expedient formation of highly functionalized chiral and achiral 
cyclohexenones. The achiral version of this Robinson annulation protocol features a previously 
unprecedented Michael reaction of β-ketoacids with sterically hindered β,β′-substituted enones and 
provides access to all carbon quaternary stereocenter-containing cyclohexenones (11 examples, 
43−83% yield). Copper(II) salts were discovered to be unique catalysts for these Michael reactions 
as the other Lewis and Brønsted acids evaluated in these studies were inferior to Cu(II) catalysts. 
A similar protocol could be applied to achieve the formation of cyclohexenes with vicinal tertiary 
centers. The later substrates were also formed asymmetrically using chiral bis(oxazoline) copper(II) 
complexes as the catalysts. This single-pot enantioselective Robinson annulation was used to 
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generate chiral cyclohexenones containing vicinal stereocenters (4 examples, 65− 85% yield, 
84−94% ee). In addition, this latter protocol was successfully applied to accomplish a single-pot 
enantioselective formation of an oxygenated 10-nor-steroid core from readily available starting 
materials in excellent yield and selectivity (85% yield, 93% ee, 8:1 dr).  
 
1.10 Experimental Information 
Methods and Reagents : 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used 
without further purification. Tetrahyrofuran (THF), dichloromethane (DCM) and diethyl ether 
(Et2O) were filtered through a column (Innovative Technology PS-MD-5) of activated alumina 
under nitrogen atmosphere. All reactions were carried out under an atmosphere of nitrogen in 
flame-or oven-dried glassware with magnetic stirring. Reactions were cooled using Neslab 
Cryocool CB-80 immersion cooler (0 to -60 °C) and Neslab Cryocool immersion cooler CC-100 
II, or via external cooling baths: ice water (0 °C), sodium chloride/ ice water (-10 °C), or dry 
ice/acetone (-78°C). Heating was achieved by use of a silicone bath with heating controlled by 
electronic contact thermometer. Deionized water was used in the preparation of all aqueous 
solutions and for all aqueous extractions. Solvents used for extraction and chromatography were 
ACS or HPLC grade. Purification of reactions mixtures was performed by flash column 
chromatography on SiO2 using SiliCycle SiliaFlash P60 (230-400 mesh). Diastereomeric ratios 
were determined by 1 H NMR analysis. Enantiomeric excess was determined by HPLC analysis 




All spectra were recorded on Varian vnmrs 700 (700 MHz), Varian vnmrs 500 (500 MHz), 
Varian MR400 (400 MHz), Varian Inova 500 (500 MHz) spectrometers and chemical shifts (δ) 
are reported in parts per million (ppm) and referenced to the 1H signal of the internal 
tetramethylsilane according to IUPAC recommendations. Data are reported as (br = broad, s = 
singlet, d = doublet, t = triplet, q = quartet, qn = quintet, sext = sextet, m = multiplet; coupling 
constant(S) in Hz; integration). High resolution mass spectra (HRMS) were recorded on 
MicromassAutoSpecUltima or VG (Micromass) 70-250-S Magnetic sector mass spectrometers in 
the University of Michigan mass spectrometry laboratory. Infrared (IR) spectra were recorded as 
thin films on NaCl plates on a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption peaks 
were reported in wavenumbers (cm-1).  
Synthesis of Michael Acceptors (β,β’-disubstituted vinyl ketones) 
Method A. ((E)-selective HWE reaction32, Weinreb amide synthesis,33 Grignard33)  
General Procedure: 
1) (E)-selective Horner–Wadsworth–Emmons reaction32 
Triethyl phosphonoacetate (1.0 eq), cesium carbonate (1.2 eq), and DBU (0.2 eq) were 
added and stirred in the flame dried reaction flask. After 10 min, a corresponding ketone (1.0 eq) 
was added to the reaction mixture. Then the reaction mixture was stirred in neat condition at 40 oC 
for 3 days under N2. After reaction complete, the reaction was quenched with water and the crude 
product was extracted with EtOAc two times. The organic extract was washed with brine, and 
27 
 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude mixture 
was purified by a flash column chromatography on SiO2 (100% hexanes) to afford mixture of (E) 
and (Z) isomers of vinyl ester. ((E)-isomer is the major isomer)  
2) Weinreb amide synthesis 
The (E)- and (Z)- mixtures of vinyl ester (1.0 eq), N,O-dimethylhydroxylamine 
hydrochloride (2.0 eq), and THF (0.4 M) were added in a flame dried flask. Then a solution of 
iPrMgCl (4.3 eq) in THF (0.1 M) was slowly added at 0 oC. The reaction mixture was stirred for 
30 mins at 0 oC, and after that, the reaction was quenched with NH4Cl. The crude product was 
extracted with EtOAc three times, and combined organic layers were washed with brine, and dried 
over MgSO4. After the crude mixture was concentrated in vacuo, it was purified by a column 
chromatography on SiO2 (6 : 1 / Hex : EtOAc). At this gradient, the (E)- and (Z)-isomers of 
Weinreb amides could be well separated, and (E) isomer was selectively moved forward. 
3) Grignard reaction 
At -30 oC, a solution of corresponding Grignard (R3MgBr) (1.3 eq) in THF was slowly 
added to a solution of Weinreb amide (1.0 eq) in THF (0.35 M). The reaction mixture was stirred 
at -10 oC for 30 min. After reaction completion, the reaction was quenched with the NH4Cl, and 
the crude mixture was extracted with EtOAc three times. The combined organic layers were 
washed with brined, dried over MgSO4, and concentrated in vacuo. The crude mixture was purified 
by column chromatography on SiO2 on SiO2 (4 : 1 / Hex : EtOAc) to afford vinyl ketone. 





Method B. (HWE reaction, Weinreb amide ketone synthesis, Grignard)33  
 
1) Horner–Wadsworth–Emmons reaction 
To a suspension of NaH (1.4 eq) in THF (1.3 M), a solution of ketone (1.0 eq) in THF (0.1 
M) was slowly added. The reaction mixture was stirred at room temp for 30 min, and 
corresponding ketone was added at 0 oC. Then the reaction mixture was stirred at room temp for 
17 h. After the reaction is completed, a solution of saturated NaHCO3 was added to the mixture, 
then the crude product was extracted with EtOAc three times and combined organic layers were 
washed with brine. The resulting crude mixture was concentrated in vacuo, and purified by column 
(100% hexanes) to afford (E) and (Z) isomeric mixture of vinyl ester.  
2) Weinreb amide synthesis : exactly same as the method A, 2). The (E) and (Z) isomers of 
Weinreb amide could be separated by the column chromatography on SiO2. 
3) Grignard recation : exactly same as the method A, 3). Reaction was performed only with 
(E)-isomer. 
 





A corresponding β-ketoester (1.0 eq) was added to 1.5 M NaOH (1.2 eq) solution, and the 
reaction mixture was stirred at room temp for 24 h. The reaction mixture was diluted with ice water, 
and acidified with 3N HCl to pH 2. Then solid KCl was added to the reaction mixture to saturation. 
The reaction mixture was extracted with EtOAc five times, and the combined organic layers were 
dried with Na2SO4. The resulting crude mixture was then concentrated in vacuo to afford β-
ketoacids without further separation (Caution! β-ketoacids could be subjected to self-
decarboxylation. Store them in a freezer). 




To a flame dried, N2 flushed 1 dram vial, a stir bar and β-ketoacids 1-28 (1.6 eq) was placed, 
and the reaction vial was taken to a glove box to add CuOTf (20 mol%). The closed vial was taken 
out from the glove box, and vinyl ketone 1-29 (1.0 eq) was added to the reaction mixture under N2 
flow. The reaction was left to stir at room temp for 12 h (or 3 days). After the reaction completed, 
pTSA (0.50 eq) and THF (0.1 M) was added to the reaction mixture. The reaction was stirred at 
room temp for overnight, and the reaction was quenched with NaHCO3. The crude mixture was 
extracted with DCM three times and the combined organic layers were washed with brine, dried 
over Na2SO4, and concentrated in vacuo. Crude material was purified by a flash column 
chromatography on SiO2 to afford 1-30. 
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(FYI: Since the reaction is performed under neat condition, the stirring might not be 
efficient. All of the used vinyl ketones were liquid, which is not always the case for β-ketoacids. 
For solid β-ketoacids, stirring might be problematic. However, the problem goes away as the 
reaction proceeds because β-ketoacids partially decarboxylate to provide liquid ketones, which 
would solubilize solid residue and thus improve the stirring.) 
 
3,5,5-trimethylcyclohex-2-en-1-one (1-30a) 
(Following the general procedure): β-ketoacids 1-28a (60 µL, 0.70 mmol, 1.6 eq), Cu(OTf)2 (31 
mg, 0.09 mmol, 20 mol%), vinyl ketone 1-29a (50 µL, 0.43 mmol, 1.0 eq), pTSA (37 mg, 0.22 
mmol, 0.50 eq), THF (4.3 mL, 0.1 M). The purification by the flash column chromatography on 
SiO2 (9 : 1 / Hex : EtOAc) afforded 1-30a (49 mg, 83 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 5.85 (s, 1H), 2.16 (s, 2H), 2.14 (s, 2H), 1.91 (s, 3H), 1.00 
(s, 6H). 13C NMR (175 MHz, Chloroform-d) δ 200.0, 160.5, 125.6, 50.8, 45.4, 33.6, 28.4, 24.6. 
IR (thin film, cm-1):2956, 2923, 2850, 1721, 1462. HRMS (ESI+) (m/z): [M+H]+ calcd for C9H14O 
139.1117, found 139.1123  
 
  (7R)-4,4,7-trimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (1-30b) 
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(Following the general procedure): β-ketoacids 1-28a (60 µL, 0.69 mmol, 1.6 eq), Cu(OTf)2 (31 
mg, 0.086 mmol, 20 mol%), vinyl ketone 1-29b (70 µL, 0.43 mmol, 1.0 eq), pTSA (37mg, 0.22 
mmol, 0.50 eq), THF (4.3 mL, 0.1 M). The purification by the flash column chromatography on 
SiO2 (100% hexanes) afforded 1-30b (50 mg, 57 %) as a clear yellow oil. 
1H NMR (500 MHz, Chloroform-d) δ 5.78 (s, 1H), 2.42 (m, 1H), 2.19 (q, 2H), 2.02 – 1.95 (m, 
2H), 1.89 – 1.81 (m, 2H), 1.60 – 1.50 (m, 1H), 1.30 (dd, J = 13.3, 3.5 Hz, 1H), 1.17 – 1.12 (m, 
1H), 1.03 (s, 3H), 0.98 (d, J = 6.5 Hz, 3H), 0.93 (s, 3H).13C NMR (175 MHz, Chloroform-d). δ 
200.2, 166.1, 122.7, 50.3, 49.2, 45.2, 35.6, 34.8, 34.8, 28.8, 28.2, 24.8, 22.5. IR (thin film, cm-1): 
2951, 2925, 2869, 1714, 1681, 1627, 1254, 730. HRMS (ESI+) (m/z): [M+H]+ calcd for C13H20O 
193.1592, found 193.1591.  
 
1,4,5-trimethyl-1,6-dihydro-[1,1'-biphenyl]-3(2H)-one (1-30c) 
(Following the general procedure): β-ketoacids 1-28b (46.4 mg, 0.40 mmol, 1.6 eq), Cu(OTf)2 (18 
mg, 0.05 mmol, 20 mol%), vinyl ketone 1-29c (40 µL, 0.25 mmol, 1.0 eq), pTSA (21.5 mg, 0.12 
mmol, 0.50 eq), THF (2.5 mL, 0.1 M). a flash column chromatography on SiO2 (9 : 1 / Hex : 
EtOAc) to afford 1-30c (28 mg, 53 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.34 – 7.27 (m, 4H), 7.20 (tt, J = 5.4, 2.1 Hz, 1H), 2.86 (m, 
2H), 2.66 – 2.55 (m, 2H), 1.94 (s, 3H), 1.73 (s, 3H), 1.33 (s, 3H). 13C NMR (175 MHz, 
Chloroform-d) δ 198.6, 152.5, 147.4, 130.8, 128.6, 126.4, 125.3, 49.8, 46.2, 39.8, 29.5, 21.8, 10.7. 
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IR (thin film, cm-1): 2947, 2924, 2868, 1711, 1660, 1639, 1444, 1072,1029, 763, 697 HRMS 
(ESI+) (m/z): [M+H]+ calcd for C15H18O 215.1436, found 215.1432.  
 
 
4-ethyl-1,5-dimethyl-1,6-dihydro-[1,1'-biphenyl]-3(2H)-one (1-30d)  
(Following the general procedure): β-ketoacids 1-28a (70 µL, 0.70 mmol, 1.6 eq), Cu(OTf)2 (31 
mg, 0.086 mmol, 20 mol%), vinyl ketone 1-29a (50 µL, 0.43 mmol, 1.0 eq), pTSA (37 mg, 2.15 
mmol, 5 eq), THF (4.3 mL, 0.1 M). The purification by the flash column chromatography on SiO2 
(9 : 1 / Hex : EtOAc) afforded 1-30d (42 mg, 43 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.33 – 7.28 (m, 4H), 7.22 – 7.18 (m, 1H), 2.90 (d, J = 15.9 
Hz, 1H), 2.82 (d, J = 17.7 Hz, 1H), 2.61 (dd, J = 16.4, 13.3 Hz, 2H), 2.32 – 2.17 (m, 2H), 1.74 (s, 
3H), 1.33 (s, 3H), 1.02 (t, J = 7.6 Hz, 3H) 13C NMR (175 MHz, Chloroform-d) δ 199.2, 157.6, 
147.5, 130.0, 128.6, 126.4, 125.3, 49.8, 44.0, 39.8, 29.2, 28.4, 11.4, 10.2. IR (thin film, cm-1): 
2965, 2927, 2873, 1713, 1659, 1638, 1496, 1444, 763, 698 HRMS (ESI+) (m/z): [M+H]+ calcd 






(Following the general procedure): β-ketoacids 1-28b (64 mg, 0.55 mmol, 1.6 eq), Cu(OTf)2 (25 
mg, 0.069 mmol, 20 mol%), vinyl ketone 1-29e (60 µL, 0.34 mmol, 1.0 eq), pTSA (30 mg, 0.17 
mmol, 0.50 eq), THF (3.4 mL, 0.1 M). The purification by the flash column chromatography on 
SiO2 (9 : 1 / Hex : EtOAc) afforded 1-30e (46.3 mg, 59 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.31 – 7.27 (m, 2H), 7.22 – 7.17 (m, 3H), 2.93 (dd, J = 15.9, 
1.8 Hz, 1H), 2.79 (d, J = 17.6 Hz, 1H), 2.67 – 2.61 (m, 2H), 1.93 (s, 3H), 1.73 – 1.70 (m, 2H), 1.69 
(s, 3H), 0.59 (t, J = 7.4 Hz, 3H). 13C NMR (175 MHz, Chloroform-d) δ 198.6, 152.4, 144.9, 131.2, 
128.4, 126.2, 126.2, 47.7, 44.5, 43.5, 35.1, 21.9, 10.7, 8.3. IR (thin film, cm-1): 2963, 2924, 2870, 
1714, 1661, 1637, 1496, 1457, 759, 695. HRMS (ESI+) (m/z): [M+H]+ calcd for C16H20O 




(Following the general procedure): β-ketoacids 1-28b (48.5 mg, 0.41 mmol, 1.6 eq), Cu(OTf)2 (20 
mg, 0.048 mmol, 20 mol%), vinyl ketone 1-29f (50 µL, 0.26 mmol, 1.0 eq), pTSA (22.4 mg, 0.13 
mmol, 0.50 eq), THF (2.6 mL, 0.1 M). The purification by the flash column chromatography on 
SiO2 (9 : 1 / Hex : EtOAc) afforded 1-30f (35 mg, 55 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.27 (m, 2H), 7.21 – 7.18 (m, 2H), 2.86 (dd, J = 15.9, 1.5 
Hz, 1H), 2.77 (d, J = 17.9 Hz, 1H), 2.63 – 2.56 (m, 2H), 1.93 (s, 3H), 1.72 (s, 3H), 1.31 (s, 3H). 
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13C NMR (175 MHz, Chloroform-d) δ 198.17, 152.17, 145.77, 132.19, 131.07, 128.71, 126.86, 
49.81, 46.13, 39.71, 29.70, 21.83, 10.72. IR (thin film, cm-1): 2956, 2921, 2852, 1712, 1660, 1634, 
1492, 1449, 1092, 1009, 821, 760, 711, 666, 626. HRMS (ESI+) (m/z): [M+H]+ calcd for 
C15H17OCl 249.1049, found 249.1043.  
 
4'-methoxy-1,4,5-trimethyl-1,6-dihydro-[1,1'-biphenyl]-3(2H)-one (1-30g) 
(Following the general procedure): β-ketoacids 1-28b (49 µL, 0.42 mmol, 1.6 eq), Cu(OTf)2 (19 
mg, 0.053 mmol, 20 mol%), vinyl ketone 1-29g (50 µL, 0.26 mmol, 1.0 eq), pTSA (22.6 mg, 0.13 
mmol, 0.50 eq), THF (2.6 mL, 0.1 M). The purification by the flash column chromatography on 
SiO2 (9 : 1 / Hex : EtOAc) afforded 1-30g (33 mg, 51 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.23 (t, J = 8.0 Hz, 1H), 6.89 – 6.85 (m, 1H), 6.82 (t, J = 
2.2 Hz, 1H), 6.76 – 6.73 (m, 1H), 3.79 (s, 3H), 2.88 (d, J = 15.8 Hz, 1H), 2.81 (d, J = 17.9 Hz, 
1H), 2.63 – 2.56 (m, 2H), 1.94 (s, 3H), 1.74 (s, 3H), 1.32 (s, 3H). 13C NMR (175 MHz, 
Chloroform-d) δ 198.5, 159.8, 152.4, 149.3, 130.8, 129.6, 117.8, 112.0, 111.0, 55.3, 49.9, 46.2, 
39.9, 29.3, 21.8, 10.7. IR (thin film, cm-1): 2959, 2926, 2833, 1708, 1661, 1601, 1582, 1429, 1376, 
1285, 1243, 1214, 1174, 1070, 868, 699. HRMS (ESI+) (m/z): [M+H]+ calcd for C16H20O2 





(Following the general procedure): β-ketoacids 1-28b (75 mg, 0.64 mmol, 1.6 eq), Cu(OTf)2  (30 
mg, 0.08 mmol, 20 mol%), vinyl ketone 1-29h (70 µL, 0.40 mmol, 1.0 eq), pTSA (34mg, 0.20 
mmol, 0.50 eq), THF (4.3 mL, 0.1 M). The purification by the flash column chromatography on 
SiO2 (9 : 1 / Hex : EtOAc) afforded 1-30h (35 mg, 60 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.18 – 7.16 (m, 2H), 7.11 (d, J = 8.1 Hz, 2H), 2.88 (d, J = 
15.9 Hz, 1H), 2.80 (d, J = 17.9 Hz, 1H), 2.59 (m, 2H), 2.31 (s, 3H), 1.93 (s, 3H), 1.73 (s, 3H), 1.31 
(s, 3H). 13C NMR (175 MHz, Chloroform-d). δ 198.7, 152.5, 144.4, 135.9, 130.8, 129.3, 125.2, 
49.9, 46.3, 39.5, 29.6, 21.9, 21.0, 10.7. IR (thin film, cm-1): ): 2948, 2923, 2865, 1731, 1662, 1514, 




(Following the general procedure): β-ketoacids 1-28b (50 mg, 0.43 mmol, 1.6 eq), Cu(OTf)2 (20 
mg, 0.054 mmol, 20 mol%), vinyl ketone 1-29i (50 µL, 0.27 mmol, 1.0 eq), pTSA (23.2 mg, 0.14 
mmol, 0.50 eq), THF (2.7 mL, 0.1 M). The purification by the flash column chromatography on 
SiO2 (9 : 1 / Hex : EtOAc) afforded 1-30i (40 mg, 62 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.28 (d, J = 7.6 Hz, 2H), 7.17 (dd, J = 20.1, 7.2 Hz, 3H), 
2.63 – 2.52 (m, 2H), 2.38 – 2.34 (m, 2H), 2.30 (d, J = 15.2 Hz, 1H)  2.21 (d, J = 18.0 Hz, 1H), 
1.90 (s, 3H), 1.78 (s, 3H), 1.65 – 1.60 (m, 2H), 1.06 (s, 3H). 13C NMR (175 MHz, Chloroform-d). 
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δ 199.20, 152.32, 142.54, 130.20, 128.56, 128.40, 125.96, 49.62, 45.50, 43.77, 35.65, 30.41, 24.99, 
21.79, 10.73. IR (thin film, cm-1): 2952, 2926, 2871, 1737, 1662, 1636, 1454, 721, 680. HRMS 
(ESI+) (m/z): [M+H]+ calcd for C17H22O 243.1749, found 243.1745.  
 
5-butyl-2,3,5-trimethylcyclohex-2-en-1-one (1-30j) 
(Large scale reaction. N2 filled balloon is needed in the system for storage of generated CO2.) 
 (Following the general procedure): β-ketoacids 1-28b (1.06 g, 9.13 mmol, 1.6 eq), Cu(OTf)2 (412 
mg, 1.142 mmol, 20 mol%), vinyl ketone 1-29j (0.8 mL, 5.71 mmol, 1.0 eq), pTSA (491.6 mg, 
2.86 mmol, 0.50 eq), THF (10 mL, 0.57 M). The purification by the flash column chromatography 
on SiO2 (9 : 1 / Hex : EtOAc) afforded 1-30j (770 mg, 70 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 2.31 – 2.26 (m, 2H), 2.21 (dd, J = 15.7, 1.3 Hz, 1H), 2.12 
(d, J = 18.0 Hz, 1H), 1.90 (s, 3H), 1.76 (s, 3H), 1.31 – 1.20 (m, 6H), 0.94 (s, 3H), 0.89 (t, J = 7.1 
Hz, 3H). 13C NMR (175 MHz, Chloroform-d) δ 199.7, 152.5, 130.1, 49.8, 45.5, 41.5, 35.4, 26.1, 
25.1, 23.5, 21.8, 14.2, 10.7. IR (thin film, cm-1): 2955, 2928, 2860, 1710, 1638, 1376, 1081, 720. 





 (Following the general procedure): β-ketoacids 1-28c (115 mg, 0.70 mmol, 1.6 eq), Cu(OTf)2 (31 
mg, 0.086 mmol, 20 mol%), vinyl ketone 1-29a (50 µL, 0.43 mmol, 1.0 eq), pTSA (0.37 mg, 0.22 
mmol, 0.50 eq), THF (4.3 mL, 0.1 M). The reaction was heated at 60 oC for 1d for the cyclization. 
The purification by the flash column chromatography on SiO2 (9 : 1 / Hex : EtOAc) afforded 1-
30k (70 mg, 82 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 7.56 – 7.51 (m, 2H), 7.41 (m, 3H), 6.42 (s, 1H), 2.65 (s, 
2H), 2.35 (s, 2H), 1.13 (s, 6H). 13C NMR (175 MHz, Chloroform-d) 200.3, 157.7, 139.2, 130.1, 
128.9, 126.3, 124.5, 51.1, 42.5, 33.9, 28.6. IR (thin film, cm-1): 2956, 2868, 1657, 1606, 1467, 
1361, 902, 754, 690. MS (ESI+) (m/z): [M+H]+ calcd for C14H16O 201.1279, found 201.1272.  
Copper(II)-catalyzed decarboxylative Robinson annulation resulting in vicinal tertiary 
stereocenters  
                           
General Procedure: 
Racemic reaction: To a flame dried, N2 flushed 1 dram vial, a stir bar and β-ketoacids 1-31 (1.6 
eq) was placed, and the reaction vial was taken to a glove box to add Cu(OTf)2 (20 mol%). The 
closed vial was taken out from the glove box, and vinyl ketone 1-32 (1.0 eq) and DCM (0.2 M) 
were added to the reaction mixture under N2 flow. The reaction was left to stir at rt for 5 h. After 
the reaction completed, pTSA (0.50 eq) and THF (0.1 M) was added to the reaction mixture. The 
reaction was stirred at rt for overnight, and the reaction was quenched with NaHCO3. The crude 
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mixture was extracted with DCM three times and the combined organic layers were washed with 
brine, dried over Na2SO4, and concentrated in vacuo. Crude material was purified by a flash 
column chromatography on SiO2 to afford 1-33.  
Enantioselective reaction: To a flame dried, N2 flushed 1 dram vial, a stir bar and β-ketoacids 1-
31 (1.6 eq) was placed, and the reaction vial was taken to a glove box to add (R,R) copper(II)-(Box) 
catalyst (10 mol%). The closed vial was taken out from the glove box, and vinyl ketone 1-32 (1.0 
eq) and DCM (0.2M) were added to the reaction mixture at -10 oC under N2 flow. The reaction 
was placed in the cryocool, which was set to -10 oC, and stirred at -10 oC for 1 (or 3) days. After 
the reaction completed, pTSA (0.50 eq) and THF (0.1 M) was added to the reaction mixture. The 
reaction was stirred at rt for overnight, and the reaction was quenched with NaHCO3. The crude 
mixture was extracted with DCM three times and the combined organic layers were washed with 
brine, dried over Na2SO4, and concentrated in vacuo. Crude material was purified by a flash 
column chromatography on SiO2 to afford 1-33. 
 
N1-((1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)-N3-((1S,2R)-2-hydroxy-2,3-dihydro-1H-
inden-1-yl)-2,2-dimethylmalonamide L1 and (4S,4'S)-2,2'-(propane-2,2-diyl)bis(4-phenyl-4,5-
dihydrooxazole) L3 were synthesized based on the known procedure.34 Bis((R)-4-phenyl-4,5-
dihydrooxazol-2-yl)methane L2 and (4R,4'R)-2,2'-(cyclopropane-1,1-diyl)bis(4-phenyl-4,5-






Racemic reaction (entry 1) (following the general procedure): β-ketoacids 1-31a (88.3 mg, 0.76 
mmol, 1.6 eq), Cu(OTf)2 (35 mg, 0.095 mmol, 20 mol%), vinyl ketone 1-32a (60 µL, 0.48 mmol, 
1.0 eq), DCM (2.3 mL, 0.2M), pTSA (41mg, 0.24 mmol, 0.50 eq), THF (4.7 mL, 0.1 M). Purified 
by a flash column chromatography on SiO2 (9 : 1 / Hex : EtOAc to 5 : 1 / Hex : EtOAc) to afford 
1-33a (49 mg, 58 %) as a colorless oil 
Enantioselective reaction (entry 2) (following the general procedure): β-ketoacids 1-31a (88.3 
mg, 0.761 mmol, 1.6 eq), (R,R) cyclopropane-substituted diphenyl bis-(oxazoline)-copper(II) 
catalyst (41.2 mg, 0.0476 mmol, 10 mol%), vinyl ketone 1-32a (60 µL, 0.476 mmol, 1.0 eq), DCM 
(2.3 mL, 0.2 M), reaction for 1 day, pTSA (41 mg, 0.238 mmol, 0.50 eq), THF (4.7 mL, 0.1 M), 
Purified by a flash column chromatography on SiO2 (9 : 1 / Hex : EtOAc to 5 : 1 / Hex : EtOAc) 
to afford 1-33a (55 mg, 65 %) as a colorless oil.  
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1H NMR (700 MHz, Chloroform-d) δ 5.86 (s, 1H), 2.47 (d, J = 12.1 Hz, 1H), 2.35 – 2.29 (m, 1H), 
2.23 (q, J = 7.5 Hz, 2H), 2.06 – 2.00 (m, 3H), 1.41 – 1.34 (m, 2H), 1.33 – 1.28 (m, J = 5.6, 4.6 Hz, 
4H), 1.10 (t, J = 7.4 Hz, 3H), 0.90 (t, 3H). 13C NMR (175 MHz, Chloroform-d) δ 200.6, 167.3, 
124.5, 44.0, 36.6, 35.6, 35.2, 31.0, 28.9, 22.9, 14.2, 11.4. IR (thin film, cm-1): 2955, 2922, 2857, 
1664, 1636, 1429, 1378, 1131, 1083, 714. HRMS (ESI+) (m/z): [M+H]+ calcd for C12H20O 
181.1592, found 181.1586 [α]D = -36.3 (c 0.9, CHCl3) Enantiopurity was determined to be 92% ee 
by chiral HPLC (DAICEL CHIRALPAK IA, 4.6 X 250 mm, hexanes/2-proponal = 99.5/0.5, flow 





Racemic reaction (entry 1) (following the general procedure): β-ketoacids 1-31b (66 mg, 0.507 
mmol, 1.6 eq), Cu(OTf)2 (23 mg, 0.0634 mmol, 20 mol%), vinyl ketone 1-32a (40 µL, 0.317 mmol, 
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1.0 eq), DCM (1.6 mL, 0.2M), pTSA (27mg, 0.159 mmol, 0.50 eq), THF (3.1 mL, 0.1 M). Purified 
by a flash column chromatography on SiO2 (10 : 1 / Hex : EtOAc to 5 : 1 / Hex : EtOAc) to afford 
1-33b (38 mg, 63 %) as a colorless oil 
Enantioselective reaction (entry 2) (following the general procedure): β-ketoacids 1-31b (66 mg, 
0.507 mmol, 1.6 eq), (R,R) cyclopropane-substituted diphenyl bis-(oxazoline)-copper(II) catalyst 
(27.5 mg, 0.032 mmol, 10 mol%), vinyl ketone 1-32a (40 µL, 0.317 mmol, 1.0 eq), DCM (1.6 mL, 
0.2M), reaction for 1 day, pTSA (27 mg, 0.16 mmol, 0.50 eq), THF (3.1 mL, 0.1 M), Purified by 
a flash column chromatography on SiO2 (10 : 1 / Hex : EtOAc to 5 : 1 / Hex : EtOAc) to afford 1-
33b (41 mg, 67 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 2.51 – 2.46 (m, 1H), 2.34 – 2.23 (m, 3H), 2.11 – 1.95 (m, 
3H), 1.93 (s, 3H), 1.30 (m, 6H), 0.90 (m, 6H). 13C NMR (175 MHz, Chloroform-d) δ 199.3, 154.2, 
137.0, 44.4, 39.7, 35.7, 34.5, 28.8, 22.9, 21.1, 18.5, 14.2, 13.6. IR (thin film, cm-1): 2957, 2926, 
2871, 2854, 1687, 1630, 1460, 1380, 980, 728, 650. HRMS (ESI+) (m/z): [M+H]+ calcd for 
C13H22O 195.1749, found 195.1743 [α]D = 50.1 (c 0.7, CHCl3) Enantiopurity was determined to 
be 91% ee by chiral HPLC (DAICEL CHIRALPAK IA, 4.6 X 250 mm, hexanes/2-proponal = 






 3-(tert-butyl)-5-butylcyclohex-2-en-1-one (1-33c) 
Racemic reaction (entry 1) (following the general procedure): β-ketoacids 1-31c (110 mg, 0.76 
mmol, 1.6 eq), Cu(OTf)2 (35 mg, 0.095 mmol, 20 mol%), vinyl ketone 1-32a (60 µL, 0.48 mmol, 
1.0 eq), DCM (2.3 mL, 0.2M), pTSA (41mg, 0.238 mmol, 0.50 eq), THF (4.7 mL, 0.1 M). The 
reaction was heated at 60 oC for 1 day for the cyclization. Purified by a flash column 
chromatography on SiO2 (10 : 1 / Hex : EtOAc to 5 : 1 / Hex : EtOAc) to afford 1-33c (62 mg, 
69 %) as a colorless oil 
Enantioselective reaction (entry 2) (following the general procedure): β-ketoacids 1-31c (110 
mg, 0.761 mmol, 1.6 eq), (R,R) cyclopropane-substituted diphenyl bis-(oxazoline)-copper(II) 
catalyst (41.2 mg, 0.048 mmol, 10 mol%), vinyl ketone 1-32a (60 µL, 0.48 mmol, 1.0 eq), DCM 
(2.3 mL, 0.2 M), reaction for 1 day, pTSA (41 mg, 0.24 mmol, 0.50 eq), THF (4.7 mL, 0.1 M). 
The reaction was heated at 60 oC for 1 day for the cyclization. Purified by a flash column 
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chromatography on SiO2 (10 : 1 / Hex : EtOAc to 5 : 1 / Hex : EtOAc) to afford 1-33c (66 mg, 
73 %) as a colorless oil. 
1H NMR (700 MHz, Chloroform-d) δ 5.94 (s, 1H), 2.51 – 2.46 (m, 2H), 2.05 – 1.94 (m, 3H), 1.41 
– 1.27 (m, 6H), 1.12 (s, 9H), 0.91 (t, J = 6.4 Hz, 3H).13C NMR (175 MHz, Chloroform-d) δ 201.33, 
173.1, 123.0, 44.0, 36.9, 35.7, 35.6, 32.8, 29.0, 28.4, 22.9, 14.2. IR (thin film, cm-1): 2956, 2928, 
2871, 1706, 1666, 1614, 1466, 1364, 890, 728. HRMS (ESI+) (m/z): [M+H]+ calcd for C14H24O 
209.1905, found 209.1902 [α]D = -6.87 (c 0.7, CHCl3) Enantiopurity was determined to be 84% ee 
by chiral HPLC (DAICEL CHIRALPAK IA, 4.6 X 250 mm, hexanes/2-proponal = 99/1, flow rate 




 4-butyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (1-33d) 
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Racemic reaction (entry 1) (following the general procedure):  β-ketoacids 1-31d (65 mg, 0.46 
mmol, 1.6 eq), Cu(OTf)2 (21 mg, 0.058 mmol, 20 mol%), vinyl ketone 1-32a (37 µL, 0.29 mmol, 
1.0 eq), DCM (1.45 mL, 0.2 M), pTSA (24.8 mg, 0.14 mmol, 0.50 eq), THF (2.9 mL, 0.1 M). 
Purified by a flash column chromatography on SiO2 (8 : 1 to 3 : 1 / Hex : EtOAc) to afford 1-33d 
(50 mg, 85%) as a colorless oil. 
The most optimized enantioselective reaction (entry 5) (following the general procedure): β-
ketoacids 1-31d (65 mg, 0.460 mmol, 1.6 eq), (R,R) cyclopropane-substituted diphenyl bis-
(oxazoline)-copper(II) catalyst (24 mg, 0.029 mmol, 10 mol%), vinyl ketone 1-32a (37 µL, 0.29 
mmol, 1.0 eq), DCM (1.45 mL, 0.2 M), reaction for 1 day, pTSA (24.8mg, 0.14 mmol, 0.50 eq), 
THF (2.9 mL, 0.1 M). Purified by a flash column chromatography on SiO2 (8 : 1 to 3 : 1 / Hex : 
EtOAc) to afford 1-33d (44 mg, 75 %) as a colorless oil. 
Major diastereomer (Trans stereochemistry was assigned based on 3J (H4-H5) = 12 Hz) 
1H NMR (700 MHz, Chloroform-d) δ 5.80 (s, 1H), 2.49 – 2.43 (m, 2H), 2.21 – 2.15 (m, 2H), 2.09 
(dd, J = 15.8, 11.6 Hz, 1H), 2.02 (dt, J = 12.4, 6.4 Hz, 1H), 1.91 (ddt, J = 12.6, 4.9, 2.4 Hz, 1H), 
1.89 – 1.85 (m, 1H), 1.74 – 1.69 (ddp, J = 12.0, 8.2, 4.1 Hz, 1H), 1.47 (dt, J = 13.1, 3.4 Hz, 1H), 
1.42 – 1.32 (m, 3H), 1.32 – 1.25 (m, 3H), 1.23 – 1.17 (m, 1H), 1.13 (qd, J = 12.9, 3.6 Hz, 1H), 
0.89 (t, J = 7.2 Hz, 3H). 13C NMR (175 MHz, Chloroform-d) δ 200.38, 166.98, 123.98, 43.63, 
41.83, 39.82, 36.33, 32.98, 32.86, 28.73, 27.39, 26.00, 22.96, 14.16. IR (thin film, cm-1): 2951, 
2924, 2868, 1768, 1715, 1673, 1453, 943, 861, 736 HRMS (ESI+) (m/z): [M+H]+ calcd for 
C14H22O 207.1749, found 207.1741. Enantiopurity was determined to be 94% ee by chiral HPLC 
(DAICEL CHIRALPAK IA, 4.6 X 250 mm, hexanes/2-proponal = 99/1, flow rate = 1 mL/min, λ 
= 242.0 nm, RT(minor) = 18.3 min, RT(major) = 12.4 min). 
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Racemic reaction (entry 1): To a flame dried, N2 flushed 1 dram vial, a stir bar, β-ketoacids 1-
31d (65.5 mg, 0.46 mmol, 1.6 eq), and vinyl ketone 1-32b25b (60 mg, 0.29 mmol, 1.0 eq) were 
placed, and the reaction vial was taken to a glove box to add Cu(OTf)2 (21 mg, 0.058 mmol, 20 
mol%). The closed vial was taken out from the glove box, and DCM (1.4 mL, 0.2 M) were added 
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to the reaction mixture at room temp under N2 flow. The reaction was left stirring at rt for 5 h. 
After the reaction completed, pTSA (24.8 mg, 0.14 mmol, 0.50 eq) and THF (2.9 mL, 0.1 M) was 
added to the reaction mixture. The reaction was stirred at 40 oC for overnight, and the reaction was 
quenched with NaHCO3. The crude mixture was extracted with DCM three times and the 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo. 
Crude material was purified by a flash column chromatography on SiO2 (5 : 1 to 3 : 1 / Hex : 
EtOAc) to afford 1-33e (66 mg, 80 %) as a white solid. 
The most optimized enantioselective reaction (entry 8) To a flame dried, N2 flushed 1 dram vial, 
a stir bar, β-ketoacids 1-31d (956 mg, 6.73 mmol, 1.6 eq), and vinyl ketone 1-32b (1.0 g, 4.81 
mmol, 1.0 eq) were placed, and the reaction vial was taken to a glove box to add (R,R) 
cyclopropane-substituted diphenyl bis-(oxazoline)-copper(II) catalyst (416 mg, 0.48 mmol, 10 
mol%). The closed vial was taken out from the glove box, and DCM (24 mL, 0.2 M) were added 
to the reaction mixture at -10 oC under N2 flow. The reaction was placed in the cryocool, which 
was set to -10 oC, and stirred at -10 oC for 3 days. After the reaction completed, pTSA (413 mg, 
2.41 mmol, 0.50 eq) and THF (24 mL, 0.2 M) was added to the reaction mixture. The reaction was 
stirred at 40 oC for overnight, and the reaction was quenched with NaHCO3. The crude mixture 
was extracted with DCM three times and the combined organic layers were washed with brine, 
dried over Na2SO4, and concentrated in vacuo. Crude material was purified by a flash column 
chromatography on SiO2 (5 : 1 to 3 : 1 / Hex : EtOAc) to afford 1-33e (1.1 g, 85 %) as a white 
solid. 
IR (thin film, cm-1): 3455, 2938, 2858, 1739, 1669, 1640, 1447, 1141, 1047, 984, 959, 856, 635 
HRMS (ESI+) (m/z): [M+H]+ calcd for C18H24O3 289.1804, found 289.1802. 
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Major diastereomer: 1H NMR (700 MHz, Chloroform-d) δ 5.85 (s, 1H), 4.46 (s, 1H), 2.56 – 
2.46 (m, 2H), 2.41 – 2.35 (m, 2H), 2.25 (ddd, J = 12.1, 5.6, 2.5 Hz, 1H), 2.22 – 2.16 (m, 2H), 2.14 
– 2.07 (m, 2H), 1.98 – 1.94 (m, 1H), 1.93 – 1.86 (m, 2H), 1.70 – 1.62 (m, 1H), 1.51 – 1.30 (m, 
6H), 1.09 (s, 3H), 1.04 (qd, J = 12.9, 3.5 Hz, 1H). 13C NMR (175 MHz, Chloroform-d) δ 220.39, 
201.98, 167.50, 125.14, 80.2, 53.19, 52.22, 43.64, 41.94, 35.61, 32.94, 32.11, 31.23, 27.91, 26.38, 
25.41, 25.38, 12.84. [α]D = -38.4 (c 0.34, MeOH). 
Minor diastereomer: 1H NMR (700 MHz, Chloroform-d) δ 5.85 (s, 1H), 4.55 (s, 1H), 2.52 (dt, 
J = 19.6, 9.9 Hz, 1H), 2.46 – 2.42 (m, 1H), 2.41 – 2.37 (m, 2H), 2.32 – 2.28 (m, 1H), 2.24 – 2.15 
(m, 2H), 2.13 (dd, J = 9.7, 2.4 Hz, 2H), 2.10 – 2.03 (m, 2H), 1.97 – 1.92 (m, 1H), 1.65 – 1.60 (m, 
1H), 1.51 – 1.47 (m, 2H), 1.45 – 1.40 (m, 2H), 1.39 – 1.37 (m, 2H), 1.09 (s, 3H). 13C NMR (175 
MHz, Chloroform-d) δ 220.40, 202.30, 171.80, 122.85, 47.87, 43.79, 38.03, 37.66, 33.00, 31.21, 
30.59, 29.01, 27.92, 26.33, 24.29, 13.00. [α]D = -55.5 (c 0.16, MeOH) Enantiopurity was 
determined to be 93% ee by chiral HPLC (DAICEL CHIRALPAK IA, 4.6 X 250 mm, hexanes/2-
proponal = 80/20, flow rate = 1 mL/min, λ = 242.0 nm, RT(major) = 10.3 min, RT(minor) = 35.2 
min). 
Structure Determination of 1-33e by X-ray crystallography. 
 Colorless needles of 1-33e were grown from a diethyl ether solution of the compound at  
-10 deg. C.  A crystal of dimensions 0.24 x 0.06 x 0.03 mm was mounted on a Rigaku AFC10K 
Saturn 944+ CCD-based X-ray diffractometer equipped with a low temperature device and 
Micromax-007HF Cu-target micro-focus rotating anode ( = 1.54187 A) operated at 1.2 kW power 
(40 kV, 30 mA).  The X-ray intensities were measured at 85(1) K with the detector placed at a 
distance 42.00 mm from the crystal.  A total of 2028 images were collected with an oscillation 
width of 1.0 in   The exposure times were 1 sec. for the low angle images, 3 sec. for high angle.  
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Rigaku d*trek images were exported to CrysAlisPro for processing and corrected for absorption.  
The integration of the data yielded a total of 22575 reflections to a maximum 2 value of 138.70 
of which 2743 were independent and 2706 were greater than 2(I).  The final cell constants (Table 
1) were based on the xyz centroids of 15492 reflections above 10(I).  Analysis of the data showed 
negligible decay during data collection.  The structure was solved and refined with the Bruker 
SHELXTL (version 2016/6) software package, using the space group P2(1)2(1)2(1) with Z = 4 for 
the formula C18H24O3.  All non-hydrogen atoms were refined anisotropically with the hydrogen 
atoms placed in a combination of idealized and refined positions.  Full matrix least-squares 
refinement based on F2 converged at R1 = 0.0327 and wR2 = 0.0833 [based on I > 2sigma(I)], R1 
= 0.0333 and wR2 = 0.0847 for all data.  Additional details are presented in Table 1 and are given 
as Supporting Information in a CIF file.  Acknowledgement is made for funding from NSF grant 
CHE-0840456 for X-ray instrumentation. 
 
      Table 1.10.1.  Crystal data and structure refinement for 1-33e.  
      Identification code               1-33e  
      Empirical formula                 C18 H24 O3  
      Formula weight                    288.37  
      Temperature                       85(2) K  
      Wavelength                        1.54184 A  
      Crystal system, space group       Orthorhombic,  P2(1)2(1)2(1)  
      Unit cell dimensions              a = 6.18680(10) A   alpha = 90 deg.  
                                        b = 12.45830(10) A    beta = 90 deg.  
                                        c = 19.1309(3) A   gamma = 90 deg.  
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      Volume                            1474.55(4) A^3  
      Z, Calculated density             4,  1.299 Mg/m^3  
      Absorption coefficient            0.691 mm^-1  
      F(000)                            624  
      Crystal size                      0.240 x 0.060 x 0.030 mm  
      Theta range for data collection   4.235 to 69.349 deg.  
      Limiting indices                  -7<=h<=7, -14<=k<=15, -23<=l<=22  
      Reflections collected / unique    22575 / 2743 [R(int) = 0.0668]  
      Completeness to theta = 67.684    100.0 %  
      Absorption correction             Semi-empirical from equivalents  
      Max. and min. transmission        1.00000 and 0.85056  
      Refinement method                 Full-matrix least-squares on F^2  
      Data / restraints / parameters    2743 / 0 / 196  
      Goodness-of-fit on F^2            1.068  
      Final R indices [I>2sigma(I)]     R1 = 0.0327, wR2 = 0.0833  
      R indices (all data)              R1 = 0.0333, wR2 = 0.0847  
      Absolute structure parameter      0.22(11)  
      Extinction coefficient            0.0051(8)  
      Largest diff. peak and hole       0.175 and -0.199 e.A^-3  
Table 1.10.2.  Atomic coordinates ( x 10^4) and equivalent isotropic displacement parameters 
(A^2 x 10^3) for 1-33e.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
         ________________________________________________________________  
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                         x             y             z           U(eq)  
         ________________________________________________________________  
   
          O(1)         1401(2)       8491(1)       8424(1)       30(1)  
          O(2)         6363(2)       8256(1)       7292(1)       30(1)  
          O(3)         7681(2)       8059(1)       5926(1)       32(1)  
          C(1)         2063(3)       8326(2)       7836(1)       23(1)  
          C(2)         1938(3)       9101(2)       7228(1)       25(1)  
          C(3)         3118(3)       8544(1)       6619(1)       23(1)  
          C(4)         4563(3)       7703(2)       6982(1)       20(1)  
          C(5)         5394(3)       6784(1)       6521(1)       19(1)  
          C(6)         6862(3)       7156(2)       5932(1)       22(1)  
          C(7)         7391(3)       6360(2)       5401(1)       23(1)  
          C(8)         6436(3)       5389(2)       5377(1)       20(1)  
          C(9)         7245(3)       4513(2)       4902(1)       24(1)  
          C(10)        5425(3)       3970(2)       4487(1)       26(1)  
          C(11)        3676(3)       3585(2)       4986(1)       25(1)  
          C(12)        2788(3)       4518(2)       5414(1)       24(1)  
          C(13)        4555(3)       5094(1)       5841(1)       19(1)  
          C(14)        3599(3)       6049(1)       6244(1)       19(1)  
          C(15)        2176(3)       5662(1)       6851(1)       24(1)  
          C(16)        1333(3)       6582(1)       7304(1)       23(1)  
          C(17)        3169(3)       7295(2)       7594(1)       22(1)  
51 
 
          C(18)        4407(4)       6745(2)       8181(1)       33(1)  
         ________________________________________________________________  
           Table 1.10.3.  Bond lengths [A] and angles [deg] for 1-33e.  
           _____________________________________________________________  
   
            O(1)-C(1)                     1.215(2)  
            O(2)-C(4)                     1.438(2)  
            O(2)-H(2)                     0.93(4)  
            O(3)-C(6)                     1.234(2)  
            C(1)-C(2)                     1.513(3)  
            C(1)-C(17)                    1.527(2)  
            C(2)-C(3)                     1.540(3)  
            C(2)-H(2A)                    0.9900  
            C(2)-H(2B)                    0.9900  
            C(3)-C(4)                     1.543(3)  
            C(3)-H(3A)                    0.9900  
            C(3)-H(3B)                    0.9900  
            C(4)-C(5)                     1.534(2)  
            C(4)-C(17)                    1.540(3)  
            C(5)-C(6)                     1.520(3)  
            C(5)-C(14)                    1.534(2)  
            C(5)-H(5)                     1.0000  
            C(6)-C(7)                     1.456(3)  
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            C(7)-C(8)                     1.347(3)  
            C(7)-H(7)                     0.9500  
            C(8)-C(9)                     1.506(2)  
            C(8)-C(13)                    1.509(2)  
            C(9)-C(10)                    1.534(3)  
            C(9)-H(9A)                    0.9900  
            C(9)-H(9B)                    0.9900  
            C(10)-C(11)                   1.520(3)  
            C(10)-H(10A)                  0.9900  
            C(10)-H(10B)                  0.9900  
            C(11)-C(12)                   1.524(3)  
            C(11)-H(11A)                  0.9900  
            C(11)-H(11B)                  0.9900  
            C(12)-C(13)                   1.542(2)  
            C(12)-H(12A)                  0.9900  
            C(12)-H(12B)                  0.9900  
            C(13)-C(14)                   1.536(2)  
            C(13)-H(13)                   1.0000  
            C(14)-C(15)                   1.534(2)  
            C(14)-H(14)                   1.0000  
            C(15)-C(16)                   1.527(3)  
            C(15)-H(15A)                  0.9900  
            C(15)-H(15B)                  0.9900  
53 
 
            C(16)-C(17)                   1.546(3)  
            C(16)-H(16A)                  0.9900  
            C(16)-H(16B)                  0.9900  
            C(17)-C(18)                   1.522(3)  
            C(18)-H(18A)                  0.9800  
            C(18)-H(18B)                  0.9800  
            C(18)-H(18C)                  0.9800  
   
            C(4)-O(2)-H(2)              104(2)  
            O(1)-C(1)-C(2)              125.97(17)  
            O(1)-C(1)-C(17)             124.96(18)  
            C(2)-C(1)-C(17)             109.07(15)  
            C(1)-C(2)-C(3)              105.67(15)  
            C(1)-C(2)-H(2A)             110.6  
            C(3)-C(2)-H(2A)             110.6  
            C(1)-C(2)-H(2B)             110.6  
            C(3)-C(2)-H(2B)             110.6  
            H(2A)-C(2)-H(2B)            108.7  
            C(2)-C(3)-C(4)              103.86(14)  
            C(2)-C(3)-H(3A)             111.0  
            C(4)-C(3)-H(3A)             111.0  
            C(2)-C(3)-H(3B)             111.0  
            C(4)-C(3)-H(3B)             111.0  
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            H(3A)-C(3)-H(3B)            109.0  
            O(2)-C(4)-C(5)              109.61(15)  
            O(2)-C(4)-C(17)             106.19(15)  
            C(5)-C(4)-C(17)             112.25(15)  
            O(2)-C(4)-C(3)              108.02(15)  
            C(5)-C(4)-C(3)              116.19(15)  
            C(17)-C(4)-C(3)             103.99(14)  
            C(6)-C(5)-C(14)             111.03(14)  
            C(6)-C(5)-C(4)              113.58(15)  
            C(14)-C(5)-C(4)             113.69(15)  
            C(6)-C(5)-H(5)              105.9  
            C(14)-C(5)-H(5)             105.9  
            C(4)-C(5)-H(5)              105.9  
            O(3)-C(6)-C(7)              121.50(17)  
            O(3)-C(6)-C(5)              121.96(17)  
            C(7)-C(6)-C(5)              116.36(16)  
            C(8)-C(7)-C(6)              122.46(17)  
            C(8)-C(7)-H(7)              118.8  
            C(6)-C(7)-H(7)              118.8  
            C(7)-C(8)-C(9)              121.71(16)  
            C(7)-C(8)-C(13)             122.46(16)  
            C(9)-C(8)-C(13)             115.79(16)  
            C(8)-C(9)-C(10)             112.82(16)  
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            C(8)-C(9)-H(9A)             109.0  
            C(10)-C(9)-H(9A)            109.0  
            C(8)-C(9)-H(9B)             109.0  
            C(10)-C(9)-H(9B)            109.0  
            H(9A)-C(9)-H(9B)            107.8  
            C(11)-C(10)-C(9)            109.66(15)  
            C(11)-C(10)-H(10A)          109.7  
            C(9)-C(10)-H(10A)           109.7  
            C(11)-C(10)-H(10B)          109.7  
            C(9)-C(10)-H(10B)           109.7  
            H(10A)-C(10)-H(10B)         108.2  
            C(10)-C(11)-C(12)           110.69(15)  
            C(10)-C(11)-H(11A)          109.5  
            C(12)-C(11)-H(11A)          109.5  
            C(10)-C(11)-H(11B)          109.5  
            C(12)-C(11)-H(11B)          109.5  
            H(11A)-C(11)-H(11B)         108.1  
            C(11)-C(12)-C(13)           112.60(16)  
            C(11)-C(12)-H(12A)          109.1  
            C(13)-C(12)-H(12A)          109.1  
            C(11)-C(12)-H(12B)          109.1  
            C(13)-C(12)-H(12B)          109.1  
            H(12A)-C(12)-H(12B)         107.8  
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            C(8)-C(13)-C(14)            113.79(15)  
            C(8)-C(13)-C(12)            110.37(15)  
            C(14)-C(13)-C(12)           110.70(15)  
            C(8)-C(13)-H(13)            107.2  
            C(14)-C(13)-H(13)           107.2  
            C(12)-C(13)-H(13)           107.2  
            C(5)-C(14)-C(15)            110.03(15)  
            C(5)-C(14)-C(13)            110.93(15)  
            C(15)-C(14)-C(13)           110.94(14)  
            C(5)-C(14)-H(14)            108.3  
            C(15)-C(14)-H(14)           108.3  
            C(13)-C(14)-H(14)           108.3  
            C(16)-C(15)-C(14)           112.91(14)  
            C(16)-C(15)-H(15A)          109.0  
            C(14)-C(15)-H(15A)          109.0  
            C(16)-C(15)-H(15B)          109.0  
            C(14)-C(15)-H(15B)          109.0  
            H(15A)-C(15)-H(15B)         107.8  
            C(15)-C(16)-C(17)           112.60(16)  
            C(15)-C(16)-H(16A)          109.1  
            C(17)-C(16)-H(16A)          109.1  
            C(15)-C(16)-H(16B)          109.1  
            C(17)-C(16)-H(16B)          109.1  
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            H(16A)-C(16)-H(16B)         107.8  
            C(18)-C(17)-C(1)            112.37(15)  
            C(18)-C(17)-C(4)            115.28(16)  
            C(1)-C(17)-C(4)             101.73(15)  
            C(18)-C(17)-C(16)           112.11(17)  
            C(1)-C(17)-C(16)            105.28(15)  
            C(4)-C(17)-C(16)            109.16(14)  
            C(17)-C(18)-H(18A)          109.5  
            C(17)-C(18)-H(18B)          109.5  
            H(18A)-C(18)-H(18B)         109.5  
            C(17)-C(18)-H(18C)          109.5  
            H(18A)-C(18)-H(18C)         109.5  
            H(18B)-C(18)-H(18C)         109.5  
           _____________________________________________________________  
           Symmetry transformations used to generate equivalent atoms:  




    Table 1.10.4.  Anisotropic displacement parameters (A^2 x 10^3) for 1-33e.  
    The anisotropic displacement factor exponent takes the form:  
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    O(1)     31(1)      32(1)      26(1)     -10(1)       2(1)       6(1)  
    O(2)     21(1)      32(1)      38(1)     -16(1)      -3(1)      -3(1)  
    O(3)     32(1)      23(1)      41(1)      -4(1)      10(1)      -9(1)  
    C(1)     20(1)      22(1)      27(1)      -7(1)      -4(1)       0(1)  
    C(2)     24(1)      16(1)      35(1)      -3(1)       1(1)       0(1)  
    C(3)     27(1)      16(1)      27(1)       2(1)       1(1)       0(1)  
    C(4)     19(1)      18(1)      23(1)      -3(1)      -2(1)      -2(1)  
    C(5)     21(1)      17(1)      19(1)      -1(1)      -1(1)      -1(1)  
    C(6)     21(1)      21(1)      23(1)       1(1)      -1(1)      -1(1)  
    C(7)     24(1)      26(1)      18(1)       2(1)       1(1)      -2(1)  
    C(8)     21(1)      23(1)      16(1)       1(1)      -2(1)       1(1)  
    C(9)     25(1)      26(1)      20(1)      -3(1)       2(1)       0(1)  
    C(10)    32(1)      27(1)      19(1)      -5(1)      -1(1)       0(1)  
    C(11)    30(1)      21(1)      24(1)      -5(1)      -2(1)      -4(1)  
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    C(12)    25(1)      22(1)      24(1)      -4(1)      -1(1)      -4(1)  
    C(13)    21(1)      16(1)      19(1)      -1(1)       0(1)      -2(1)  
    C(14)    22(1)      16(1)      18(1)       0(1)       0(1)      -2(1)  
    C(15)    30(1)      17(1)      25(1)      -1(1)       7(1)      -3(1)  
    C(16)    28(1)      17(1)      24(1)       1(1)       6(1)      -3(1)  
    C(17)    25(1)      21(1)      19(1)      -2(1)       0(1)       4(1)  
    C(18)    40(1)      40(1)      19(1)       1(1)      -1(1)      17(1)  
    _______________________________________________________________________  
 
      Table 1.10.5.  Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 
10^3) for 1-33e.  
         ________________________________________________________________  
                         x             y             z           U(eq)  
         ________________________________________________________________  
   
          H(2)         7170(60)      8480(30)      6909(17)      67(10)  
          H(2A)        2653          9788          7347          30  
          H(2B)         414          9248          7103          30  
          H(3A)        4000          9064          6351          28  
          H(3B)        2076          8195          6298          28  
          H(5)         6311          6326          6831          23  
          H(7)         8448          6532          5059          27  
          H(9A)        8001          3964          5185          29  
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          H(9B)        8305          4821          4570          29  
          H(10A)       4801          4486          4149          31  
          H(10B)       6012          3353          4222          31  
          H(11A)       4283          3035          5304          30  
          H(11B)       2488          3251          4716          30  
          H(12A)       1665          4245          5737          29  
          H(12B)       2096          5041          5096          29  
          H(13)        5103          4570          6196          22  
          H(14)        2677          6473          5916          23  
          H(15A)        931          5259          6659          29  
          H(15B)       3023          5165          7147          29  
          H(16A)        498          6280          7699          27  
          H(16B)        340          7030          7022          27  
          H(18A)       5650          7188          8314          50  
          H(18B)       4915          6042          8021          50  
          H(18C)       3454          6652          8586          50  
         ________________________________________________________________  
 
         Table 1.10.6.  Torsion angles [deg] for 1-33e.  
         ________________________________________________________________  
   
          O(1)-C(1)-C(2)-C(3)                                 176.52(18)  
          C(17)-C(1)-C(2)-C(3)                                 -3.3(2)  
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          C(1)-C(2)-C(3)-C(4)                                 -20.85(19)  
          C(2)-C(3)-C(4)-O(2)                                 -75.25(18)  
          C(2)-C(3)-C(4)-C(5)                                 161.16(15)  
          C(2)-C(3)-C(4)-C(17)                                 37.28(17)  
          O(2)-C(4)-C(5)-C(6)                                 -59.6(2)  
          C(17)-C(4)-C(5)-C(6)                               -177.32(15)  
          C(3)-C(4)-C(5)-C(6)                                  63.2(2)  
          O(2)-C(4)-C(5)-C(14)                                172.17(15)  
          C(17)-C(4)-C(5)-C(14)                                54.4(2)  
          C(3)-C(4)-C(5)-C(14)                                -65.1(2)  
          C(14)-C(5)-C(6)-O(3)                                145.09(18)  
          C(4)-C(5)-C(6)-O(3)                                  15.5(2)  
          C(14)-C(5)-C(6)-C(7)                                -39.7(2)  
          C(4)-C(5)-C(6)-C(7)                                -169.26(15)  
          O(3)-C(6)-C(7)-C(8)                                -176.66(18)  
          C(5)-C(6)-C(7)-C(8)                                   8.1(3)  
          C(6)-C(7)-C(8)-C(9)                                -169.99(17)  
          C(6)-C(7)-C(8)-C(13)                                  7.6(3)  
          C(7)-C(8)-C(9)-C(10)                               -132.61(19)  
          C(13)-C(8)-C(9)-C(10)                                49.6(2)  
          C(8)-C(9)-C(10)-C(11)                               -53.4(2)  
          C(9)-C(10)-C(11)-C(12)                               57.9(2)  
          C(10)-C(11)-C(12)-C(13)                             -58.3(2)  
62 
 
          C(7)-C(8)-C(13)-C(14)                                 9.9(2)  
          C(9)-C(8)-C(13)-C(14)                              -172.38(15)  
          C(7)-C(8)-C(13)-C(12)                               135.03(18)  
          C(9)-C(8)-C(13)-C(12)                               -47.2(2)  
          C(11)-C(12)-C(13)-C(8)                               51.2(2)  
          C(11)-C(12)-C(13)-C(14)                             178.09(15)  
          C(6)-C(5)-C(14)-C(15)                               178.57(14)  
          C(4)-C(5)-C(14)-C(15)                               -51.9(2)  
          C(6)-C(5)-C(14)-C(13)                                55.42(19)  
          C(4)-C(5)-C(14)-C(13)                              -175.03(14)  
          C(8)-C(13)-C(14)-C(5)                               -41.0(2)  
          C(12)-C(13)-C(14)-C(5)                             -165.97(14)  
          C(8)-C(13)-C(14)-C(15)                             -163.60(16)  
          C(12)-C(13)-C(14)-C(15)                              71.42(19)  
          C(5)-C(14)-C(15)-C(16)                               52.3(2)  
          C(13)-C(14)-C(15)-C(16)                             175.40(16)  
          C(14)-C(15)-C(16)-C(17)                             -55.6(2)  
          O(1)-C(1)-C(17)-C(18)                               -30.0(3)  
          C(2)-C(1)-C(17)-C(18)                               149.78(17)  
          O(1)-C(1)-C(17)-C(4)                               -153.88(18)  
          C(2)-C(1)-C(17)-C(4)                                 25.92(19)  
          O(1)-C(1)-C(17)-C(16)                                92.3(2)  
          C(2)-C(1)-C(17)-C(16)                               -87.92(17)  
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          O(2)-C(4)-C(17)-C(18)                               -46.5(2)  
          C(5)-C(4)-C(17)-C(18)                                73.2(2)  
          C(3)-C(4)-C(17)-C(18)                              -160.36(16)  
          O(2)-C(4)-C(17)-C(1)                                 75.35(17)  
          C(5)-C(4)-C(17)-C(1)                               -164.90(15)  
          C(3)-C(4)-C(17)-C(1)                                -38.49(17)  
          O(2)-C(4)-C(17)-C(16)                              -173.73(14)  
          C(5)-C(4)-C(17)-C(16)                               -53.97(19)  
          C(3)-C(4)-C(17)-C(16)                                72.43(17)  
          C(15)-C(16)-C(17)-C(18)                             -74.0(2)  
          C(15)-C(16)-C(17)-C(1)                              163.52(15)  
          C(15)-C(16)-C(17)-C(4)                               55.0(2)  
         ________________________________________________________________  
         Symmetry transformations used to generate equivalent atoms:  
           
 Table 1.10.7.  Hydrogen bonds for 1-33e [A and deg.].  
 ____________________________________________________________________________  
 D-H...A                      d(D-H)      d(H...A)    d(D...A)    <(DHA)  
 O(2)-H(2)...O(3)             0.93(4)     1.98(3)     2.749(2)    139(3)  
 ____________________________________________________________________________  
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Chapter 2  
Regioselective Derivatization of Polyols by Chiral Brønsted Acids 
2.1 Introduction 
Polyols, such as carbohydrates and other compounds containing multiple hydroxyl groups, 
represent an important class of organic molecules. The selective functionalization of polyol-
containing compounds is of great importance as a number of easily accessible polyol building 
blocks can be transformed into more synthetically useful compounds, which may be used as 
pharmaceuticals, cosmetics, or in polymer industry.1 Among various selective organic 
transformations, selective glycosylation of polyols has attracted a lot of attention over the past 
decades. This is partly due to the fact that simple carbohydrates like mono- and oligosaccharides  




are common structural motifs in drug discovery.2 Due to their drug-like characteristics, numerous 
carbohydrate scaffolds are found in many prescribed drugs such as erythromycin (antibiotic), 
zanamivir (antiviral), heparin (anticoagulant), kanamycin (antibiotic) acarbose (antidiabetic) 
(Figure 2.1). The importance of selective glycosylation of polyol-containing molecule is 
emphasized again by observing the improvement of therapeutic properties by sugar modifications3 
(Scheme 2.1). For instance, Thorsen group has demonstrated that in vitro cytotoxicity of cardiac 
glycoside digitoxin was enhanced by neoglycorandomization (Scheme 2.1a).3d In one of their 
examples, the IC50 value of digitoxin against human cancer cell line, HCT-116 was improved from 
440 nM to 18 nM after modifications in the sugar structure. Similarly, Zhang group has 
investigated the development of new analogues of daunorubicin to improve its properties against 
drug-resistant leukemia (Scheme 2.1b) 3a By modifying L-rhamnose portion of doxorubicin into 
more complex 3-azidosugar, Zhang and coworkers achieved ~17 fold improvement in the IC50 
value against K563/Dox, which is doxorubicin-resistant leukemia cell line. These examples 
suggest that the modification in the sugar structure may significantly enhance the biological 
activity of natural products. However, these medicinal chemistry explorations are often hindered 








Scheme 2. 1. Improving the therapeutic properties of natural polyols s by sugar modification: a) 
Thorsen group’s neoglycorandomization work. b) Zhang group’s sugar modification work. 
 
 
2.2 Regioselective glycosylation of poylols 
The selective functionalization of polyols is challenging due to the intrinsic complexity of 
these molecules. In addition to their intricate structures, unpredictable inherent reactivity of 
primary and secondary alcohols introduces the synthetic hurdles for their selective 
functionalization. Accomplishing selective glycosylation of polyols is even more difficult because 
it requires optimization and control of many factors, such as protecting groups, leaving groups, 
promoters, solvents, concentrations, and reaction temperature.4 In carbohydrate synthesis, not only 
the control of regioselectivity, but also the stereoselectivity is crucial. To avoid the inherent 
complex outcome of glycosylation reactions, three general methods for regioselective 
glycosylations are described (Scheme 2.2).  
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One of the approaches relies on using a glycosylated fragment, and then synthetically modifying 
it to produce the desired glycosylated natural product (Scheme 2.2A). This approach avoids 
dealing with regioselectivity issues as carbohydrate is pre-installed. However, there are certain 
limitations with this approach because it essentially requires accomplishing total synthesis of a 
complex structure.  
Scheme 2. 2. Three approaches of regioselective glycosylation reaction. 
 
Another approach is based on site-selective derivatization of the existing natural products. 
This may be done through selective protecting group manipulations (Scheme 2.2B) or by a direct 
glycosylation (Scheme 2.2C). The former approach typically requires selective protection, 
glycosylation of the remaining site and subsequent deprotection. This approach is achievable only 
when the selective protection of the other alcohols is possible, with the desired alcohol being 
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unprotected. While it is frequently being used to generate semisynthetic derivatives, this approach 
might require laborious protecting-group manipulations.  
The last approach to regioselective glycosylation reaction relies on the direct glycosylation 
of polyols without pre-protection (Scheme 2.2C). This approach is the most direct and 
straightforward way of introducing carbohydrate to the polyol system. Often, the desired 
selectivity may be imposed through the substrate control. For instance, Miller group explored 
nonenzymatic site-selective glycosylation of sucrose under aqueous conditions (Scheme 2.4).8 For 
this glycosylation, unprotected sucrosyl acceptors and unprotected glycosyl fluoride donors were 
used to construct trisaccharides in a regioselective manner. Given that the enzyme 
glycosyltransferases also use unprotected sugar in buffered water for regioselective glycosylation 
reaction,9 this method perfectly mimics the enzymatic processes with a chemical control. The 
reaction was performed under very mild conditions, and the combination of a calcium salt with 
triethylamine as a base were essential for achieving both the reactivity and the selectivity in this 
transformation. From this condition, the glycosylation was promoted with complete 
stereoinversion at the anomeric position of the glycosyl donor as well as high regioselectivity for 
either 1’-position or 3’-position (mainly) of the fructofuranoside unit of sucrose acceptor. 
 




Another noticeable substrate controlled-site-selective glycosylation method was reported by the 
Taylor group in their regioselective glycosylation of digitoxin (Scheme 2.4).10 Digitoxin contains 
5 free hydroxyl groups in the structure, and only the hydroxyl group at 4’-position of terminal 
sugar was regioselectively glycosylated by using a borinic acid-based catalyst. In the presence of 
organoboron catalyst 2A, different kinds of glycosyl donors were selectively connected to the 
digitoxin in a single step. As a result, the organoboron-catalyzed late-stage regioselective 
glycosylation method allowed them to access novel cardiac glycoside analogs. 
 
Scheme 2. 4. Regioselective glycosylation of digitoxin by Taylor and coworkers. 
 
 
However, very often the direct substrate-controlled functionalization is not possible. To 
overcome this problem, nature uses enzymes to introduce carbohydrate moiety with high 
selectivities. For instance, glycogen synthase, the enzyme belonging to glycosyltransferase family, 
catalyzes the conversion of glucose to glycogen by promoting the formation of α(1→4) glycosidic 
linkage (Scheme 2.5). The glycogen synthase employs unprotected uridine diphosphate glucose 
(UDP-Glucose) and unprotected glucose as building blocks, and oligosaccharide primer, called 
glycogenin is required to initiate the glycosylation reactions.6 It is truly amazing to see the  
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Scheme 2. 5. Example of enzyme controlled regioselective glycosylation reaction (glycogen 
synthase). 
 
enzyme’s precise control of the site-selectivity in such a complex polyol system. In addition to 
controlling the regioselectivity of glycosylation reactions, enzyme-catalyzed glycosylations 
feature remarkable levels of stereocontrol. In order to access both α- and β-stereoisomers, nature 
employs two different glycosyltransferase enzymes, an inverting glycosyltransferase, and a 
retaining glycosyltransferase (Scheme 2.6).7 The inverting glycosyl-transferases catalyze the 
glycosylation reaction through a direct displacement SN2-like reaction via single oxocarbenium 
ion-transition state, which results in inverted stereogenic center at the anomeric position. On the 
other hand, the retaining glycotransferases catalyze the glycosylation reactions with retention of 
the stereogenic center at the anomeric positions through double-displacement mechanism, which 
involves the formation of a covalent linkage between the enzyme and the sugar donor. Inspired by 
these spectacular examples of enzyme-controlled selective glycosylations, a great number of 
researches have searched for small-molecule-based catalysts capable of achieving similar levels 





Scheme 2. 6. Example of enzyme controlled stereoselective glycosylation reaction (inverting 
glycosyltransferase and retaining glycosyltransferase). 
 
 
2.3 Chiral catalyst-controlled regioselective functionalization of polyols. 
 As already discussed above, direct functionalization of poylols represents the most direct 
and straightforward way to access polyol derivatives. Inspired by the work of the Miller group, a 
number of studies have investigated the use of chiral catalysts to control regioselective 
functionalization of polyols (Scheme 2.7a). In their pioneering study, the Miller group achieved 
catalyst-controlled site-selective acylation of polyol erythromycin A by using simple peptides as 
the chiral catalysts.11 While achiral catalyst N-methylimidazole (2B)-catalyzed acetylation of the 
C2’-alcohols present in the sugar moiety, the peptide-based chiral catalyst 2C promoted the 
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acetylation reaction of the C11-alcohols of the macrolactone ring in erythromycin A. The 
selectivity that was produced by the catalyst 2B is dictated by the substrates; however, the catalysts 
2C clearly overturned this selectivity. Following the Miller’s study, the Kawabata group also 
demonstrated the possibility of catalyst-controlled regioselective acylation of lanatoside C by 
employing a chiral organocatalyst 2E (Scheme 2.7b).12 The chiral catalyst 2E promoted acylation 
reaction with regioselectivity on C4’’’’-position of the terminal sugar of lanatoside C with 90:10 
= C4’’’’:C3’’’’ selectivity. On the other hand, the achiral DMAP-based catalyst 2D introduced the 
acyl group to the C3’’’’-position of the terminal sugar of  latanoside C with 3:97 = C4’’’’:C3’’’’ 
selectivity, which is essentially the substrate-controlled selectivity. Using these catalysts, a diverse 
set of the acyl groups was introduced in both C3’’’’-and C4’’’’-position in latanoside C selectively. 
These results highlight the utility of the chiral catalysts for controlling site-selective modification 
of natural polyols.  
 In addition to the polyol natural products, simple monosaccharides have also been targeted 
for regioselective functionalization. In 2013, Tan group reported chiral catalyst-controlled 
regioselective functionalization of 1,2-cis-diol- and 1,2,3-triol-containing monosaccharides 
(Scheme 2.8).13 Tan and coworkers were able to employ two different chiral organocatalysts 2F 
and 2G, which are pseudoenantiomers of each other, to achieve a regiodivergent protection of 1,2-
cis diol moiety in D-(+)-mannose derivative 2-6 and other monosaccharides to afford 2-7 and 2-8 
respectively. The regioselectivity was imposed by the chiral catalysts 2F and 2G that form a 
reversible covalent bond with one of the alcohols in the diol or triol moieties based on the 
recognition of the substrate chirality within the chiral binding pocket. This regioselective 
protection method was also successfully applied to different monosaccharides like L-rhamnose, D-
arabinose, D-galactose. Once the method for the regioselective functionalization of 1,2-diols was 
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Scheme 2. 7. Chiral-catalysts driven regioselective protection of polyols. a) Miller’s 





developed for the monosaccharide-based substrates, Tan group successfully expanded this method 
to other diols, such as uridine, mupirocin methyl ester, and digitoxin. This method was very 
selective in that even the less kinetically reactive sites within 1,2-diol moieties were protected with 
high regioselectivities. 
Scheme 2. 8. Tan’s chiral catalyst-controlled regioselective functionalization of cis-1,2-diols.  
 
Chiral catalysts can be employed not only for the selective protection of polyols, but also 
for the selective glycosylation reactions of carbohydrates. The Jacobsen group in 2012 introduced 
a catalyst-controlled stereoselective glycosylation reaction using glycosyl chloride donors 2-9 and 
acceptor 2-10 with a macrocyclic bis-thiourea chiral (R,R)-catalyst 2H and isobutylene oxide (IBO) 
as a base (Scheme 2.9a).14 This method provided β-selective glycosides of various monosaccharide, 
such as D-glucose, D-galactose, D-mannose, 2-deoxy-D-glucose, L-fucose, D-xylose. Following the 
Jacobsen’s study, Galan promoted α-stereoselective glycosylation using a different thiourea-based 
chiral (S,S)-catalyst 2I (Scheme 2.9b).15 Galan used 2-nitroglycal donor 2-12 and acceptor 2-13 to 
access α-selective glycoside 2-14. In addition to the aforementioned studies, several studies 
including ours have demonstrated the use of chiral phosphoric acid to achieve functionalization 
and glycosylation of chiral polyols. The following sub-chapter provides an overview of this work. 
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Scheme 2. 9. Chiral thiourea-catalyzed stereoselective glycosylation reaction. a) Jacobsen’s β-
selective glycosylation. b) Galan’s α-selective glycosylation.  
 
 
2.4 BINOL-based chiral phosphoric acid 
Among the various chiral catalysts explored to date, chiral phosphoric acids demonstrated 
a lot of promise as the catalysts for the site-selective and stereoselective functionalization of 
polyols. The following chapters overview the use of chiral phosphoric acid to achieve control over 
the selectivity in functionalization of carbohydrates. As a guide for understanding the mechanistic 
intricacies of chiral phosphoric acid catalysis, a brief history of chiral phosphoric acid, and their 
utility is provided. (vide infra) 
Organocatalysis is a term that describes the use substoichiometric quantities of organic 
compounds to accelerate chemical transformations. Considering the usefulness and importance of 
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organocatalysis nowdays, the history of organocatalysis is surprisingly short. One of the most 
famous early example of organocatalysis is proline-catalyzed aldol reaction for the synthesis of 
optically active steroid partial structures, independently reported by Eder, Sauer and Wiechert in 
1971.16 and Hajos and Parrish in 1974.17 Even with few successful examples of organocatalyzed 
transformation, organocatalysis was not still considered as a mainstream in the field of catalysis 
until 1990s. In 1990, Dieter Seebach even excluded the organocatalysis from future of organic 
synthesis18 by emphasizing only the importance the fields of biological and organometallic 
chemistry in his review of organic synthesis.19 In the late 1990s, however, the field of 
organocatalysis became more and more popular as organocatalysis was conceptualized. Since 
early 2000s, the usage of organocatalysis has been exploded in many fields, such as assymetric 
catalysis and organic synthesis, owing to considerable contribution from Shi,20 Denmark,21 Yang,22 
Jacobsen,23 Corey,24 Miller,25 Barbas, Lerner and List,26 and MacMillan27 groups.  
One of the major factors that were responsible for the huge success of organocatalysts was 
identifying generic modes of catalyst activation. Understanding the generic modes of catalyst 
induction is useful as we can use them as a platform to devise enantioselective transformation.18 
Since late 1990s, various types of generic modes of organocatalyst activation, such as imminium, 
enamine, ammonium, ylide, phase transfer, carbene, and hydrogen bonding, have been found. By 
utilizing these concepts of organocatalyst activation, numerous enantioselective reactions have 
been designed and carried out successfully.  
As an outcome of hydrogen bonding activation mode in organocatalyst, chiral Brønsted acid 
catalysts were devised for asymmetric reactions. Among the chiral Brønsted acids reported, chiral 
phosphoric acids derived from axially chiral biaryls were widely applied in variety of organic 
transformations.28 In 2004, Akiyama29 and Terada30 group independently introduced 1,1'-Bi-2-
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naphthol (BINOL)-based chiral phosphoric acid (CPA) as a chiral organocatalyst in the 
asymmetric Mannich reaction. Both studies suggested that the enantioselectivity is controlled by 
chiral environment of the BINOL backbone, which is connected via hydrogen bonding network 
with the amine and alcohol substrate. Interestingly, BINOL-CPA was present even 30 years before 
Akiyama and Terada’s report in 2004. This shows the power of the concept of organocatalysis, 
which turned on the potential of already existing molecule to a powerful tool in an asymmetric 
catalysis. After Terada and Akiyama’s report on BINOL-CPA in asymmetric transformation, the 
number of studies on CPA catalysis have been grown dramatically (Figure 2.2).31 These numerous 
studies on CPA established the new routes of asymmetric synthesis and enantioselective catalysis, 
which were not accessible before. Now, CPAs are considered as the major subclass of 
organocatalysts.31 
 
Figure 2. 2. Number of papers on CPA-catalyzed reactions between 2008 and 2017.31 
 
The important factor of huge success on BINOL-CPA is in part due to three features of its structure 
(Figure 2.3). First, the axially chiral biaryl skeleton of BINOL backbone provides chiral 
environment for the asymmetric reactions. Due to its axially chiral characteristics, BINOL 
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backbone has been actively ued as a ligand for metal-mediated asymmetric catalysis since Noyori’s 
discovery in 1979.32 Second, BINOL-CPA contains both Brønsted acidic proton and Lewis basic 
lone pair, which is beneficial in activating the substrate in the reaction. While the acidic proton 
can activate the electrophile through either hydrogen bond or protonation, the Lewis basic lone 
pair can be involved in a hydrogen bond with an acidic proton in the substrate. These interactions 
would enhance the reactivity by either increasing the nucleophilicity or electrophilicity of the 
corresponding substrate. The final feature is that the reactivity and acidity of the catalyst can be 
tuned by altering the substitution on 3,3’-position of the BINOL backbone. Considering that the 
reaction rate can be greatly dependent on the acidity of the catalysts, the ability to tune CPA acidity 
is a very important feature of the BINOL-CPA catalysis. The acidity of phosphoric acid could be 
enhanced by installing an electron withdrawing group and be decreased by installing a donating 
group at the 3,3’-position of the BINOL backbone. In addition to the reactivity and the acidity of 
the catalyst, the substitution at the 3,3’-position of the BINOL backbone can also affect the 
selectivity of the reactions. Terada reported that bulky substituents enabled both high 
enantioselectivity with high yield.30 Not only 3,3’-position, but other positions of the BINOL 
backbone can also be substituted with functional groups to tune the catalyst. In addition to altering 
the substitution patterns, BINOL can be directly hydrogenated to H-8 BINOL using single step 
redox manipulations developed by the Nagorny group.33 Catalyst’s highly tunable structure and its 
ability to engage in various modes of activation made BINOL-CPA be of great utility in a wide 
range of organic transformations. 
As a result, BINOL-based CPAs have emerged as powerful Brønsted acid catalysts and 
have been extensively used in asymmetric catalysis. 28 In 2012, our group disclosed the CPA-
catalyzed enantioselective and diastereoselective spiro-ketalizations (Scheme 2.10).34 The chiral 
82 
 
Figure 2. 3. Structure of a BINOL-based CPA and examples of CPAs.  
 
 
catalyst (S)-2J was able to override the intrinsic preference for the thermodynamic α-
spiroketal 2-16a formation, and promoted highly selective spiroketalization leading to 
nonthermodyamic β-product 2-16b. The reaction mechanism and rationale for the high selectivity 
were subsequently elucidated by the mechanistic and computational studies, which suggested that 
the reaction happened through an asynchronous concerted mechanism proceeding through a short-
lived oxocarbenium-like transition state. This result suggested that BINOL-CPA (S)-2J can 




Scheme 2. 10. Nagorny’s CPA-catalyzed stereoselective spiroketalization. 
 
 
Along with the highly selective CPA-catalyzed diastereoselective and enantioselective 
spiroketalization method, our group has also developed a method for the CPA-catalyzed 
regioselective acetailization of carbohydrate‐derived 2,3‐diols (cf. Table 2.1).35 This approach 
featured high regioselectivity, which was directly controlled by the catalyst (R)-2K. Catalyst (R)-
2K promoted C2-selective protection of D-glucose and D-galactose-based substrates 2-20a and 2-
20b, which is the opposite to the inherent C3-regioselectivity exhibited by the diol substrate 2-19a 
and 2-19b respectively (entry 1-2). D-Mannose based-substrate 5-3c, in contrast, exhibited 
preference for the formation of the C3-product for the (R)-2K catalyzed acetalization reaction 
(entry 3). When compared to D-glucose and D-galactose substrates 2-20a and 2-20b, the relative 
value of regioselectivity was lower for the D-mannose-based substrate 2-21c. In this study, three 
enol ethers, 4-dihydro-2H-pyran, 2-methoxypropene and 1-methoxycyclohexene, were used for 
acetalization, and the highest regioselectivities were afforded with 2-methoxypropene as an 
electrophile. These conditions tolerated various protecting groups at the 4,6-positions of substrates 
(benzylidine acetal, dimethyl acetal, tert-Butyldimethylsilyl, benzyl, etc) as well as the anomeric 
position (thioglycoside, O-glycosides).  
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Table 2. 1. Nagorny’s CPA-catalyzed regioselective acetalization on sugar-derived 2,3-diols. 
 
In 2015, List group demonstrated that axially chiral biaryl phosphoric acids  could promote 
desymmetrizative silylation of meso-1,2-diols (Scheme 2.13).36 Generally, the enantioselective 
desymmetrization of meso-alcohols is one of the most popular methods to access the corresponding 
mono-protected derivatives in their enantiopure form.36 The nonenzymatic desymmetrization of 
meso-alcohols has been achieved through asymmetric monoacylation37, hydrolysis of acetals38, 
hydrolysis of meso-diesteres and oxidation of diols39. While those approaches commonly include 
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the use of chiral amines or chiral Lewis acids as the catalysts, the List group reported the methods 
for desymmetrization of meso-alcohols catalyzed by axially chiral biaryl phosphoric acid catalysts. 
In this study, the catalyst (R)-2J and 2M promoted enantioselective desymmetrizative silyation of 
meso-compound 2-22 using the silylating reagent 2-23 to afford 2-24. 
 




2.5 CPA-catalyzed steroselective and regioselective glycosylations 
The chiral backbone of CPA has been used to achieve stereodifferentiation in a variety of 
chemical transformation. Considering the possible complicated outcomes of glycosylation arising 
from the formation of mixtures of stereoiosmers, regioisomers, and diastereomers, the use of CPAs 
can potentially reduce the number of isomeric entities and render glycosylation reactions selective.  
The first example of CPA-catalyzed glycosylation reaction was reported by the Fairbanks 
group, who demonstrated stereoselective glycosylation with BINOL-CPA (S)-2N (Scheme 
2.12a).40 As a result, β-selective glycoside 2-27 was obtained from the D-glucose-derived donor 2-
25 and acceptor 2-26. Interestingly, both (R)-2N and (S)-2N catalyst could promote β-selective 
glycosylation, but the (S)-2N produced higher β-selectivity than (R)-2N, which indicated that the 
catalyst chirality can affect the stereochemical outcome of the reaction. This result suggested that 
the choice of chirality of CPA catalyst is important for the selectivity control. Later, the Toshima 
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group developed a glycosylation-based resolution of racemic alcohols using CPAs (Scheme 
2.12b).41 Based on Fairbanks’ work, Toshima group employed the same CPA (S)-2N to promote 
glycosylative resolution of racemic alcohol 2-29 that resulted in selective glycosylation of one of 
the stereoisomers only to afford 2-30.  
 
Scheme 2. 12. a) Fairbanks’ CPA-catalyzed stereoselective glycosylation. b) Toshima’s CPA-
catalyzed glycosylation-based resolution of racemic alcohols. 
 
 
Similarly, Bennett group reported stereoselective glycosylation of 2-deoxy-D-glucose 
derivative 2-31 using a hydrogenated  CPA 2O (Scheme 2.13).42 In this study, the authors observed 
matched and mismatched relationships between the CPA and the stereochemistry of 
trichloroacetimidate (TCA) donor 2-31. For the α-donor, (S)-CPA matched better and catalyzed 
the glycosylation reaction to afford the β-product β-2-32. On the other hand, β-donor β-2-31 
matched with (R)-CPA, and α-glycoside α-2-32 was obtained as a main product in this reaction. 
The authors hypothesized that different combinations of the donor and catalyst configurations 
could take different reaction pathways, which resulted in different outcomes of the reactions.  
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Following these interesting observations of stereoselectivity control by CPAs, the Galan 
group introduced another interesting use of CPA in glycosylations. The Galan group suggested 
that a combination of the CPA (R)-2N and thiourea catalyst 2P can produce a synergistic effect in 
α-stereoselective glycosylatation of glycal substrate 2-33 (Scheme 2.14). 43 The authors suggested 
that the stereoselectivity was soley controlled by the chirality of CPA, while H-bonding between 
(R)-2N and 2P can enhance the glycosylation reaction rate.  
 
 











 While previous examples were mainly focused on stereoselectivity control, the Nagorny 
and Sherman groups reported CPA catalyzed regioselective glycosylation reactions on 6-deoxy-
Erythronolide B (6-dEB) (Scheme 2.15a).44 Nature transforms 6-dEB to erythromycin A by 
enzyme-catalyzed regioselective glycosylations and subsequent oxidations. Our group accessed 
the glycosylated 6-dEB analogs by mimicking the enzymes glycosyltransferases with chiral acids. 
In this study, various phosphoric acids with different axially chiral biaryls backbones were used to 
control the regioselectivity for the glycosylation of macrolide. While (S)-SPINOL-based CPA (S)-
2Q catalyzed regioslective glycosylation of the C3-OH of 6-dEB 2-35, (S)-BINOL-based CPA 
(S)-2N catalyzed regioselective glycosylation of the C5-OH of 6-dEB 2-35 with high 
regioselectivity (r.r. = 73:27 and r.r. = 99:1 respectively) and excellent stereoseletivity (α:β = 99:1). 
Regioselective glycosylation of C11-OH of macrolactone was also accomplished using transient 
protection of the C3, C5-hydroxyl groups with phenylboronic acid. This followed by the in situ 
glycosylation and deprotection to provide the desired C11-glycoside. In this study, the authors 
proposed that mechanism for the CPA-catalyzed glycosylation involved in a covalently linked 
anomeric phosphates rather than oxocarbenium-phosphate ion pairs as a reaction intermediate 
(Scheme 2.15b). Using 31P NMR, the formation of β-anomeric phosphate 2-41 was observed 
arising from the α-donor 2-39 and diphenyl phosphoric acid 2L in a SN2-type of mechanism 
through transition state of 2-40. The anomeric phosphate intermediate 2-41 was then exchanged 
with 2,4-pentadiol 2-42 to generate an intermediate 2-43, followed by another SN2-like reaction to 
afford α-glycoside 2-45. The authors revealed that syn-1,3 diol moiety is geometrically suited for 
the inversion at the anomeric center during the glycosylation reaction. The proposed mechanism 




Scheme 2. 15. a) Nagorny’s chiral Brønsted acid catalyzed regiodivergent glycosylation on 6-





 The importance of selective transformation of polyol-containing compounds and various 
methods for the selective functionalization of polyols were discussed. Organocatalysis, involving 
CPAs in particular, have been widely employed to functionalize polyols and several examples 
demonstrated that CPA could serve as a powerful tool in controlling the selectivity for polyol 
functionalization. The following chapters of this dissertation discuss new applications of CPA 
catalysts in 1) desymmetrizative glycosylation, which provides a direct access to new types of 
aminoglycosides, 2) regioselective and stereoselective glycosylations in carbohydrate‐derived 2,3‐
diols, 3) regioselective single-pot functionalization of monosaccharides. These studies provide 
new and effective methods for the selective modification of carbohydrates and expand the frontiers 
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Chapter 3  
Chiral Phosphoric Acid-Catalyzed Desymmetrizative Glycosylation of 2-Deoxystreptamine 
and its Application to Aminoglycoside Synthesis 
(This chapter was partially published in: Lee, J.; Borovika, A.; Khomutnyk, Y.; Nagorny, P., 
Chem. Commun. 2017, 53 (64), 8976-8979.) 
3.1 Introduction of aminoglycosides 
 Aminoglycosides are a group of carbohydrate-based antibiotics used broadly in clinical 
application against microbial infections in humans. Under physiological conditions, the protonated 
amine functionalities of aminoglycosides would provide good affinity for negatively charged 
nucleotides,1 particularly the acceptor (A) site of 16S rRNA. Aminoglycosides interfere with the 
recognition of tRNA by rRNA during the translation and perturb translocation of tRNA from A 
site to the P (peptidyl-tRNA) site, which leads to the inhibition of protein synthesis and cell death. 
Crystallographic analysis supports these ideas as the 30S ribosomal particle or an A-site 
oligonucleotide sequence was revealed to bind in 2-DOS with similar binding pattern throughout 
different AGAs leading to the same damage of translational fidelity.2 In addition to their 
antibacterial properties, aminoglycosides are potent antiviral (HIV) agents that could be employed 
to suppress genetic diseases.3 While certain aminoglycosides, such as paromomycin or gentamycin, 
are FDA-approved drugs for the treatment of bacterial infections, their extensive clinical use has 
been curtailed by both their toxicity and the rapid increase of aminoglycoside resistant strains of 
bacteria.4 Even though their usage has not completely died out, their importance decreased due to 
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the appearance of other classes of broad-spectrum antibiotics with fewer side effects, such as 
fluoroquinoloes, carbapenems, cephalosporins, and β-lactam/β-lactamase inhibitor combinations.5  
Recently the focus has returned to development of new aminoglycosides in the face of 
prevalent antibiotic resistant to the other classes of antibiotics. These issues represent an important 
challenge in the design of new modified aminoglycosides with improved pharmacological 
properties. Despite the extensive interest in this class of natural products, specific challenges of 
current synthetic approaches to aminoglycosides include the time, which often prohibitively long, 
and limitations in the structural modifications that can be introduced.6 In terms of structure of 
aminoglycoside, aminoglycosides are mainly built up by diverse aminosugars, which often consist 
of 6-amino or 2,6-diamino functional groups as the name aminoglycoside suggests. The key  




significant feature in each aminoglycoside structure would be a cyclohexitol ring termed 2-
deoxystreptamine (1,3-diamino-4,5,6-trihydroxycyclohexane, 2-DOS) (Figure 3.1b). The 
importance of 2-DOS present in almost all aminoglycosides could be explained by its crucial role 
for the biological activity, particularly against Gram-negative bacteria. The majority of 
aminoglycosides contain an achiral (meso) 2-DOS subunit that carries glycosylation at either the 
C4/C5 (i.e. neomycin B) or C4/C6 (i.e. amikacin) hydroxyl groups (Figure 3.1a). The possibility 
of desymmetrizing 2-DOS has attracted significant attention as the obtained desymmetrized 
derivatives can be used to provide a direct access to a wide range of functionalized 
aminoglycosides.7, 6b, 8, 9 While the most concise way to desymmetrize 2-DOS is through the direct 
glycosylation, only enzymatically controlled glycosylations of the C4 position of 2-DOS are 
known.10 These enzymatic transformations provide powerful means for the assembly of 
aminoglycosides, but at the same time suffer from the limited substrate scope, indicating that the 
desirability of complementary non-enzymatic methods for the desymmetrizative glycosylation of 
2-DOS.  
3.2 Chiral phosphoric acid catalyzed regioselective functionalization of carbohydrates 
Our group has long-standing interests in developing and exploring chiral phosphoric acid 
(CPA)-catalyzed reactions of acetals.11,12 Recently, our group13 along with Toshima and co-
workers14 demonstrated that CPA-catalyzed acetal/glycoside formation might proceed with the 
recognition of alcohol chirality in racemic alcohols and carbohydrate-derived diols. Based on these 
observations, we surmised that CPA-catalyzed glycosylation of 2-DOS derivative 3-1 (Scheme 
3.1) with protected D-mannose donor 3-2 (Scheme 3.2) might proceed selectively and lead to 
desymmetrization of 2-DOS, thus providing key disaccharides α -3-3A and α -3-3B (Table 3.1). 
These compounds can be further used for the assembly of various aminoglycoside antibiotics and 
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their isomeric forms with the inversed C4/C6 connectivity (Figure 3.2). This work presents our 
studies on selective synthesis of α -3-3A and α -3-3B through CPA-controlled desymmetrizative  
Figure 3. 2. Application of desymmetrizative glycosylation to synthesis of aminoglycosides. 
 
glycosylation of meso-diol 3-1, and further functionalization of α -3-3B to provide isomeric 
neamine 3-5 and kanmycin B derivative 3-18 that are not readily accessible by the traditional 
semisynthetic methods.6  
3.3 Preparataion of 2-DOS acceptor 3-1 and D-mannose-derived trichloroacetimidate 
donor 3-2 
These studies were done by Dr. Alina Borovika (Part of her dissertation thesis: Borovika, A. (2015) 
Advances in Bronsted Acid Catalysis: Reactions of Oxocarbenium Ions. Ph.D dissertation, 
University of Michigan, Ann Arbor, MI) 
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Our studies commenced with the synthesis of 2-DOS meso-derivative 3-1 (Scheme 3.1). 
This substrate can be obtained by direct derivatization of 2-deoxystreptamine hydrobromide salt, 
which is readily available by degradation of neomycin B trisulfate.15 This salt was subjected to a 
two-step protocol that involves protection of amines as azides (52% yield),16 and the selective 
TBS-protection of more reactive C5 hydroxyl group (81% yield) to provide meso-derivative 3-1. 
The azide-based protection of C1 and C3 amines of 3-1 was selected due to the relatively small 
steric size and polarity of the azido group, which is beneficial for the reactivity of 3-1 in 
glycosylation reactions. As the introduction of two azides into six carbon-containing 2-DOS 
resulted in a shock-sensitive triol, the stability of azide was evaluated. There are several tests 
available to evaluate the stability of organic azides. The impact sensitivity of energetic compounds 
is tested with the fall hammer equipment. Samples are exposed to the impact of a falling weight 
from variable heights and the measured sensitivity parameter is the height at which the samples 
explode or decompose. The drop test was performed on diazo-2-deoxystreptamine 3-1, and it 
showed some mild shock sensitivity. Thus, 10 mg of 3-1 went off in 30 % of tests when 1 lbs 
weight was dropped from 145 cm height; however, it did not explode or decompose when the same 
weight was dropped from 125 cm height. While this test gave us only preliminary data, it became 
clear that diazo-2-deoxystreptamine 3-1 has to be treated with caution. Hence, this compound has 
always been stored in small, up to 200 mg, quantities. Diazo-2-deoxystreptamine 3-1 was not 
found to be heat-sensitive based on the Differential Scanning Calorimetry (DSC) analysis, and its 










Scheme 3. 2. Synthesis of D-mannose trichloroacetimidate 3-2.  
 
 
Along with preparation of the 2-deoxystreptamine-based acceptor 3-1, the D-mannose-
based trichloroacetimidate donor was also prepared from the reported intermediate.17 The diol was 
protected by para-methoxy benzyl group, and then, the anomeric sulfide was hydrolyzed by NBS, 
acetone and water. Finally, trichloroacetonitrle was introduced to afford α-selective D-mannose 
trichloroacetimidate donor 3-2. 
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3.4 CPA-catalyzed desymmetrizative glycosylation reactions 
These studies were done by Dr. Alina Borovika (Part of her dissertation thesis: Borovika, A. (2015) 
Advances in Bronsted Acid Catalysis: Reactions of Oxocarbenium Ions. Ph.D dissertation, 
University of Michigan, Ann Arbor, MI) 
With the meso-derivative 3-1 and 3-2 in hand, the catalyst-controlled glycosylation of 3-1 
with trichloroacetimidate 3-2 was investigated next (Table 3.1). The D-mannose-derived 
trichloroacetimidates undergo α -selective glycosylations, which is required for the synthesis of 
natural aminoglycosides, such as kanamycin B.18 To test the inherent selectivity of the 
glycosylation reaction, the mixture of 3-1 and 3-2 was subjected to catalytic quantities of TMSOTf. 
While the formation of ~1 : 1 mixture of disaccharides α-3-3A and α-3-3B was indeed observed, 
the substantial quantities of other isomeric disaccharides inseparable from α-3-3A and α-3-3B 
complicated further analysis.  
Similarly, the attempts to promote the reaction by using diphenylphosphoric acid (2L) as 
the catalyst (entry 1), did not result in clean formation of α-3-3A or α-3-3B, but rather led to 
decomposition of the starting materials. To our delight, BINOL backbone-containing CPAs19 were 
found to be significantly better catalysts of this glycosylation.13,14,20,21 One limitation, however, 
was the observed strong dependence of the catalytic activity on the nature of the 3,3’-aryl 
substituents, which affects glycosylation reaction. CPAs without electron withdrawing group on 
their backbones (entry 2) failed to promote the reaction at all. However, more acidic catalysts with 
electron withdrawing 3,3’ -aryl groups did promote the formation of inseparable mixtures of α-3-
3A and α-3-3B with variable selectivities (entries 3–15). Remarkably, the use of (S)-3I resulted in 
α-3-3B as the main product (86:14 d.r., 74% yield, entry 14). Finally, the use of enantiomeric (R)-
3I overturned the selectivity and favored α-3-3A. (67:33 d.r., 51% yield, entry 15). 
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Table 3. 1. a) Optimization of desymmetrizative glycosylation of protected 2-deoxystreptamine 






3.5 Confirmation of structure 
The α -C1 configuration of 3-3A and 3-3B could be conveniently confirmed by observing 
the J(C1–H) to be 173 and 169 Hz (Figure 3.3), which is consistent with the values typically 
observed for the α -mannosides (~170 Hz) and inconsistent with the J(C1–H) for the β-mannosides 
(~160 Hz). However, the proposed connectivity (i.e. C4-vs. C6) required further validation 
(Scheme 3.3). This was achieved by converting the 86 : 14 mixture of α-3-3B and α-3-3A into 
molecule 3-5 and comparing it with the known neamine derivative 3-6. The synthesis of 3-5 
103 
 




(Scheme 3.3b) from α-3-3B commenced with subjecting α-3-3B to TBAF to remove C5-TBS 
group (82% yield), reprotecting the resultant diol as a benzyl ether (84% yield), and removing of 
the PMB protecting groups on D-mannose subunit by DDQ (67% yield) to provide disaccharide 3-
4. Diol 3-4 was subjected to a two-step protocol that included converting the D-mannose subunit 
to 2,6-bis-triflate, which was subjected to nucleophilic substitution with sodium azide in DMF to 
provide desired derivative 3-5 in 30% yield (2 steps). The 1H and 13C NMR spectra for the synthetic 
derivative 3-5 were distinctly different from the corresponding spectra of known natural neamine 
derivative 3-6 (Scheme 3.3a)15 supporting the glycosylation at the C6 position of 2-DOS in α-3-





Scheme 3. 3. Stereochemical assignment of products 3-3. a) synthesis of protected natural-
neamine 3-6. b) synthesis of protected unnatural-neamine 3-5 from α-3-3B.a 
 
 
3.6 Synthesis of the donor 3-13 
The synthesis of the isomeric kanamycin B from α-3-3B required access to amino-sugar 
derivative 3-7. The first attempt to obtain this amino-sugar was based on the acidic degradation of 
aminoglycoside amikacin (Scheme 3.4). This idea originated from our prior studies where we 
produced 2-DOS, using the degradation of neomycin B (Scheme 3.1). However, this simple 
hydrolysis-based approach did not provide us the desired amino-sugar 3-7, but rather produced a 
complex, and inseparable mixture of unprotected saccharides. To avoid these problems, 
protection/hydrolysis strategy was attempted instead. We hoped that pre-protection would simplify 
the separation of the hydrolysis product 3-8 or 3-9. Amine groups of amikacin were substituted 
with azides, and all of the hydroxyl groups were protected as benzyl ethers. The resulting protected 
amikacin was then, hydrolyzed by HBr and HCl under reflux condition. Unfortunately, these 
105 
 
conditions were too harsh and the cleavage of the benzyl ethers was observed. Rather than 
protection/hydrolysis, a hydrolysis/protection sequence was also attempted, but this was not 
successful and the desired amino-sugar 3-10 was not isolated. 
Scheme 3. 4. Failed attempt of hydrolysis of amikacin to generate desired sugar moiety 3-7.  
 
 
While the hydrolysis strategy was inefficient and unpredictable, chemical synthesis seemed 
to be a more realistic method to access the amino-sugar 3-13 (Scheme 3.5). In our synthetic 
approach, D-allose was chosen as a starting material since it contains the desired stereochemistry 
for the installation of the C3-amino group. The synthesis of the desired donor 3-13 commenced 
with the preparation of thioglycoside 3-11 by using a known procedure.22 The equatorial alcohol 
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of 3-11 was then selectively protected as the benzyl ether using Sn(IV)-alkoxide chemistry to 
provide the inverted derivative S3-11. The remaining C3-hydroxyl group was triflated and then 
reacted with NaN3. The anomeric sulfide moiety of 3-12 was hydrolyzed by trichloro-cyanuric 
acid (TCAA) in acetone and water, and then trichloroacetimidate functionality was introduced to 
afford 3-13. 
Scheme 3. 5. Synthesis of the trichloroacetimidate donor 3-13. 
 
3.7 Synthesis of isomeric kanamycin B derivative 
The stereoselective synthesis of disaccharide α-3-3B offered an intriguing possibility of 
converting this substrate to isomeric kanamycin B with reverse connectivity of the sugars at the 
C4 and C6 position (Scheme 3.5). The direct functionalization of kanamycin B to form this 
derivative represents a significant challenge, while the desymmetrizative functionalization of 2-
DOS would provide a more straightforward access to aminoglycosides of this type.6  
In order to install all of the functionalities required for the iso-kanamycin B, direct 
glycosylation of donor 3-13 to the disaccharide α-3-3B was attempted to generate the desired 
saccharide 3-20. However, the common glycosylation promoter did not promote the desired 
glycosylation reactions, and only the just the starting material was recovered after the reaction 
107 
 
(Scheme 3.6). Later we realized that the C5-TBS group of α-3-3B was too sterically hindered and 
blocked the access of donor 3-13 to C4-alcohol of α-3-3B. 
 
Scheme 3. 6. Failed attempts to carry a direct glycosylation of 3-13 to α-3-3B. 
 
 
Thus, the synthesis of iso-kanamycin B commenced with the cleavage of the C5 TBS group 
of α-3-3B that resulted in diol 3-14 (70% yield) along with the regioisomeric product arising from 
the deprotection of α-3-3A (12% yield). This deprotection was necessary as the TBS group 
obstructed the glycosylation of the C4 position. The product 3-14 was subjected to glycosylation 
with trichloroacetimidate 3-13 to provide trisaccharide 3-15 as a single diastereomer and 
regioisomer in 66% yield, and the observed J(H1–H2) = 3 Hz for the new anomeric stereocenter 
of 3-15 was consistent with the α-configuration.  
The formation of protected iso-kanamycin B (3-18) was completed by oxidizing the 
trisaccharide with DDQ to remove the PMB groups in the D-mannose subunit (86% yield). The 
resultant diol was subjected to bis-triflation and azide substitution to yield compound 3-18. While 
the bis-triflation proceeded smoothly, the displacement of the C2-triflate of the D-mannose subunit 
with sodium azide23 was found to be sluggish and provided the desired protected iso-kanamycin 




Scheme 3. 7. Application to the synthesis of isomeric kanamycin B derivative 3-18. 
 
3.8 Plausible mechanism 
The plausible reaction intermediates for the formation of α-3-3A and α-3-3B are proposed 
in figure 3.4. Our prior mechanistic and theoretical studies of CPA-catalyzed regioselective 
glycosylation of 6-dEB- and oleandomycin-derived macrolactones24 identified covalently linked 
anomeric phosphates such as 3-19A as viable reaction intermediates. However, considering that 
the exclusive formation of α-3-3A and α-3-3B from α-3-2 is observed in these studies, the 
formation of an oxocarbenium-based ion pair 3-19B cannot be ruled out.  
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In summary, we were able to demonstrate that chiral phosphoric acids could catalyze 
desymmetrizative glycosylation of 2-deoxystreptamine-derived meso-diol 3-1 with D-mannose-
derived trichloroacetimidate donor 3-2. While the evaluated achiral acids could not promote this 
glycosylation selectively, the (S)-enantiomer of CPA (Ar = 3,5-(SF5)2-C6H3) catalyzed 
diastereoselective formation of the C6 glycosylated product α-3-3B in 86 : 14 d.r. This 
transformation was accomplished on significant scale (0.3 g of α-3-3B), and is of utility for the 
preparation of functionalized aminoglycosides. Thus, intermediate α-3-3B was converted into the 
isomeric protected aminoglycosides neamine and kanamycin B with reversed connectivity at the 







3.10 Experimental Information 
 
Methods and Reagents: 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used without 
further purification. Toluene (PhMe), dichloromethane (DCM) and diethyl ether (Et2O) were 
filtered through a column (Innovative Technology PS-MD-5) of activated alumina under nitrogen 
atmosphere. All reactions were carried out under an atmosphere of nitrogen in flame-or oven-dried 
glassware with magnetic stirring. Reactions were cooled via external cooling baths: ice water 
(0 °C), Neslab Cryotrol CB-80 immersion cooler (0 to -60 °C) or Neslab Cryocool immersion 
cooler CC-100 II. Purification of the reactions mixtures was performed by flash column 
chromatography on SiO2 using SiliCycleSiliaFlash P60 (230-400 mesh) silica gel.  
Instrumentation :  
All spectra were recorded on Varian vnmrs 700 (700 MHz), Varian vnmrs 500 (500 MHz), Varian 
MR400 (400 MHz), Varian Inova 500 (500 MHz) spectrometers and chemical shifts (δ) are 
reported in parts per million (ppm) and referenced to the 1H signal of the internal tetramethylsilane 
according to IUPAC recommendations. Data are reported as (br = broad, s = singlet, d = doublet, 
t = triplet, q = quartet, qn = quintet, sext = sextet, m = multiplet; coupling constant(S) in Hz; 
integration). High resolution mass spectra (HRMS) were recorded on MicromassAutoSpecUltima 
or VG (Micromass) 70-250-S Magnetic sector mass spectrometers in the University of Michigan 
mass spectrometry laboratory. Infrared (IR) spectra were recorded as thin films on NaCl plates on 
a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption peaks were reported in 





1,3-diol (3-1).  
(1R,2r,3S,4R,6S)-4,6-diazidocyclohexane-1,2,3-triol8b (770 mg, 3.60 mmol) was dissolved in 33 
mL of dry THF under nitrogen, and cooled down to 0 °C. To the solution 2,6-lutidine (1.51 mL, 
13.1 mmol) and tert-butyldimehylsilyl trifluoromethanesulfonate (1.66 mL, 7.2 mmol) were added 
dropwise. The reaction mixture was warmed up to room temperature and quenched with methanol 
after 3 h. Column chromatography on SiO2 (10 : 1  to 8 : 1 hexanes/ethyl acetate) resulted in of 
white crystalline material 1 (964 mg, 81%). NMR spectra of 3-1 matched to the NMR spectra of 
the same compound from the previous report.25 
1H NMR (400 MHz, Chloroform-d) δ 3.43 – 3.31 (m, 5H), 2.43 (s, 2H), 2.22 – 2.16 (m, 1H), 1.44 
– 1.31 (m, 1H), 0.92 (s, 9H), 0.16 (s, 6H). 13C NMR (100 MHz, Chloroform-d) δ 77.3, 76.7, 60.3, 
32.1, 26.1, 18.4, -4.2. IR (thin film, cm-1): 3489, 2926, 2170, 2103, 1472, 1357, 1249, 1137, 1071, 
1029, 982, 874, 834, 778, 691. 
 
(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-((4-methoxybenzyl)oxy)-6-
(((4methoxy benzyl)oxy)methyl) tetrahydro-2H-pyran-2-yl 2,2,2-trichloroacetimidate (3-2).  
A 250 mL round bottom flask was charged with S1 (2.17g, 3.119 mmol) and dissolved in a 9 : 1 
mixture of acetone (18 mL) and water (2 mL). The reaction mixture was cooled down to 0 °C and 
112 
 
N-bromosuccinimide (NBS, 1.16 g, 6.55 mmol) was added. The reaction mixture was monitored 
by TLC and was quenched with solid NaHCO3 upon reaction completion. Acetone was removed 
in vacuo and organics were extracted with ethyl acetate. The combined organic layers were washed 
with saturated sodium bicarbonate and brine, dried with magnesium sulfate, and concentrated in 
vacuo. The crude product S2 was purified by flash column chromatography on SiO2 (3:1 to 1:1 
hexanes/ ethyl acetate) resulting in 1.69 g (90 %) of colorless oil (α/β = 2 : 1). 
An oven dried and nitrogen flushed 250 mL round bottom flask was charged with the D-mannose 
derivative S2 (1.69 g, 2.81 mmol) from the previous step and dry DCM (20 mL). The reaction 
mixture was cooled down to 0 °C and trichloroacetonitrile (0.847 mL, 8.40 mmol) was added, 
followed by 1,8-diaza bicyclo(5,4,0)undec-7ene (0.21 mL, 1.40 mmol). The resulting reaction 
mixture was warmed up to room temperature and stirred for 6 h. The crude product was purified 
by column chromatography on SiO2 (5 : 1 to 3 : 1 hexanes/ethyl acetate) resulting in the pure 
product 3-2 as pale-yellow oil (1.57 g, 75%, α/β = 20 : 1). 
1H NMR δ H (700 MHz, Benzene-d6, α only ) δ 8.47 (s, 1H), 7.30 (t, J = 7.8 Hz, 4H), 7.26 (d, J = 
7.6 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 7.14 (dt, J = 7.5, 3.6 Hz, 3H), 7.10 – 7.04 (m, 2H), 6.77 – 
6.72 (m, 5H), 5.00 (d, J = 11.0 Hz, 1H), 4.65 (d, J = 11.0 Hz, 1H), 4.61 – 4.56 (m, 3H), 4.56 – 
4.49 (m, 3H), 4.39 (d, J = 11.5 Hz, 1H), 4.28 – 4.25 (m, 1H), 4.16 (dd, J = 9.6, 3.1 Hz, 1H), 4.03 
(t, J = 2.6 Hz, 1H), 3.89 (dd, J= 11.3, 4.1 Hz, 1H), 3.73 (dd, J = 11.3, 1.7 Hz, 1H), 3.30 (s, 3H), 
3.29 (s, 3H). 13C NMR δ C (175 MHz, C6D6, α only) 160.7, 159.9, 159.7, 139.4, 139.0, 131.2, 
130.7, 129.9, 129.7, 128.6, 128.5, 128.3, 127.8, 127.6, 114.1, 114.1, 97.0, 91.7 79.8, 76.1, 75.5, 
74.9, 74.0, 73.4, 73.4, 72.8, 72.3, 68.9, 54.8, 54.8. IR (thin film, cm-1): 3473, 2928, 1723, 1612, 
1514, 1454, 1363, 1249, 1108, 1035, 836, 698. HRMS (ESI+) (m/z): [M+NH4]
+ calcd for 
C38H44Cl3N2O8 761.2158, found 761.2152. 
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Chiral phosphoric acid-catalyzed glycosylation studies 
General protocol for the CPA-catalyzed glycosylation reactions: 
A flame-dried 4 mL vial was charged with D-mannose trichloroacetimidate 3-2 (0.024 mmol), 2-
deoxystreptamine 3-1 (0.012 mmol), 4 Å MS (~20 mg), and CPA catalyst (0.0024 mmol). The 
resulting mixture was refluxed in dry dichloromethane (0.1 mL) for 3 days, then quenched with 
triethylamine and analyzed by crude 1H NMR. 
(1R,2S,3S,4R,6S)-4,6-diazido-3-(((2S,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-((4-methoxy-
benzyl)oxy)-6-(((4-methoxybenzyl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-2-((tert-
butyldimethylsilyl)oxy)cyclohexan-1-ol (α-3-A and α-3-3B).  
A flame-dried 4 mL vial was charged with the D-mannose trichloroacetimidate donor 3-2 (544 mg, 
0.73 mmol), 2-deoxystreptamine acceptor 3-1 (150 mg, 0.457 mmol), flame dried 4 Å MS (150 
mg), and (S)-SF5-chiral phosphoric acid (CPA) catalyst
26 (45.9 mg, 0.0457 mmol). The resulting 
mixture was flushed with nitrogen, then dry DCM (2.4 mL) was added. The resulting mixture was 
refluxed for 3 days, then quenched with triethylamine. Crude 1H NMR showed 88% conversion 
with 1:6 selectivity. The mixture was purified by column chromatography on SiO2 (9:1 
hexanes/ethyl acetate). Purification resulted in some mixed fractions of glycal with glycosylated 
product and fractions of pure glycosylation products (5.7:1 diastereoselectivity). All fractions 
containing glycosylation products were combined as a colorless oil (α-3-3A/B mix, 307mg, 74% 
yield) The J1(C-H) coupling constant for the anomeric C-H groups is consistent with the α-3-3A 
and α-3-3B configuration (169.05 and 173.425 Hz respectively).  An aliquot of this mixture was 




α-3-3A (C4-glycosylated isomer):  
1H NMR 700 MHz, C6D6) δ 7.44 (d, J = 8.5 Hz, 2H), 7.39 (2 H, d, J = 8.5 Hz), 7.30 (2 H, d, J = 
7.5 Hz), 7.25 (2 H, d, J = 8.5 Hz), 7.21-7.17 (m, 3H), 7.14-7.05 (m, 3H), 6.82 (2 H, d, J = 8.5 Hz), 
6.76 (2 H, d, J = 8.5 Hz), 5.70 (1 H, d, J = 1.6 Hz), 5.16 (1 H, d, J = 11.0 Hz), 5.01 (2 H, d, J = 
11.7 Hz), 4.85 (1 H, d, J = 11.9 Hz), 4.79 (1 H, d, J = 11.0 Hz), 4.76 (1 H, d, J = 11.9 Hz), 4.67 (1 
H, d, J = 11.4 Hz), 4.62 (1 H, d, J = 11.4 Hz), 4.55 (1 H, dd, J = 9.5, 5.0 Hz), 4.45 (1 H, d, J = 11.7 
Hz), 4.34 (1 H, dd, J = 9.5, 2.4 Hz), 4.22 (1 H, t, J = 2.4 Hz), 3.96 (1 H, dd, J = 11.0, 4.8 Hz), 3.89 
(1 H, dd, J = 11.0, 1.4 Hz), 3.50 (1 H, t, J = 9.5 Hz), 3.32 (s, 3H), 3.315 (s, 3H), 3.23 (1 H, t, J = 
8.9 Hz), 2.68 (1 H, dd, J = 9.5, 4.0 Hz), 2.47 (1 H, ddd, J = 12.3, 9.7, 4.6 Hz), 1.81(1 H, d, J = 3.9 
Hz), 1.49 (1 H, dt, J = 12.3, 4.6 Hz), 1.0 (s, 9H), 0.19 (s, 3H), 0.18 (s, 3H). IR (thin film, cm-
1):3478, 3031, 2933, 2857, 1612, 1514, 1248, 1095, 1037, 837. HRMS (ESI+) (m/z): [M+NH4]
+ 
calcd for C48H62N6O10SiNH4 928.4635, found 928.4635. 
 
α-3-3B (C6-glycosylated isomer):  
1H NMR 700 MHz, C6D6) δ 7.40 (4 H, t, J = 8.0 Hz), 7.34 (2 H, d, J = 7.3 Hz), 7.30-7.25 (m, 3H), 
7.25-7.18 (m, 2H), 7.12-7.07 (m, 3H), 6.82 (2 H, d, J = 8.3 Hz), 6.78 (2 H, d, J = 8.3 Hz), 5.64 (1 
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H, d, J = 1.7 Hz), 5.02 (1 H, d, J = 10.9 Hz), 4.85 (1 H, d, J = 12.5 Hz), 4.78 (1 H, d, J = 10.9 Hz), 
4.75 (1 H, d, J = 5.5 Hz), 4.68 (1 H, d, J = 11.7 Hz), 4.62 (1 H, d, J = 10.9 Hz), 4.60 (1 H, d, J = 
10.9 Hz), 4.46-4.38 (m, 3H), 4.29-4.26 (m, 2H), 3.92 (1 H, dd, J = 10.1, 4.7 Hz), 3.84 (1 H, d, J = 
10.9 Hz), 3.33 (s, 3H), 3.31 (s, 3H), 3.17 (2 H, dd, J = 12.5, 8.1 Hz), 2.79 (1 H, dt, J = 12.2, 9.5, 
4.2 Hz), 2.49 (1 H, ddd, J = 12.5, 9.8, 4.8 Hz), 1.90 (1 H, d, J = 3.6 Hz), 1.45 (1 H, dt, J = 12.5, 
4.5 Hz), 1.02 (s, 9H), 0.88 (1 H, q, J = 12.7 Hz), 0.33 (s, 3H), 0.21 (s, 3H). 13C NMR (only major 
isomer (α-3B) reported, 175 MHz, C6D6) δ 159.8, 159.6, 139.6, 139.4, 131.4, 131.3, 129.7, 128.7, 
128.5, 128.3, 128.1, 128.0, 128.0, 127.8, 114.1, 114.0, 99.8, 99.0, 81.6, 80.1, 77.8, 76.6, 75.9, 75.1, 
74.0, 73.3, 73.2, 72.5, 69.9, 60.7, 60.0, 54.8, 54.7, 32.2, 26.4, 18.6, -3.2. IR (thin film, cm-1):3478, 
3031, 2933, 2857, 1612, 1514, 1248, 1095, 1037, 837. HRMS (ESI+) (m/z): [M+NH4]
+ calcd for 






2,3-bis(benzyl oxy)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-ol (3-4) 
The benzylated product  S4 from above (45.8 mg, 0.0469 mmol) was mixed together with DDQ 
(21.3 mg, 0.0937 mmol), then 0.32 mL of DCM was added along with 1 drop of water. The mixture 
was stirred at room temperature for 1.5 h. Then the reaction was quenched with saturated sodium 
bicarbonate, and extracted with DCM. Organics were washed with saturated sodium bicarbonate, 
brine, dried with magnesium sulfate. Column chromatography on SiO2 (4:1 to 3:2 hexanes/ethyl 
acetate resulted in 23.1 mg (67%) of 3-4 as a colorless oil.  
1H NMR (400 MHz, Benzene-d6) δ 7.37 – 7.31 (m, 4H), 7.26 – 7.21 (m, 4H), 7.18 (d, J = 7.3 Hz, 
3H), 7.14 – 7.02 (m, 9H), 5.65 (d, J = 1.7 Hz, 1H), 4.86 (dd, J = 18.6, 11.1 Hz, 2H), 4.75 – 4.62 
(m, 4H), 4.53 (s, 2H), 4.29 (t, J = 2.4 Hz, 1H), 4.15 – 4.04 (m, 2H), 3.97 (dd, J = 8.5, 3.2 Hz, 1H), 
3.73 (dd, J = 12.2, 2.1 Hz, 1H), 3.61 (d, J = 12.1 Hz, 1H), 3.28 (t, J = 9.5 Hz, 1H), 2.96 (dt, J = 
26.3, 9.3 Hz, 2H), 2.65 (dddd, J = 19.0, 16.2, 11.6, 5.5 Hz, 3H), 1.44 (dt, J = 13.1, 4.5 Hz, 1H), 





(((1S,2S,3R, 4S,6R)-4,6-diazido-2,3-bis(benzyloxy)cyclohexyl)oxy) tetrahydro-2H-pyran (3-
5). 
 Diol 3-4 (23.1 mg, 0.0314 mmol) was dissolved in 0.17 mL of dry DCM and cooled down to -
15 °C under nitrogen. To this mixture pyridine (12.6 μL, 0.157 mmol) was added, followed by 
trifluoromethanesulfonic anhydride (21.1 μL, 0.125 mmol). The resulting solution was stirred at 
the same temperature for 10 mins before being diluted with DCM and water. Organics were 
extracted with DCM, and the extracts were washed with saturated sodium bicarbonate and water 
and then dried with magnesium sulfate, filtered and concentrated in vacuo.  
     The resulting crude triflate from above was dissolved in dry DMF under nitrogen. To that 
solution sodium azide (7.8 mg, 0.120 mmol) was added, the mixture was stirred at 40 °C for 4 h, 
and then was diluted with DCM and water. The organics were extracted with DCM, then washed 
with brine/water (1:1) and brine, dried over magnesium sulfate and concentrated in vacuo. The 
product was purified by column chromatography on SiO2 (4:1 hexanes/ethyl acetate). The 
procedure yielded 3 mg (30 %, 2 steps) of the desired product 3-5.  
 
1H NMR (700 MHz, Chloroform-d) δ 7.39 – 7.31 (m, 7H), 7.28 (d, J = 9.6 Hz, 7H), 7.24 – 7.10 
(m, 6H), 5.56 (d, J = 3.8 Hz, 1H), 5.30 (d, J = 0.8 Hz, 1H), 5.02 (d, J = 11.0 Hz, 1H), 4.90 – 4.86 
(m, 3H), 4.84 (d, J = 10.5 Hz, 1H), 4.79 (d, J = 11.1 Hz, 1H), 4.68 (d, J = 11.1 Hz, 1H), 4.47 (d, J 
= 11.1 Hz, 1H), 4.01 – 3.97 (m, 1H), 3.87 (t, J = 9.6 Hz, 1H), 3.61 – 3.56 (m, 1H), 3.54 – 3.47 (m, 
118 
 
4H), 3.45 – 3.43 (m, 2H), 3.40 (dd, J = 10.3, 3.7 Hz, 1H), 3.04 (dd, J = 13.6, 2.4 Hz, 1H), 2.68 (dd, 
J = 13.5, 3.5 Hz, 1H), 2.31 (dt, J = 13.4, 4.5 Hz, 1H), 1.51 – 1.47 (m, 1H). 13C NMR (175 MHz, 
Chloroform-d) δ 138.1, 137.8, 137.6, 137.3, 128.6, 128.5, 128.5, 128.4, 128.2, 128.2, 128.1, 127.9, 
127.9, 127.8, 127.7, 127.4, 97.6, 84.8, 81.9, 80.1, 78.6, 76.2, 76.0, 75.6, 75.1, 70.5, 63.6, 61.6, 
60.5, 50.4, 32.8, 29.9. IR (thin film, cm-1 ): 2924, 2103, 1722, 1454, 1361, 1260, 1124, 739, 697. 
HRMS (ESI+) (m/z): [M+Na]+ calcd for C40H42N12O6Na 809.3242, found 809.3232. 
 
 (2R,3R,4R,5R,6R)-3-azido-6-(azidomethyl)-4,5-bis(benzyloxy)-
2-(((1R,2R, 3S,4R,6S)-4,6-diazido-2,3-bis(benzyloxy)cyclo hexyl)oxy)tetrahydro-2H-pyran 
(3-6). 
Protected neamine 3-6 was prepared from kanamycin B by following the literature prep.27 The 
spectra of 3-5 and 3-6 were compared to each other in the spectra section below. 
1H NMR (500 MHz, Chloroform-d) δ 7.40 – 7.26 (m, 19H), 5.58 (d, J = 3.9 Hz, 1H), 5.03 (d, J = 
10.8 Hz, 1H), 4.94 (d, J = 10.9 Hz, 1H), 4.88 (d, J = 8.8 Hz, 4H), 4.83 (d, J = 10.5 Hz, 2H), 4.62 
(d, J = 11.2 Hz, 1H), 4.28 (ddd, J = 10.0, 4.3, 2.4 Hz, 1H), 4.01 (dd, J = 10.3, 8.9 Hz, 1H), 3.66 – 
3.57 (m, 2H), 3.56 – 3.47 (m, 3H), 3.47 – 3.37 (m, 3H), 3.32 (dd, J = 10.4, 3.9 Hz, 1H), 2.38 – 
2.29 (m, 1H), 1.50 (d, J = 12.7 Hz, 1H). 13C NMR (125 MHz, Chloroform-d) δ 138.1, 137.8, 137.8, 
137.4, 128.7, 128.6, 128.6, 128.6, 128.3, 128.2, 128.2, 128.1, 128.1, 127.9, 127.8, 127.0, 97.7, 










yl)oxy)cyclohexane-1,2-diol (3-14).  
The 86:14 mixture of disaccharide a-3-3B : a-3-3A (30 mg, 0.0329 mmol) was mixed with 25 
mg of 4Å MS, flushed with nitrogen, and then dissolved in 1.5 mL dry THF. The reaction was 
cooled down to 0 °C, and tetra-n-butylammonium fluoride (TBAF, 1.0 M in THF, 0.066 mL, 
0.066 mmol) was added. The reaction mixture was warmed up to room temperature and was 
stirred for overnight. Then the reaction mixture was quenched with saturated sodium bicarbonate 
and extracted with ethyl acetate. Organics were washed with brine/water (1:1) two times, then 
brine. Extracts were dried with magnesium sulfate, and solvent was evaporated. The mixture was 
purified by column chromatography on SiO2 (3:1 to 2:1 hexanes/ethyl acetate) to afford 
compound 3-14 (18.3 mg, 70%).  
C6-glycosylated diastereomer (3-14).  
1H NMR δ H (500 MHz, Benzene-d6) δ 7.45 – 7.39 (m, 2H), 7.34 (d, J = 8.6 Hz, 2H), 7.26 – 7.18 
(m, 6H), 7.15 – 7.07 (m, 4H), 6.86 – 6.78 (m, 4H), 5.06 – 4.92 (m, 3H), 4.74 – 4.58 (m, 4H), 4.45 
(d, J = 11.4 Hz, 1H), 4.27 – 4.20 (m, 3H), 4.15 (t, J = 2.5 Hz, 1H), 4.09 (dd, J = 9.1, 2.9 Hz, 1H), 
4.01 (t, J = 9.5 Hz, 1H), 3.81 (dd, J = 9.6, 1.9 Hz, 1H), 3.53 (t, J = 9.1 Hz, 1H), 3.35 (s, 3H), 3.30 
(s, 3H), 3.18 (t, J = 9.4 Hz, 1H), 3.06 (td, J = 8.8, 3.0 Hz, 1H), 2.96 – 2.83 (m, 3H), 2.56 (ddd, J = 
12.7, 9.5, 4.7 Hz, 1H), 1.50 (dt, J = 13.2, 4.6 Hz, 1H). 13C NMR δ C (125 MHz, C6D6) 160.1, 160.1, 
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139.1, 139.1, 130.6, 130.1, 130.0, 129.9, 128.7, 128.6, 128.5, 128.3, 128.0, 127.9, 114.2, 114.2, 
100.4, 88.1, 80.5, 76.4, 75.6, 75.2, 75.1, 75.1, 73.4, 73.3, 73.0, 72.0, 70.1, 59.6, 59.6, 54.9, 54.8, 
32.3. IR (thin film, cm-1): 3469, 2654, 1702, 1613, 1586, 1369, 1256, 1109, 1033, 816, 689, 658. 
HRMS (ESI+) (m/z): [M+NH4]
+ calcd for C42H52N7O10 814.3770, found 814.3767. 
 (2R,4aR,6R,7R,8S,8aS)-8-azido-7-(benzyloxy)-2-phenylhexa-
hydropyrano[3,2-d][1,3]dioxin-6-yl 2,2,2-trichloroacetimidate (3-13).   
(Check scheme 3.5 for the whole reaction scheme of synthesis of 3-13)  
 
Thioglycoside 3-12 (784 mg, 1.77 mmol) was dissolved in 25% (v/v) solution of water in acetone 
and cooled to 0 ºC. To this solution trichloroisocyanuric acid (825 mg, 3.55 mmol) was added.  
The resultant mixture was allowed to warm up to room temperature while being monitored by 
TLC.  Upon the full conversion to hemiacetal, the mixture was concentrated in vacuo and diluted 
with methylene chloride.  The resultant mixture was washed with saturated solution of sodium 
bicarbonate and water, dried over magnesium sulfate, filtered and concentrated in vacuo. The 
residual oil was purified by flash column chromatography on SiO2 (3:1 hexanes/ethyl acetate) to 
provide the corresponding product (400 mg, 59%) as a colorless oil. 
 The product from above (355 mg, 0.928 mmol) was dissolved in DCM (17 mL) in the atmosphere 
of N2. The reaction mixture was cooled down to 0 
oC, and trichloroacetonitrile (0.28 mL, 2.783 
mmol) and 1,8-diazabicyclo(5.4.0)undec-7-ene (DBU, 0.069 mL, 0.464 mmol) were added 
sequentially. The reaction mixture was allowed to stir until reaction mixture was warmed up to 
room temperature. The reaction mixture was diluted with toluene and the solvent was evaporated 
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in vacuo. The mixture was purified by flash column chromatography on SiO2 (5:1 to 3:1 
hexanes/ethyl acetate) to afford the title compound 3-13 (1.20 g, 91%). 
1H NMR δH (500 MHz, Chloroform-d) 8.65 (1 H, s), 7.50 (2 H, dd, J = 7.6, 1.9 Hz), 7.41 – 7.28 
(8 H, m), 6.40 (1 H, d, J = 3.6 Hz), 5.57 (1 H, s), 4.73 (2 H, s), 4.33 (1 H, dd, J = 10.5, 4.9 Hz), 
4.12 (1 H, t, J = 10.0 Hz), 4.04 (1 H, td, J = 9.9, 4.9 Hz), 3.71 (1 H, t, J = 10.3 Hz), 3.61 (1 H, dd, 
J = 9.8, 3.6 Hz), 3.54 (1 H, t, J = 9.9 Hz).13C NMR δC (125 MHz, Chloroform-d) 161.4, 137.1, 
136.7, 129.3, 128.7, 128.5, 128.3, 128.1, 126.1, 101.8, 93.6, 91.0, 79.5, 77.4, 73.3, 68.8, 65.3, 61.7. 
IR (thin film, cm-1): 3329, 2923, 2867, 2108, 1908,1672, 1454, 1370, 1278, 1088, 986, 905. 








The disaccharide acceptor 3-14 obtained above (119 mg 0.150 mmol) and donor 3-13 (119 mg, 
0.224 mmol) were azeotropped with toluene three times, and further dried under high vacuum for 
3 h. To the flask containing the resultant residue under the atmosphere of N2, dried 4 Å 
molecular sieves and dried DCM (0.6 mL) and Et2O (0.6 mL) were added. The reaction was 
cooled down to -78 °C, and TMSOTf (4 μL, 0.022 mmol) was injected. The reaction was stirred 
at -78 oC for 1 h, and quenched by the addition of triethyl amine at -78 oC  and warmed up. The 
reaction mixture was diluted with DCM and the mixture was concentrated in vacuo. The mixture 
was purified by flash column chromatography on SiO2 (5:1 to 2:1 hexanes/ethyl acetate) to 
afford the trisaccharide 3-15 (single diastereomer, 115 mg, 66 %). 
1H NMR δ H (700 MHz, Benzene-d6) 7.71 (2 H, d), 7.52 (2 H, d), 7.41 (2 H, d), 7.38 (2 H, d, J = 
8.5 Hz), 7.30 (2 H, d), 7.28 – 7.17 (12 H, m), 7.13 – 7.04 (5 H, m), 6.84 – 6.80 (4 H, m), 5.66 (1 
H, d, J = 3.8 Hz), 5.36 (1 H, s), 5.15 (1 H, d, J = 1.9 Hz), 5.08 (1 H, d, J = 11.1 Hz), 4.77 (1 H, d, 
J = 11.8 Hz), 4.72 (1 H, d, J = 11.8 Hz), 4.68 (1 H, d, J = 11.9 Hz), 4.63 (1 H, d, J = 11.9 Hz), 
4.56 (2 H, dd, J = 11.2, 6.3 Hz), 4.50 – 4.46 (2 H, m), 4.44 – 4.36 (5 H, m), 4.26 – 4.21 (3 H, m), 
4.13 (1 H, dd, J = 9.3, 3.0 Hz), 3.87 (1 H, dd, J = 10.3, 1.8 Hz), 3.73 (1 H, dd, J = 10.2, 7.0 Hz), 
3.56 (1 H, t, J = 10.2 Hz), 3.38 (3 H, s), 3.34 (1 H, t, J = 1.9 Hz), 3.33 – 3.32 (1 H, m), 3.31 (3 H, 
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s), 3.29 (1 H, dd, J = 8.9, 2.1 Hz), 3.22 (1 H, dd, J = 10.0, 8.7 Hz), 2.91 (1 H, t, J = 9.3 Hz), 2.54 
(1 H, ddd, J = 12.6, 9.9, 4.5 Hz), 2.47 (1 H, ddd, J = 12.6, 9.8, 4.4 Hz).13C NMR δ C (125 MHz, 
C6D6) 160.1, 159.8, 139.3, 139.1, 139.0, 138.2, 138.0, 130.7, 130.6, 130.1, 129.8, 129.1, 128.9, 
128.7, 128.6, 128.5, 128.4, 128.4, 128.2, 128.0, 127.8, 126.7, 114.2, 114.1, 102.0, 101.2, 97.7, 
86.3, 80.6, 80.3, 80.2, 78.5, 75.7, 75.6, 75.4, 74.8, 73.6, 73.6, 73.2, 72.8, 72.0, 70.2, 69.4, 63.8, 
62.7, 60.0, 59.1, 54.9, 54.8, 31.7. IR (thin film, cm-1): 3498, 2922, 2855, 2339, 2102, 1512, 1456, 
1254, 1092, 972. HRMS (ESI+) (m/z): [M+NH4]






acetate (3-18).  
 
To a solution of diol 3-17 (12.2 mg, 0.0126 mmol) in DCM (0.3 mL) at -78 oC, dried 2,6-lutidine 
(14 μl, 0.126 mmol) and triflic anhydride (8 μL, 0.0504 mmol) were added sequentially. The 
reaction mixture was stirred at -78 oC for 1h and then quenched with water / THF solution before 
being warmed up to room temperature. The resulting mixture was extracted with DCM three times, 
and the combined organic layers were washed with water (x 3), dried over anhydrous sodium 
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sulfate, filtered and concentrated to obtain bis-triflate (14.5 mg, 0.0118 mmol). To the solution of 
resulting crude triflate (14.5 mg, 0.0118 mmol) in dimethyl sulfoxide (2 mL), sodium azide (15 
mg, 0.236 mmol) was added in one portion. The reaction mixture was allowed to stir at 90 oC 
overnight. The mixture was diluted with brine, and then organic layers were extracted with DCM 
(x 3) and dried over sodium sulfate, filtered and concentrated in vacuo. The resulting crude oil was 
purified by flash column chromatography on SiO2 (7:1 to 3:1 hexanes / ethyl acetate) to afford the 
protected iso-kanamycin 3-18 (3.6 mg, 16% yield, 2 steps). 
1H NMR δ H (700 MHz, Benzene-d6) 7.70 – 7.65 (2 H, m), 7.38 (2 H, d, J = 7.6 Hz), 7.33 (2 H, d, 
J = 7.5 Hz), 7.27 (3 H, s), 7.21 (5 H, s), 7.13 – 7.07 (5 H, m), 7.05 (2 H, s), 5.34 (1 H, s), 4.99 (1 
H, d, J = 3.4 Hz), 4.95 (1 H, t, J = 9.5 Hz), 4.92 (1 H, d, J = 10.9 Hz), 4.86 (1 H, d, J = 3.2 Hz), 
4.78 (2 H, d, J = 11.3 Hz), 4.52 – 4.50 (1 H, m), 4.50 – 4.46 (2 H, m), 4.35 (1 H, d, J = 11.8 Hz), 
4.25 – 4.17 (2 H, m), 4.03 (1 H, t, J = 9.6 Hz), 3.97 (1 H, dt, J = 9.8, 3.4 Hz), 3.53 (1 H, t, J = 10.4 
Hz), 3.47 (1 H, t, J = 9.4 Hz), 3.39 (1 H, dd, J = 13.5, 2.5 Hz), 3.23 – 3.19 (2 H, m), 3.16 (1 H, t, 
J = 9.7 Hz), 3.09 – 3.04 (2 H, m), 2.87 (2 H, qd, J = 9.6, 5.5 Hz), 2.39 (1 H, ddd, J = 12.3, 9.4, 4.7 
Hz), 1.97 (3 H, s), 1.05 (1 H, dd, J = 11.8, 6.7 Hz).13C NMR δ C (175 MHz, C6D6) 169.9, 138.5, 
138.4, 137.8, 137.8, 129.2, 128.9, 128.7, 128.7, 128.7, 128.7, 128.4, 128.4, 128.3, 128.3, 127.8, 
126.7, 102.1, 99.2, 98.5, 82.3, 80.2, 79.8, 78.6, 75.6, 75.2, 74.0, 72.1, 69.3, 64.6, 64.3, 62.3, 61.4, 
60.4, 60.1, 51.0, 30.2, 21.6. IR (thin film, cm-1): 2920, 2845, 2101, 1755, 1457, 1201, 1116. 
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Chapter 4  
Chiral Phosphoric Acid-Catalyzed Stereoselective and Regioselective Glycosylation 
4.1 Introduction to selective glycosylation 
Glycosylation is referred to as a reaction of glycosyl donors, generally, carbohydrates with 
a leaving group, coupled to a glycosyl acceptor, generally, compounds that contain free hydroxyl 
groups, to form a glycoside. Carbohydrates, products of glycosylation reactions, play pivotal roles 
in biological systems, such as intracellular and extracellular targeting,1 protein folding, 2 peptide 
transportation,3 immunomodulation,4 and so on.5 Beyond in-flask carbohydrate synthesis, the 
glycosylation reaction itself is important in that most post-translational modifications of proteins 
occur through glycosylation across more than half of the eukaryotic proteome.6 Due to the 
important roles of carbohydrates in biological processes, even simple carbohydrates like mono-
and oligosaccharides are commonly found as structural motifs in drug discovery.7 With this 
background, numerous studies of the glycosylation of bioactive compounds have been carried out 
to enhance their therapeutic properties. Indeed, glycosylation of biologics improved a wide range 
of drug properties including in vivo circulatory half-life8, immunogenicity,9 and enhancement of 
efficacy and safety. 5,10 
In order to produce these positive effects through glycosylation, specific carbohydrates 
must be placed in a specific position of a bioactive compound, which implies that regioselective 
glycosylation is necessary. Nature employs enzymes called glycosyltransferases to carry out 
regioselective glycosylation. 11 The selective chemical glycosylation, however, is challenging due 
to the intrinsic complexity of carbohydrates. In carbohydrate synthesis, especially, not only the 
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control of regioselectivity, but also the control of stereoselectivity is crucial, which otherwise 
complicates the outcome of glycosylation.  
Despite the difficulties in selectivity control for chemical glycosylation, a considerable 
number of regioselective glycosylation methods are available. These regioselective glycosylation 
approaches could be divided into two main categories: substrate- (i.e. donor/acceptor-) controlled 
glycosylations and reagent/catalyst-controlled glycosylations.12  
First, the regioselectivity outcome can vary depending on the kind of glycosyl donors and 
glycosyl acceptors. For instance, compounds that contains multiple hydroxyl groups can have their 
own intrinsic selectivity, which could result in moderate to high regioselectivities for some 
glycosylation reactions.13 Different types of sugars possess different intrinsic reactivity of their 
hydroxyl groups, therefore, regioselectivity is affected by the types of sugar in glycosyl acceptors. 
In addition to that, the protecting groups of glycosyl acceptor and glycosyl donor can affect the 
regioselectivity outcome. For instance, the intrinsic reactivity of the hydroxyl groups on the 
glycosyl acceptor can be manipulated by changing the protecting groups. 14 The reactivity of the 
glycosyl donor is also known to be affected by the protecting groups. The concept of armed and 
disarmed donor is the representative example of the effect of different protecting groups enhancing 
or attenuating the reactivity of a glycosyl donor. Besides the type of sugars and protecting group, 
match/mismatch of glycosyl donor and acceptors also affects the regioselectivity of glycosylation. 
Both the type of the leaving group and the configuration of the glycosyl donor will impact the 
regioselectivity of glycosylation reactions. 
Second, the regioselectivity of the glycosylation reaction can be controlled either by a 
reagent or a catalyst. The reagents, such as organotin, silver-based activators, triphenylmethyl 
ethers, or boronic esters have been used to accomplish the regioselective glycosylations. A more 
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indirect way to control the regioselectivity of glycosylation is by using catalysts. Many examples 
of regioselective and stereoselective glycosylation methods are available (Refer to chapter 2). 15 
This chapter focuses on the chiral catalyst-controlled regioselective glycosylation reactions.  
4.2 CPA catalysis in carbohydrate system 
In organic synthesis, chiral phosphoric acids (CPAs) have received substantial attention as 
the catalysts for promoting asymmetric transformations (vide supra). The application of the CPA 
to achieve control of stereoselectivity is particularly beneficial in glycosylation reactions because 
it may help to avoid handling mixtures of isomeric glycosides by biasing the formation of only 
one glyco-form. By taking the advantage of CPA catalysts, the Fairbanks group was the first group 
to apply BINOL-based CPAs to enhance the stereoselectivity of β-selective galactoside 
formations.16 Subsequently, Toshima group achieved racemic secondary alcohol resolution using 
diastereoselective glycosylation with CPA catalysis.17 The Bennett group also reported 
stereoselective glycosylation of 2-deoxyglucose using a hydrogenated BINOL-CPA.18 Finally, 
Galan group suggested that a combination of the CPA and thiourea catalysts can produce a 
synergistic effect in α-stereoselective glycosylatation of glycal substrates.19 Our group also has 
long-term interests in using CPA to perform regioselective glycosylation of polyol system. The 
desymmetrizative glycosylation studies summarized in Chapter 3 represent an example of some of 
our efforts in this area.20 In addition, our group has also demonstrated that chiral phosphoric acids 
could control regioselective glycosylation of 6-deoxyerythronolide B (6-dEB), and the site of 
glycosylation was dependent on the structure and chirality of the chiral Bronsted acid.21 Given the 
successful application of CPA in the preceding studies, CPA catalysis is a very powerful tool for 
controlling the stereo- and regioselectivity of glycosylation reactions.  
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In addition to developing CPA-catalyzed methods for glycosylation, our group has 
discovered that chiral phosphoric acids are excellent catalysts for site-selective acetalization of 
carbohydrate-derived 2,3-diols.22 The reactions of carbohydrate-derived 2,3-diols are not 
inherently selective, therefore achiral catalysts promote the formation of both C2- and C3-acetals 
with C3-acetalization products slightly prevailing in the mixture. However, some BINOL-derived 
CPAs were found to provide very high regioselectivity, which was opposite to the achiral catalyst-
controlled selectivity. Considering that the CPA was able to distinguish the C2-and C3-position in 
the D-glucose-based system for acetalization reaction, we hypothesized that CPA-catalyzed 
regioselective glycosylation would also be possible using the same 2,3-diol as an acceptor. Various 
prior studies have already demonstrated the ability of CPA to control stereoselectivity; however, 
the potential of CPAs in controlling both stereo- and regioselectivity is yet to be revealed. Based 
on our prior experiences (vide supra), we believe that CPAs could control both the site-selective 
and stereoselective glycosylation of 2,3-diols (Figure 4.1a).  
 
Figure 4. 1. a) CPA-catalyzed regioselective and stereoselective glycosylation of D-glucose 







This chapter is focused on summarizing our work on exploring CPAs as the catalysts that 
control both regioselective and stereoselective glycosylation of carbohydrate-derived diols.  
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4.3 CPA-catalyzed glycosylation reaction of D-glucose-derived 2,3-diols 
Our studies commenced with establishing the optimal glycosylation conditions. A 
benzylated D-glucose-derived trichloroacetimidate (TCA) donor 4-2 and the D-glucose-derived 
2,3-diol acceptor 4-1 were selected for our initial studies. (R)-2N was selected as the initial catalyst 
for the glycosylation reaction. The reaction was performed with 1.5 equivalent of donor 4-2 and 
20 mol% of CPA in anhydrous DCM at room temperature for 24 h. Unlike the acetalization 
reaction, the glycosylation reaction was found to be significantly slower. The observed low 
reactivity is likely due to the low solubility of the acceptor diol in DCM. After the reaction was 
warmed up to 40 oC, higher conversion was obtained (71%). This glycosylation reaction generated 
4 different isomers, which were α-C2, α-C3, β-C2, and β-C3 isomers as expected (Figure 4.1a). 
(R)-2N favored the formation of the C3 isomer (C3:C2 = 75:25) and β-anomer (α:β = 12:88).  
With the promising initial results observed for the (R)-2N-catalyzed glycosylation, various 
CPAs were evaluated as the catalysts for the glycosylation of 4-1 and 4-2 (Table 4.1). First, the 
control experiment was carried out with diphenyl phosphoric acid (DPPA) as the catalyst (entry 
1), and the intrinsic β-selectivity (α:β = 36:64) and C3-selectivity (C3:C2 = 70:30) were observed. 
Compared to the control experiments, CPAs containing electron withdrawing group substituents 
at the 3,3'-aryl rings provided favored β-C3 diastereomer (entries 3-8). Compared to (R)-CPA 
catalysts, (S)-CPA catalysts afforded better C3-selectivity in general. In particular, (S)-2N and (S)-
3H were found to induce high C3-selectivities (C3:C2 = 81:19 and 85:15 correspondingly). While 
electron-withdrawing groups on 3,3’-aryl rings of CPAs promoted glycosylation reaction 
effectively, the CPAs with 3,3’ aryl groups containing electron donating substituents could not 
promote the glycosylation reaction at all (entries 9-13). This result has already been observed 
before in glycosylation of 2-deoxysterptamine, which was described in Chapter 3 of this thesis. In 
135 
 
order to see if further enhancing the acidity of catalyst is beneficial, the N-triflamide-based 
catalysts 4C and 4D were employed for the glycosylation reactions, which resulted in α-and C3-
selective formation of the products (entry 14-16). 
 




Based on the observed stereochemistry switched from β- to α- with more acidic catalyst, 
we investigated the possibility of increasing the amount of acid catalyst with the hope to further 
enhance the a-stereochemistry of glycosylation. One equivalent of diphenyl phosphoric acid was 
used for glycosylation reaction, and α-glycoside was obtained as the major product (entry 2). 
Considering that 20 mol% of diphenyl phosphoric acid provided β-selectivity, this result 
confirmed that more acidic medium favors α-selective glycosylation. In order to understand and 
rationalize the selectivity, glycosylation reactions with different conditions were performed.  
 
Table 4. 2. CPA-catalyzed glycosylation reaction with β-trichloroacetimidate donor 4-2. 
 
 
Next, to see if the selectivity is affected by the stereochemistry of trichloroacetimidate’s 
anomeric position, β-4-2 donor was employed for the glycosylation reaction instead of α-4-2 donor 
(Table 4.2). Interestingly, α-configured product prevailed in the glycosylation with β-
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trichloroacetimidate β-4-2, and the opposite stereochemical outcome was observed if α-4-2 is used. 
This result suggests that the stereochemistry of the donor influences the stereoselectivity of the 
glycosylation reaction. The catalyst still favored the reaction at the C3-position; however, the 
regioselectivity diminished in comparison to glycosylation with α-donor α-4-2. These results 
suggest that α-donors favor β-glycoside formation and β-donors favor α-glycoside formation. 
4.4 Mechanism of CPA-catalyzed glycosylation reactions 
With interesting preliminary data in hand, we investigated the glycosylation reaction 
mechanism. Initially, 31P NMR study was carried out with glycosyl donor α-4-2 and CPA (R)-2N. 
Our prior mechanistic and computational studies of CPA-catalyzed glycosylations with glycosyl 
trichloroacetimidates suggested that these reactions proceed through sugar-phosphate covalent 
intermediates.21 To validate that it is also the case in our system, α-4-2 and CPA (R)-2N were 
mixed together in d-Chloroform at room temperature, and 31P NMR was recorded right away (5 
min).We indeed observed that a-trichloroacetimidate donor α-4-2 reacted with CPA to form 
anomeric β-phosphate intermediate β-4-2P. Over the time, β-phosphate β-4-2P slowly epimerized 
to the corresponding α-phosphate α-4-2P (Scheme 4.1a). Within 12 h, which is the operation time 
frame for the glycosylation reaction, β-sugar phosphate β-4-2P was still the major observed 
intermediate for the glycosylation reaction. From our observations, β-glycoside was obtained as 
the major product from a α-trichloroacetimidate donor unless higher catalyst loading was used 
(entry 1, 3-8, Table 4.1). This result excludes the possibility of a SN2 mechanism since the product 
of a SN2 mechanism should contain the inverted stereochemistry, but α-glycoside was not the 
major product. To confirm this result, the same NMR study was carried out with β-
trichloroacetimidate donor β-4-2 (Scheme 4.1b). After mixing with β-4-2 and CPA, the exclusive 
formation of α-phosphate α-4-2P was  
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Scheme 4. 1. NMR study of CPA catalyzed glycosylation reactions: a) α-donor 4-2 forming β-
glycoside. b) β-donor 4-2 forming α-glycoside. 
 
 
observed, and α-phosphate α-4-2P slowly epimerized to β-phosphate β-4-2P over time. Within 12 
h, the α-phosphate α-4-2P was still the major species in solution, and the α-glycoside was formed 
as the major product. Altogether, α-donor α-4-2 produced β-phosphate β-4-2P as an intermediate, 
which eventually provided β-glycoside β-4-2G. Similarly, β -donor β-4-2 formed α -phosphate α-
4-2P  as an intermediate, which then reacted to provide α-glycoside α-4-2G. Simple SN1/SN2 
mechanism does not explain these results, but SNi mechanism
23 perfectly rationalizes the observed 
stereoselectivity of these glycosylation reactions. The SNi mechanism explains the stereoselectivity 
of the glycosylation reaction when the departure of the leaving group of the activated glycosyl 
donor and the front-side nucleophilic attack of the glycosyl acceptor are synchronized. Using this 
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SNi model, the mechanism of the CPA-catalyzed glycosylation reaction was defined as following 
(Figure 4.2a). Once the CPA and α-donor α-4-2 (as an example) formed β-phosphate β-4-2P, the 
glycosyl acceptor 4-1 came in participation. Here, we proposed that phosphoryl oxygen of the 
sugar phosphate and hydroxyl group of the acceptor form a hydrogen bond.  Due to the H-bond 
interaction, nucleophilic attack of the acceptor’s oxygen of the C3-position happens from the same 
face as the β-phosphate, therefore, β-glycoside is obtained as the main product. However, we 
cannot completely rule out a SN1 mechanism as there is still possibility for the formation of 
oxocarbenium/phosphate ion pairs from the covalent phosphate intermediate 4-2P (Figure 4.2b). 
To rationalize the results for the α-selective glycosylation starting with the α-donor under highly 
acidic conditions, we have carried out 31P NMR study of the reaction of donor α-4-2 and acceptor 
4-1 with both 0.2 and 1.0 equivalent of diphenyl phosphoric acid. 31P NMR reaction monitoring 
showed that both reactions initially produced β-phosphate, but the reaction containing 1.0 
equivalent of diphenyl phosphoric acid promoted rapid β-phosphate epimerization to form α-
phosphate. This observation provided an answer to the puzzling α-selectivity from the 
glycosylation reaction with α-donor α-4-2 with stoichiometric acid as the catalyst. Thus, when 
stronger acids are employed, α-donor α-4-2 initially forms β-phosphate β-4-2P, which 
subsequently epimerized to form α-phosphate α-4-2P. The subsequent glycosylation reaction of 
the α-phosphate intermediate α-4-2P and acceptor 4-1 through SNi type mechanism results in α-
glycoside α-4-2G as the major product.  






Figure 4. 2. Plausible mechanism of CPA-catalyzed glycosylation reaction. a) SNi mechanism. 
b) SN1 mechanism. 
 
 
4.5 Further optimization of the glycosylation conditions 
Given that glycosylation reactions were not sufficiently fast at room temperature, the 
further optimization of the reaction conditions was investigated. Due to the low reactivity under 
previously investigated condition, elevated reaction temperatures were required. However, higher 
temperatures can diminish the selectivity emposed by CPAs. In order to increase the reactivity and 
the stereoselectivity/regioselectivity, the reaction conditions were optimized by modifying several 
parameters of glycosylation reaction. 
Initially, the effect of the protecting groups of glycosyl donors in glycosylation reactions 
was investigated. Consequently, the glycosylation reactions were performed with para-methoxy 
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benzyl (PMB) protected donor 4-3 (Table 4.3) instead of benzylated donor 4-2. This switch in the 
donor protecting groups resulted in reduced reactivity and selectivity when compared to the 
correspondingly benzyl-protected donor (Table 4.1 entry 3-4). The glycosylation product arising 
from α-4-3 was so polar that the separation of the isomeric products could not be achieved. As 
PMB protection did not improve the reaction rate, other parameters were investigated instead. 
 
Table 4. 3. CPA-catalyzed glycosylation reaction with PMB protected D-glucose donor 4-3. 
 
 
Next, in order to enhance the reactivity and selectivity of the glycosylation with 4-1 and 4-
2 were performed using Lewis acids such as BBr3, SiCl4, AlCl3, SnCl4, LiCl, ZnCl2 as the co-
catalysts. Since these reactions at room temperature mostly resulted in the decomposition of the 
sugar donors, the glycosylations were carried out at -60 oC instead. The glycosylation reaction 
with Lewis acid co-catalysts, unfortunately, did not increase the regioselectivity, but provided α-
stereoselectivity. This result matched to our previous NMR investigation, which was that acidic 
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conditions facilitate the β-sugar-phosphate to epimerize to form α-position. Following after SNi 
type mechanism, more α-glycoside is obtained as a major stereoselectivity.   
 The huge limitation of diol acceptor 4-1 is that 4-1 is too polar to be dissolved in many 
organic solvents including DCM. Large amount of DCM was needed to fully dissolve the diol 
before the glycosylation reaction, and that was a part of reason for low conversion and necessity 
of introducing heat to promote the reaction. With a careful optimization, 4-tert-butyl thiophenol-
containing diol 4-4 found to be a suitable acceptor for our glycosylation reactions. Most 
importantly, this substrate was well-soluble in organic solvents. In addition to solubility, the 
substrate introduces the additional steric bulk arising from the t-butyl substituent, which could 
induce the regioselectivity in glycosylation reactions.  
 While the glycosylation reaction with diol acceptor 4-1 did not work at room temperature 
at all, the glycosylation reaction with diol 4-4 provided at least with 20% conversion (Table 4.4). 
This result implied that the reactivity was increased with the diol 4-4 compared to 4-1. In this study, 
both α-donor α-4-2 and β-donor β-4-2 were used for the glycosylation reaction with acceptor 4-4 
and (R)-2N as the catalyst. In general, C3-selectivity was favored in all cases, and α-donor favored 
the β-glycoside and β-donor favored the α-glycoside. In terms of regioselectivity and 
stereoselectivity, the glycosylation reaction with 4-4 resulted in an incremental improvement when 
compared to 4-1. With α-4-2, acceptor 4-4 provided C3:C2 = 79:21 regioselectivity, and acceptor 
4-1 provided C3:C2 = 75:25 (Table 4.1, entry 4). With β-4-2, acceptor 4-4 reacted to produce 
C3:C2 = 89:31, and acceptor 4-1 produced C3:C2 = 65:35 (Table 4.2, entry 3). Slight increase in 
C3-selectivity could be reasoned by the steric hinderance from t-Bu in acceptor 4-4, which can 
block of nucleophilic attack on C2-OH. However, the difference is so subtle that it could possibly 
be generated from experimental error. 
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Table 4. 4. CPA-catalyzed glycosylation reaction with donor 4-2 and acceptor 4-4. 
 
 
Even though diol 4-4 improved the solubility in organic solvents, and the reactivity of 
glycosylation reactions, there was still a lot of room for further optimization, especially in 
glycosylation reactivity. 
 
4.6 CPA-catalyzed glycosylation reaction with 6-deoxy-D-glucose donor α-4-10 
From our previous CPA-catalyzed glycosylation study,21 we found that deoxy-sugar 
donors were more reactive than more oxygenated sugar moieties. In order to enhance the rate of 
glycosylation reaction, use of deoxy-sugar was investigated next. The synthesis of 6-deoxyl-D-
glucose derivative α-4-10 is depicted in Scheme 4.2. The synthesis commenced with the tosylation 
of the 6-hydroxyl group of methyl α-D-glucopyranoside 4-5, and the resultant derivative 4-6 was 
reduced by lithium aluminum hydride to generate 4-7. The resulting alcohols of 4-7 were then 
benzylated and the methoxy group in anomeric position was hydrolyzed by acid. After introducing 
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trichloroacetimidate moiety by the reaction of 4-9 with trichloroacetonitrile and DBU, the 
benzylated 6-deoxy D-glucose-derived trichloroacetimidate donor α-4-10 was obtained in 52% 
yield after 5 steps (based on recovered starting material). 
 
Scheme 4. 2. Preparation of benzylated trichloroacetimidate 6-deoxy glucose α-4-10. 
 
 
Table 4. 5. Glycosylation reactivity comparison between acceptor 4-1 and 4-4.   
 
 
 To examine the reactivity of new donor α-4-10, glycosylation reactions were performed 
with diol acceptor 4-1 and 4-4 (Table 4.5). Delightfully, the glycosylation reaction with 6-deoxy 
glucose donor α-4-10 was efficient and high conversion was observed. With (R)-2N as the catalyst, 
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65% of desired glycoside was obtained from 4-1 and 70% of the desired glycoside was afforded 
from 4-4. This result confirmed that diol 4-4 is a more suitable substrate for these studies. In 
addition to the higher conversion, 4-4 provided better regioselectivity (C3:C2 = 75:25) than 4-1 
(C3:C2 = 65:35), which could be rationalized by tert-butyl substituent being involved in steric 
interactions in the transition state leading to C3-selective glycosylation. 
With this successful preliminary results in hand, the effect of the CPA catalysts on the 
reactions of glycosyl donor 4-10 and acceptor 4-4 were further evaluated (Table 4.6). In a control 
reaction with diphenyl phosphoric acid (entries 1 and 2), low levels of regiocontrol favoring the 
C3-glycoside were observed. As before (Table 4.1), 1.0 equivalent of diphenyl phosphoric acid 
provided α-glycoside as the major product (entry 1), presumably due to the fast epimerization of 
the β-phosphate to the α-phosphate when higher amounts of the catalysts were used. Next, CPAs 
with various electron withdrawing groups at the aryl rings of 3,3’-BINOL positions were evaluated 
with α-4-10 (Entry 3-14). In general, the glycosylation reaction was carried out efficiently at room 
temperature with stirring for 12 h. The general trend was that (S)-catalyst promoted better C3-
regioselectivity and β-stereoselectivity than the corresponding (R)-catalyst. 
Like in the case of CPA-catalyzed glycosylation of 2-deoxystreptamine (Chapter 3), (S)-
3I provided greater stereo- and regio-selectivity (entry 6), but the best C3-selectivity was obtained 
with C6F5-containing catalyst (S)-3H, which provided 79:21 = C3:C2 ratio, and high 
stereoselectivity of α:β = 87:13 (entry 8). (R)-4I also provided high C3-selectivity result (C3:C2 
= 75:25) and excellent β-stereoselectivity (α:β = 6:94) with 70% conversion (Entry 13). Next, the 
glycosylation reaction with anomeric β-glycosyl donor β-4-10 were performed (entry 15-17). As 
expected from the prior studies (Section 4.4), α-selectivity was favored with the β-donor β-4-10. 
Compared to the α donor α-4-10, β-4-10 provided diminished C3-selectivity, which was consistent  
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with what was typically observed for the reactions with other β-donors (Section 4.3 and 4.6). 
At this point, we identified catalysts that helped to achieve control over α- or β-selectivities 
and enhance the C3-regioselectivity. However, there was still one missing piece that we were very 
interested in, which was developing conditions for controlling the C2-regioselectivity. 
Unfortunately, using enantiomeric catalysts did not result in regioselectivity switch (entry 3-14). 
As a result, CPAs with electron donating substituents on the aryl groups at the 3,3’-positions of 
BINOL were evaluated. While such catalysts were not effective in promoting glycosylation 
reactions with donor α-4-2, the glycosylation reaction with more reactive donor α-4-10 was now 
successfully promoted (entry 18-25). (R)-CPA catalysts could now favor reversed selectivity 
resulting in C2-selective glycoside formation (entry 18-20, 23). Among them, (R)-2J provided the 
best C2-selectivity (C3:C2 = 25:75) with excellent β-selective stereochemistry (α:β = 4:96) (entry 
20). In general, (R)-CPA was found to favor C2-selectivity and (S)-CPA was found to favor C3-
selectivity, and both catalysts promoted glycosylation to generate β-selective glycosides. 
 
4.7 CPA-catalyzed glycosylation reactions with other deoxy-sugar donors 
The prior studies with acceptor 4-4 and donor 4-10 helped to identify (S)-3H as the catalyst 
that favors C3-selectivity, and catalyst (R)-2J that provided highest C2-selectivity for the 
formation of the corresponding disaccharide. Our subsequent studies were focused on identifying 
other glycosyl donors that follow these trends. To do so, the same acceptor 4-4 was reacted with 
different deoxy-sugars (α-4-11, α-4-12, α-4-13). 
Our studies commenced with L-rhamnose derivative α-4-11. The glycosylation with 
acceptor 4-4 and donor α-4-11 was evaluated with 11 different catalysts, which provided various 
levels of regiocontrol (Table 4.7). Unlike the prior studies, the reaction with L-rhamnose donor α-
4-11 resulted in the formation of α-glycosides α-C2-G3 and α-C3-G3 as products. The reaction  
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was very efficient in most of cases, and no inherent regioselectivity trends were observed as the 
achiral diphenyl phosphoric acid provided C3:C2 = 50:50 selectivity (entry 1). The results of 
screening different CPAs provided the same general trend as before. Thus, (S)-CPAs favored α-
C3-G3 and (R)-CPAs favored α-C2-G3 as the product. As before, more acidic catalysts containing 
electron withdrawing substituents were more effective in promoting higher conversions. 
Compared to the glycosylation with donor α-4-10 (Section 4.6), the same trends were observed for 
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the glycosylation with α-L-rhamnose donor 4-11 as the catalyst (S)-3H provided the highest C3-
selectivity (C3:C2 = 71:29, entry 5), and (R)-2J provided the highest C2-selectivity (C3:C2 = 
12:88, entry 7). These results suggest that generality in donor scope may be achieved, and that 
regiodivergent catalyst-controlled glycosylations are possible with two different catalysts. In 
addition to (R)-2J, (R)-2K also promoted C2-selective glycosylation reaction, but the conversion 
in this case was significantly lower, and elevated temperature was required to enhance the reaction 
rate.  
Next, D-fucose donor α-4-12 was selected for the glycosylation study. The benzylated 
fucose trichloroacetimidate α-4-12 and the acceptor 4-4 were reacted with different CPAs as the 
catalysts (Table 4.8 entry 1-5). It was gratifying to see that (S)-3H promoted the glycosylation 
reaction very efficiently (95% conversion) with high C3 regioselectivity (C3:C2 = 91:9) and with 
high β stereoselectivity (α:β = 15:85) (entry 4). Unlike the previously observed for α-4-10 and α-
4-11 trends, the reaction catalyzed with CPA (R)-2J favored C3- products as ~1:1 mixture of α- 
and β- isomers (entry 5). 
 The fact that glycosylation reaction with L-rhamnose donor α-4-11 favored the C2- product 
α-C2-G3, and D-fucose donor α-4-12 favored C3-glycosylated product promoted us to consider 
the effect of switching the donor enantiomeric configuration (D- or L-). For that reason, benzylated 
L-fucose trichloroacetimidate donor α-4-13 was prepared and subjected to the glycosylation 
reaction with accept 4-4 and CPA catalysts (S)-3H and (R)-2J (Table 4.8, entries 6-7). 
Interestingly, both regioselectivity and stereoselectivity of glycosylation reaction with D-and L-
fucose donors α-4-12 and α-4-13 were different. The glycosylation reaction with D-fucose α-4-12 
provided very high C3-regioselectivity, whereas for the glycosylation reaction with L-fucose α-4-
13, the regioselectivity favored C2-glycosides. While (S)-3H provided C3:C2 = 91:9 with D-fucose 
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donor α-4-12 (Table 4.8, entry 4), the regioselectivity of C3:C2 = 74:26 was obtained with L-
fucose donor α-4-13 (Table 4.8, entry 6). Similarly, with D-fucose donor case, (R)-2J did not favor 
the formation of the C2-product (C3:C2 = 68:32, Table 4.8, entry 5), whereas C2-regioselectivity 
(C3:C2 = 22:78) was obtained with L-fucose donor from (R)-2J (Table 4.8, entry 7). These 
observations suggest that the chirality of sugar donor can affect the stereoselectivity and 





In this chapter, we summarized our studies on the regioselective and stereoselective 
glycosylation reactions catalyzed by CPAs. Initial studies were focused on identifying the suitable 
donors and acceptors, and then, different CPA catalysts were employed to pose control over the 
regioselectivity and stereoselectivity in their glycosylation reactions. In general, the 
stereochemistry of the donor impacted the observed stereoselectivity result. Thus, α-donors 
favored β-selective glycosylations and β-donors favored α-selective glycosylations. These 
observations were rationalized by a SNi mechanism, which suggested that the sugar donor reacts 
with CPA to form covalent glycosyl phosphate, and the nucleophilic attack happens from the face 
of phosphate departure due to the hydrogen bonding interaction between the phosphate and the 
hydroxyl groups of acceptor. Increasing loadings of CPA facilitated the epimerization of β-
phosphate to the α-phosphate, therefore the α-glycoside was obtained as the major product. 
Regioselectivity was not only catalyst-dependent, but also donor chirality-dependent. Depending 
on the specific enantiomer of the sugar donor (D- and L-), the trends were reversed. From the 
observation of D- and L-fucose-based donors, D-sugar donors favored C3-selective glycosylation, 
whereas L-sugar donors favored C2-selective glycosylation reactions. Even though these factors 
affected the regioselectivity of glycosylation, (S)-3H promoted C3-selective glycosylation and 
(R)-2J promoted C2-selective glycosylations of acceptor 4-4. We expect that the described results 
will be further optimized and generalized, and this would provide comprehensive insights on the 





4.9 Experimental information 
Methods and Reagents : 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used without 
further purification. Tetrahyrofuran (THF), dichloromethane (DCM) and diethyl ether (Et2O) were 
filtered through a column (Innovative Technology PS-MD-5) of activated alumina under nitrogen 
atmosphere. All reactions were carried out under an atmosphere of nitrogen in flame- or oven-
dried glassware with magnetic Fstirring. Reactions were cooled using Neslab Cryocool CB-80 
immersion cooler (0 to -60 °C) and Neslab Cryocool immersion cooler CC-100 II,  or via external 
cooling baths: ice water (0 °C), sodium chloride/ ice water (-10 °C), or dry ice/acetone (-78°C). 
Heating was achieved by use of a silicone bath with heating controlled by electronic contact 
thermometer. Deionized water was used in the preparation of all aqueous solutions and for all 
aqueous extractions. Solvents used for extraction and chromatography were ACS or HPLC grade. 
Purification of reactions mixtures was performed by flash column chromatography on SiO2 using 
SiliCycle SiliaFlash P60 (230-400 mesh). Diastereomeric ratios were determined by 1 H NMR 
analysis. Enantiomeric excess was determined by HPLC analysis using a Waters e2695 
Separations Module with a Waters 2998 photodiode array detector. 
Instrumentation : 
All spectra were recorded on Varian vnmrs 700 (700 MHz), Varian vnmrs 500 (500 MHz), Varian 
MR400 (400 MHz), Varian Inova 500 (500 MHz) spectrometers and chemical shifts (δ) are 
reported in parts per million (ppm) and referenced to the 1H signal of the internal tetramethylsilane 
according to IUPAC recommendations. Data are reported as (br = broad, s = singlet, d = doublet, 
t = triplet, q = quartet, qn = quintet, sext = sextet, m = multiplet; coupling constant(S) in Hz; 
integration). High resolution mass spectra (HRMS) were recorded on MicromassAutoSpecUltima 
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or VG (Micromass) 70-250-S Magnetic sector mass spectrometers in the University of Michigan 
mass spectrometry laboratory. Infrared (IR) spectra were recorded as thin films on NaCl plates on 
a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption peaks were reported in 
wavenumbers (cm-1).  




To a solution of (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(phenylthio)tetrahydro-2H-pyran-3,4,5-
triol (2.3 g, 8.45 mmol) and PhCH(OMe)2 (1.66 mL, 11.0 mmol) in dry CH3CN (45 mL) was 
added p-TsOH (78 mg 0.42 mmol). The reaction mixture was stirred at 60 °C overnight. The 
resulting mixture was neutralized by Et3N (3.0 mL), diluted with EtOAc (50 mL), then washed 
with brine, dried over anhydrous Na2SO4, and concentrated. The residue was purified by flash 
column chromatography on a silica gel (10:1, Hexanes-EtOAc). Compound 4-1 as a white solid, 
yield 2.22 g (75%). 
1H NMR (700 MHz, Chloroform-d) δ 7.60 – 7.51 (m, 2H), 7.50 – 7.44 (m, 2H), 7.39 – 7.29 (m, 
6H), 5.53 (s, 1H), 4.63 (dd, J = 9.7, 1.2 Hz, 1H), 4.40 – 4.36 (m, 1H), 3.84 (t, J = 8.2 Hz, 1H), 3.81 
– 3.75 (m, 1H), 3.57 – 3.50 (m, 2H), 3.47 (t, J = 9.1 Hz, 1H), 2.88 (s, 1H), 2.73 (s, 1H). 13C NMR 
(176 MHz, Chloroform-d) δ 136.98, 133.22 (2C), 131.40, 129.48, 129.28 (2C), 128.64, 128.51 
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(2C), 126.42 (2C), 102.09, 88.76, 80.34, , 74.72, 72.73, 70.69, 68.72. HRMS (ESI+) (m/z): 





A flame-dried 2 dram vial was charged with the D-glucose-derived 2,3-diol 4-1 (1.0 equiv), D-
glucose trichloroacetimidate donor 4-2 (1.4 equiv) and chiral phosphoric acid (CPA) catalyst (0.02 
equiv). The resulting mixture was flushed with nitrogen, then dry DCM (0.04M) was added. The 
resulting mixture was refluxed for 1day, then quenched with triethylamine. The mixture was 
purified by a flash column chromatography on SiO2 (10:1 hexanes/ethyl acetate to 5:1 
hexanes/ethyl acetate). Purification resulted in some mixed fractions of hydrolyzed donor with 
glycosylated product G1 and fractions of pure isomeric mixture of glycosylation products G1. All 





In order to measure the selectivity, an NMR study and reverse phase HPLC (RP HPLC) 
assay were carried out. For the NMR assay, the crude mixture of glycosylation product was 
purified by flash column chromatography on SiO2 and distinct proton peaks, such as the proton 
adjacent to the benzylidine acetal and anomeric proton, of each isomer were assigned. Using that 
information, each isomer’s distinct proton peak in the NMR of a crude product mixture was 
integrated and then the selectivity was measured. However, there was a limitation to this approach 
due to the overlap of the proton peak of one isomer with the proton peak of another to isomer as 
well as the the proton peaks of the side products. For these reasons, a reverse phase HPLC assay 
was developed. In order to measure the desired selectivity more accurately, relatively clean 
samples of the four different isomers were injected to the reverse phase HPLC. Once the retention 
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time of each isomer was found, the crude product mixture was injected to the reverse phase HPLC 
and then the peaks corresponding to each isomer were integrated to determine the selectivity 
between isomers. The conditions and retention time results are following:  
 
Reverse phase HPLC (Shimadzu Prominence SPD M20A, 3.9*150mm C18 column, 77% 
acetonitrile in water with isocratic flow): 
Retention time:  α-C3 : 14.647 min, β-C3: 15. 277 min,  α-C2 : 16.973 min, β-C2: 17. 115 min.  
 
Under these conditions, the retention times of two isomers (α-C2 and β-C2) were close 
enough to complicate the integration, and these ratios were determined by NMR. Fortunately, 
combination of selectivity information from the NMR and RP HPLC provided complementary 
results. The glycosylation reactions of diol 4-1 and α-trichloroacetimidate 4-2 were carried out 
with various chiral phosphoric acids with different substitution at the 3- and 3’- position of the 
BINOL backbone. The selectivity between 4 isomers was determined from the crude mixture by 








1H NMR (700 MHz, Chloroform-d) δ 7.55 – 7.50 (m, 2H), 7.48 – 7.42 (m, 2H), 7.38 – 7.26 (m, 
19H), 7.26 – 7.22 (m, 6H), 7.13 (dd, J = 6.9, 2.6 Hz, 2H), 5.49 (s, 1H), 4.88 – 4.79 (m, 4H), 4.76 
(d, J = 10.8 Hz, 1H), 4.69 (d, J = 7.8 Hz, 1H), 4.64 (d, J = 9.8 Hz, 1H), 4.52 (dd, J = 11.5, 4.7 Hz, 
2H), 4.40 (d, J = 12.1 Hz, 1H), 4.33 (dd, J = 10.5, 4.9 Hz, 1H), 3.89 (t, J = 8.9 Hz, 1H), 3.76 (t, J 
= 10.3 Hz, 1H), 3.67 – 3.57 (m, 6H), 3.53 (t, J = 8.3 Hz, 1H), 3.45 (dtd, J = 25.7, 9.1, 8.7, 3.7 Hz, 
2H), 3.34 (q, J = 4.1 Hz, 1H). 13C NMR (176 MHz, Chloroform-d) δ 138.48, 138.33, 138.13, 
137.79, 137.32, 133.27, 131.95, 129.09, 128.69, 128.56, 128.54, 128.51, 128.45, 128.43, 128.33, 
128.23, 128.17, 128.07, 128.01, 127.93, 127.92, 127.83, 127.71, 126.38, 103.33, 101.50, 88.04, 
85.30, 84.16, 81.98, 78.52, 78.05, 75.73, 75.40, 75.20, 75.11, 73.78, 72.80, 71.22, 68.92, 68.70. 





1H NMR (700 MHz, Chloroform-d) δ 7.52 (d, J = 7.0 Hz, 2H), 7.39 (d, J = 7.4 Hz, 2H), 7.37 – 
7.26 (m, 17H), 7.23 (d, J = 7.0 Hz, 2H), 7.14 (t, J = 7.4 Hz, 1H), 7.11 – 7.04 (m, 4H), 6.87 (d, J = 
7.5 Hz, 2H), 5.48 (s, 1H), 5.42 (d, J = 3.6 Hz, 1H), 4.97 (d, J = 10.9 Hz, 1H), 4.76 (dd, J = 10.8, 
4.0 Hz, 2H), 4.62 (d, J = 12.0 Hz, 1H), 4.54 (dd, J = 19.4, 11.0 Hz, 2H), 4.42 (t, J = 11.1 Hz, 2H), 
4.37 (dd, J = 10.7, 5.1 Hz, 1H), 4.32 – 4.25 (m, 2H), 4.02 (t, J = 9.1 Hz, 1H), 3.92 (t, J = 9.3 Hz, 
1H), 3.74 (ddd, J = 29.5, 15.6, 6.8 Hz, 3H), 3.64 (d, J = 10.5 Hz, 1H), 3.61 – 3.53 (m, 2H), 3.52 – 
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3.44 (m, 2H), 2.75 (s, 1H). 13C NMR (176 MHz, Chloroform-d) δ 163.38, 138.85, 138.13, 137.82, 
137.53, 136.92, 133.69, 130.41, 129.44, 129.15, 128.64, 128.44, 128.36, 128.32, 128.14, 128.08, 
128.06, 127.83, 127.73, 127.48, 127.41, 126.36, 102.07, 96.48, 88.73, 81.59, 81.05, 78.49, 78.01, 
77.44, 75.63, 75.15, 73.51, 71.19, 70.63, 70.59, 69.98, 68.72, 68.32. HRMS (ESI+) (m/z): 
[M+Na]+ calcd for C53H54NaO10S 905.3335, found 905.3351. 
α-C2-G1 and β-C2-G1 were inseparable. 




To a solution of glucose tetraol phenyl thioglycoside (2.5 g, 7.61 mmol) and PhCH(OMe)2 (1.49 
mL, 9.90 mmol) in dry CH3CN (50 mL) was added p-TsOH (65.5 mg 0.38 mmol). The reaction 
mixture was stirred at 60°C overnight. The resulting mixture was neutralized by Et3N (3.0 mL), 
diluted with EtOAc (50 mL), then washed with brine, dried over anhydrous Na2SO4, and 
concentrated in vacuo. The residue was purified by flash column chromatography on a silica gel 
(10:1, Hexanes-EtOAc). Compound 4-4 as a white solid, yield 1.85g (68%). 
1H NMR (500 MHz, Chloroform-d) δ 7.53 – 7.44 (m, 4H), 7.39 – 7.32 (m, 5H), 5.53 (s, 1H), 4.59 
(d, J = 9.7 Hz, 1H), 4.39 (dd, J = 10.6, 3.5 Hz, 1H), 3.89 – 3.75 (m, 2H), 3.56 – 3.49 (m, 2H), 3.45 
(t, J = 9.2 Hz, 1H), 2.79 (s, 1H), 2.65 (s, 1H), 1.33 (s, 9H). 13C NMR (126 MHz, Chloroform-d) δ 
152.12, 137.01, 133.40 (2C), 132.47, 129.47, 128.50 (2C), 127.48, 126.41 (2C), 126.38 (2C), 
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102.08, 88.90, 80.37, 74.71, 72.64, 70.71, 68.75, 34.83, 31.37 (3C). HRMS (ESI+) (m/z): 






An oven dried and nitrogen flushed 250 mL round bottom flask was charged with 4-9 (440 mg, 
1.01 mmol) and dry DCM (10 mL). The reaction mixture was cooled down to 0 °C and 
trichloroacetonitrile (0.31 mL, 3.04 mmol) was added, followed by 1,8-diaza bicyclo(5,4,0)undec-
7ene (45 µL, 0.30 mmol). The resulting reaction mixture was warmed up to room temperature and 
stirred for 3 h. The crude product was purified by a flash column chromatography on SiO2 (1% 
Et3N and 10 : 1 to 5 : 1 hexanes/ethyl acetate) resulting in the pure product 4-10 as a clear oil (α: 
250 mg, 43%,  β: 180 mg, 31%). 
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α-product: 1H NMR (400 MHz, Chloroform-d) δ 8.55 (s, 1H), 7.38 – 7.28 (m, 15H), 6.40 (d, J = 
3.5 Hz, 1H), 5.00 – 4.88 (m, 2H), 4.83 (d, J = 10.9 Hz, 1H), 4.77 – 4.62 (m, 3H), 4.08 – 3.89 (m, 
2H), 3.72 (dd, J = 9.6, 3.6 Hz, 1H), 3.22 (t, J = 9.4 Hz, 1H), 1.27 (d, J = 6.2 Hz, 3H). HRMS 




A flame-dried 1 dram vial was charged with the 2,3-diol 4-4 (1.0 equiv), donor α-4-10 (1.4 equiv) 
and chiral phosphoric acid (CPA) catalyst (0.015 equiv). The resulting mixture was flushed with 
nitrogen, then dry DCM (0.04M) was added. The resulting mixture was stirred at room temperature 
for 12 h, then quenched with triethylamine. The mixture was purified by a flash column 
chromatography on SiO2 (10:1 hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate). Purification 
resulted in some mixed fractions of hydrolyzed donor with glycosylated product G2 and fractions 
of pure isomeric mixture of glycosylation products G2. All fractions containing glycosylation 
products were combined and concentrated to afford a white solid. 
- The regioselectivity and stereoselectivity was measured by a reverse phase HPLC assay. 
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Retention time  (Reverse phase HPLC assay (isocratic 87% acetonitrile in water) 
α-C3-G2: 12.837 min, β-C3-G2: 13.928 min, α-C2-G2: 16.583 min, β-C2-G2: 17.980 min. 
 




An oven dried and nitrogen flushed 250 mL round bottom flask was charged with the tri-O-benzyl-
L-rhamnose with free alcohol at anomeric position (2.1 g, 4.83 mmol) and dry DCM (40 mL). The 
reaction mixture was cooled down to 0 °C and trichloroacetonitrile (0.97 mL, 9.67 mmol) was 
added, followed by 1,8-diaza bicyclo(5,4,0)undec-7ene (0.22 mL, 1.45 mmol). The resulting 
reaction mixture was warmed up to room temperature and stirred for 3 h. The crude product was 
purified by a flash column chromatography on SiO2 (1% Et3N and 10 : 1 to 5 : 1 hexanes/ethyl 
acetate) resulting in the pure product α-4-11 as clear oil (α only 78 %). 
1H NMR (500 MHz, Chloroform-d) δ 8.52 (s, 1H), 7.45 – 7.29 (m, 15H), 6.26 (s, 1H), 4.97 (d, J 
= 10.8 Hz, 1H), 4.78 (s, 2H), 4.64 (dt, J = 23.4, 11.2 Hz, 3H), 3.97 – 3.85 (m, 3H), 3.72 (t, J = 9.5 
Hz, 1H), 1.36 (d, J = 6.0 Hz, 3H). 13C NMR (126 MHz, Chloroform-d) δ 160.67, 138.45, 138.27, 
138.04, 128.56 (2C), 128.53 (2C), 128.52 (2C), 128.33 (2C), 128.09 (4C), 127.94, 127.92, 127.86, 
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96.15, 91.19, 79.92, 79.03, 75.72, 73.98, 72.94, 72.47, 71.22, 18.19. HRMS (ESI+) (m/z): 
[M+Na]+ calcd for C29H30NaNO5Cl3 600.1087, found 600.1100. 
 
General Procedure: 
A flame-dried 1 dram vial was charged with the 2,3-diol 4-4 (1.0 equiv), trichloroacetimidate 
donor α-4-11 (1.4 equiv) and chiral phosphoric acid (CPA) catalyst (0.015 equiv). The resulting 
mixture was flushed with nitrogen, then dry DCM (0.04M) was added. The resulting mixture was 
stirred at room temperature for 12 h, then quenched with triethylamine. The mixture was purified 
by column chromatography on SiO2 (10:1 hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate). 
Purification resulted in some mixed fractions of hydrolyzed donor with glycosylated product G3 
and fractions of pure isomeric mixture of glycosylation products G3 that were concentrated to 







1H NMR (700 MHz, Chloroform-d) δ 7.46 – 7.43 (m, 4H), 7.38 – 7.36 (m, 4H), 7.32 – 7.27 (m, 
12H), 7.25 – 7.21 (m, 4H), 5.49 (s, 1H), 5.28 (s, 1H), 4.88 (d, J = 11.0 Hz, 1H), 4.71 (q, J = 12.6 
Hz, 2H), 4.60 – 4.52 (m, 5H), 4.36 (dd, J = 10.6, 4.3 Hz, 1H), 4.00 (dt, J = 12.4, 6.2 Hz, 1H), 3.88 
– 3.82 (m, 3H), 3.75 (t, J = 9.8 Hz, 1H), 3.54 (t, J = 9.2 Hz, 1H), 3.50 – 3.41 (m, 3H), 2.34 (d, J = 
2.4 Hz, 1H), 1.33 (s, 9H), 1.00 (d, J = 6.2 Hz, 3H). HRMS (ESI+) (m/z): [M+Na]+ calcd for 






1H NMR (500 MHz, Chloroform-d) δ 7.47 – 7.44 (m, 4H), 7.38 – 7.35 (m, 6H), 7.33 – 7.30 (m, 
14H), 5.50 (s, 1H), 5.33 (d, J = 1.7 Hz, 1H), 4.96 – 4.93 (m, 1H), 4.80 – 4.75 (m, 1H), 4.69 – 4.63 
(m, 3H), 4.57 – 4.52 (m, 2H), 4.35 (dd, J = 10.6, 4.3 Hz, 1H), 4.27 – 4.20 (m, 1H), 3.95 – 3.89 (m, 
2H), 3.83 – 3.79 (m, 1H), 3.78 – 3.71 (m, 2H), 3.69 – 3.56 (m, 3H), 2.46 (d, J = 2.4 Hz, 1H), 1.37 








An oven dried and nitrogen flushed 250 mL round bottom flask was charged with the tri-O-benzyl-
D-fucose with free alcohol at anomeric position (295 mg, 0.68 mmol) and dry DCM (6 mL). The 
reaction mixture was cooled down to 0 °C and trichloroacetonitrile (0.14ml, 1.36 mmol) was added, 
followed by 1,8-diaza bicyclo(5,4,0)undec-7ene (30 µL, 0.203 mmol). The resulting reaction 
mixture was warmed up to room temperature and stirred for 3 h. The crude product was purified 
by a flash column chromatography on SiO2 (1% Et3N and 10 : 1 to 5 : 1 hexanes/ethyl acetate) 
resulting in the pure product α-4-12 as white solid (α: 160 mg, 41%, β: 120 mg, 31%). 
NMR spectra matched the previously reported data (Org. Biomol. Chem. 2014, 12 (17), 2729-
2736). 
IR (film) 3343, 3064, 3030, 2935, 2904, 2874,1731, 1669, 1603, 1497, 1454, 1356, 1293, 1216, 
1103, 1066, 1027, 968, 943, 838, 794, 735, 697, 644 cm-1 1H NMR (500 MHz, Chloroform-d) δ 
8.53 (s, 1H, NH), 7.41–7.29 (m, 15H, aromatic), 6.55 (d, J1,2 = 3.4 Hz, 1H, H-1), 5.04 (d, J = 11.5 
Hz, 1H, CH-a, 4-O-Bn), 4.89 (d, J = 11.7 Hz, 1H, CH-a, 3-O-Bn), 4.80 – 4.78 (m, 3H, CH-b, 3-
O-Bn, CH-a, CH-b, 2-O-Bn), 4.71 (d, J = 11.5 Hz, 1H, CH-b, 4-O-Bn), 4.27 (dd, J2,3 = 10.0 Hz, 
J1,2 = 3.4 Hz, 1H, H-2), 4.12 (q, J5,6 = 6.4 Hz, 1H, H-5), 4.06 (dd, J2,3 = 10.0 Hz, J3,4 = 2.6 Hz, 1H, 
H-3), 3.74 (s, 1H, H-4), 1.19 (d, J5,6 = 6.4 Hz, 1H, H-6). 13C NMR (126 MHz, Chloroform-d) δ 
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161.3, 138.6, 138.5, 138.4, 128.5 (2C), 128.42 (2C), 128.37 (2C), 128.29 (2C), 128.26, 127.74 
(2C), 127.70, 127.6, 127.5 (2C), 95.3, 91.6, 78.3, 77.3, 75.8, 75.0, 73.2, 72.8, 69.6, 16.7;. HRMS 




An oven dried and nitrogen flushed 250 mL round bottom flask was charged with the 
(3S,4R,5R,6S)-3,4,5-tris(benzyloxy)-6-methyltetrahydro-2H-pyran-2-ol (680 mg, 1.56 mmol) and 
dry DCM (13 mL). The reaction mixture was cooled down to 0 °C and trichloroacetonitrile (0.32 
mL, 3.13 mmol) was added, followed by 1,8-diaza bicyclo(5,4,0)undec-7ene (70 µL, 0.47 mmol). 
The resulting reaction mixture was warmed up to room temperature and stirred for 3 h. The crude 
product was purified by a flash column chromatography on SiO2 (1% Et3N and 10 : 1 to 5 : 1 
hexanes/ethyl acetate) resulting in the pure product α-4-13 as white solid (α: 450 mg, 50%, β: 300 
mg, 33%). 
NMR spectra matched the previously reported data (Chem.: Eur. J. 2012, 18 (46), 14671-14679). 
IR (film) 3343, 3064, 3030, 2935, 2904, 2874,1731, 1669, 1603, 1497, 1454, 1356, 1293, 1216, 
1103, 1066, 1027, 968, 943, 838, 794, 735, 697, 644 cm-1, 1H NMR (500 MHz, Chloroform-d) δ 
8.53 (s, 1H, NH), 7.41–7.29 (m, 15H, aromatic), 6.55 (d, J1,2 = 3.4 Hz, 1H, H-1), 5.04 (d, J = 11.5 
Hz, 1H, CH-a, 4-O-Bn), 4.89 (d, J = 11.7 Hz, 1H, CH-a, 3-O-Bn), 4.80 – 4.78 (m, 3H, CH-b, 3-
O-Bn, CH-a, CH-b, 2-O-Bn), 4.71 (d, J = 11.5 Hz, 1H, CH-b, 4-O-Bn), 4.27 (dd, J2,3 = 10.0 Hz, 
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J1,2 = 3.4 Hz, 1H, H-2), 4.12 (q, J5,6 = 6.4 Hz, 1H, H-5), 4.06 (dd, J2,3 = 10.0 Hz, J3,4 = 2.6 Hz, 1H, 
H-3), 3.74 (s, 1H, H-4), 1.19 (d, J5,6 = 6.4 Hz, 1H, H-6)13C NMR (126 MHz, Chloroform-d) δ 
161.3, 138.6, 138.5, 138.4, 128.5 (2C), 128.42 (2C), 128.37 (2C), 128.29 (2C), 128.26, 127.74 
(2C), 127.70, 127.6, 127.5 (2C), 95.3, 91.6, 78.3, 77.3, 75.8, 75.0, 73.2, 72.8, 69.6, 16.7;. HRMS 




A flame-dried 1 dram vial was charged with the 2,3-diol 4-4 (1.0 equiv), trichloroacetimidate 
donor α-4-12 (1.4 equiv) and chiral phosphoric acid (CPA) catalyst (0.015 equiv). The resulting 
mixture was flushed with nitrogen, then dry DCM (0.04M) was added. The resulting mixture was 
stirred at room temperature for 12 h, then quenched with triethylamine. The mixture was purified 
by a flash column chromatography on SiO2 (10:1 hexanes/ethyl acetate to 5:1 hexanes/ethyl 
acetate). Purification resulted in some mixed fractions of hydrolyzed donor with glycosylated 







1H NMR (700 MHz, Chloroform-d) δ 7.54 – 7.42 (m, 4H), 7.38 – 7.27 (m, 20H), 5.51 (s, 1H), 
4.93 (d, J = 11.6 Hz, 1H), 4.85 (s, 2H), 4.73 – 4.64 (m, 3H), 4.56 (dd, J = 19.9, 8.8 Hz, 2H), 4.34 
(dd, J = 10.5, 4.9 Hz, 1H), 3.98 (d, J = 2.1 Hz, 1H), 3.93 (dd, J = 9.6, 7.8 Hz, 1H), 3.82 – 3.71 (m, 
2H), 3.63 – 3.49 (m, 3H), 3.47 – 3.29 (m, 3H), 1.32 (s, 9H), 1.16 (d, J = 6.3 Hz, 3H). 13C NMR 
(176 MHz, Chloroform-d) δ 151.63, 138.65, 138.25, 137.91, 137.36, 133.57, 128.87, 128.66, 
128.61, 128.59, 128.43, 128.28, 128.10, 128.05, 127.88, 127.71, 126.26, 126.10, 104.24, 100.94, 
87.83, 85.31, 83.65, 78.85, 78.52, 77.34, 77.16, 76.98, 76.04, 75.44, 74.77, 72.68, 72.47, 71.23, 
70.86, 68.68, 63.11, 34.78, 31.40, 17.04. HRMS (ESI+) (m/z): [M+Na]+ calcd for C50H56NaO9S 
855.3543, found 855.3554. 
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Chapter 5  
Regioselective Single-Pot Functionalization of Carbohydrates Based on Chiral Phosphoric 
Acid Directed Regioselective Acetalization 
 
5.1 Introduction  
Carbohydrates are essential molecules that not only serve as immediate energy sources, but 
also are also associated with numerous biological activities.1 Accordingly, the studies of 
carbohydrates have been the focus of many ongoing investigation in the fields of organic chemistry, 
biochemistry, and drug discovery.2 More complex oligosaccharides are comprised of the simpler 
building blocks- monosaccharides. Common monosaccharides such as D-glucose, D-galactose, and 
D-mannose are abundant in nature, but they need to be functionalized to be useful as unique 
building blocks in modern carbohydrate synthesis. Functionalization of monosaccharides, 
however, represents a synthetic challenge as they contain many stereocenters with multiple 
hydroxyl groups, which have similar selectivity.3 To address the challenges associated with 
selective functionalization of monosaccharides, numerous efficient methods have been previously 
developed.4 Among these methods is a highly efficient single-pot procedure for regioselective 
protection of D-glucose through silylated intermediate by the Hung group.5  This method allowed 





Scheme 5. 1. Hung group’s single-pot regioselective protection of D-glucose. 
 
 
5.2 CPA-catalyzed regioselective acetalization of carbohydrate derived 2,3-diols 
Previously, our group disclosed selective functionalization of monosaccharides 
using 1,1'-bi-2-naphthol (BINOL)-derived chiral phosphoric acids (CPAs) as the catalysts 
to direct regioselective acetalization of carbohydrate-derived 2,3-diols (discussed in section 
2.4).6 Even though this study introduced a powerful method for highly regioselective 
installation of acetal protection in carbohydrates in an exclusively regioselective manner, 
there is a limitation as the regioselectivity was controlled in only one direction. In D-glucose 
or D-galactose substrates, exclusive C2-selectivity was obtained with the catalyst (R)-2K, 
but low C3-selectivity was observed with (S)-2K as the catalyst (Scheme 5.2). Based on 
the observations made for CPA-catalyzed glycosylations, we surmised that increased steric 
size for the anomeric thiophenol will result in higher selectivities for the C3-control. 
Therefore, we investigated acetalization of substrates 5-1d - 5-1f (Table 5.1). Similar to the 
previous examples, the (R)-2K catalyzed the acetalization reaction to form C2-products 
selectively. Delightfully, 5-1f could also undergo a regioselective acetalization at the C3-
position when (S)-2K was employed as the catalyst (entry 3). The diol 5-1f contains 
dimethyl groups in the ortho-positions of the anomeric thiophenol, and the ortho-positions 
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Scheme 5. 2. CPA-catalyzed C2-selective acetalization of 2,3-diol. a) D-glucose moiety. b) D-
galactose moiety.   
 
 
are adjacent to the C2-hydroxyl group of the diol. It is likely that the steric control comes 
in play to induce the (S)-2K to preferably coordinate to the C3-hydroxyl group of the diol 
5-1f. Considering that an achiral catalyst, biphenyl phosphoric acid, promoted acetalization 
with barely any regioselectivity, there is no inherent C3-regioselectivity exhibited by the 
diol substrate. This result indicates the C3-regioselectivity originates from the catalyst (S)-
2K control. Interestingly, not only (S)-2K, but the commercially available (S)-TRIP CPA 
catalyst (S)-2J also catalyzed the acetalization reaction of the diol 5-1f to provide the same 
C3-regioselectivity as in the (S)-2K case. Considering that prior screening experiments6 
indicated that (R)-2K induced higher C2-selectivity than (R)-2J in substrate 5-1a, the 
presence of adamantyl group in the catalyst has less effect on the C3-regioselective 






Table 5. 1. a) CPA-catalyzed regioselective acetalization of substituted thioglycosides 5-1d – 5-
1f.a b) Structures of catalysts used for this study. 
 
Along with the studies of anomeric substituent effect on the regioselectivity in CPA-
catalyzed acetalization reactions, the role of the temperature was also examined (Figure 
5.1). Both 2-methoxypropene and 1-methoxycyclohexene were subjected to the (R)-2K-
catalyzed acetalization reaction of diol 5-1a at different temperatures. Generally, the 
acetalization of 1-methoxycyclohexene was prone to induce higher C2-selectivity than the 
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reaction with 2-methoxypropene at the same temperature. The role of the reaction medium 
temperature was found to be very significant. At the relatively higher temperature (-10 oC 
– 0 oC), low selectivities with the slight preference for the C3-acetal were observed. 
Similarly, little-to-no regioselectivity was observed at -30 ºC. However, a sudden increase 
in the C2-regioselectivity was observed for both enol ethers at -50 oC. At -78 oC, the 
exclusive formation of C2-acetals was observed in both cases. These observations imply 
that there is a switch of mechanism happening at ~ -40 oC.  
 
Figure 5. 1. Dependence of selectivity on reaction temperature for the (R)-2K-catalyzed 
acetalization of 5-1a. 
 
With these results in hands, the application of this method to the synthesis of 
functionalized carbohydrates was investigated. The regioselective acetalization reaction 
resulted in derivatized monosaccharides containing strategically positioned free hydroxyl 
groups (C3-OH for D-glucose and D-galactose, and C2-OH for D-mannose). By utilizing 
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this free hydroxyl group, regioselective functionalization can be achieved, and the acetal 
moiety may serve as an easily removable mask for the hydroxyl group. Removal of the 
acetal can be accomplished under very mild, slightly acidic conditions, and it would provide 
another free hydroxyl group that could be further functionalized. Inspired by the studies of 
the Hung’s group, we investigated the possibility of performing further functionalization 
of acetal products in a single-pot. 
This chapter describes efficient and selective single-pot monosaccharides 
functionalization based on the following operations: selective C2-acetalization, protection 
of free C3-OH, selective C-2 acetal cleavage, and protection/glycosylation of resulting free 
C2-OH. This single-pot regioselective protection/glycosylation protocol was generally 
applied to generate valuable derivatives of different sugars such as D-glucose, D-galactose, 
and D-mannose. 
5.3 Initial optimization of regioselective single-pot functionalization of monosaccharides 
Our study was commenced with a selective C2-acetalization reaction. To ensure the 
full conversion which is essential for the subsequent studies, the acetalization reaction was 
stirred until completion at -50 oC with 1-methoxycyclohexene, and at -78 oC with 2-
methoxypropene. Reaction monitoring revealed that the acetalization is completed in 24 h. 
In addition to the reaction time, the quenching temperature was also important for 
maintaining high conversions. From our observations, we noted that reaction should be 
quenched at the same temperature as the temperature at which the reaction was running. 
When the reaction was quenched at the room temperature, a higher amount of the starting 
diol 5-1a was regenerated, and the lower overall conversions were observed. With the 24 h 
reaction time and low-temperature quenching step, the conversions of regioselective 
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acetalization of D-glucose, D-galactose, and D-mannose were consistently 99%, 99%, and 
95% respectively. 
To accomplish full functionalization of monosaccharide-based substrates in a single-
pot, a method for the in situ selective acetal cleavage was also necessary. As acetals are 
generally acid labile, 0.05M HCl solution in DCM was prepared. This solution 
corresponded to the acidity range, which was required for selective cleavage of C2-acetals 
without deprotecting the 4,6-benzylidine acetal. In addition, high volatility of 0.05 M HCl 
solution in DCM was also suitable for the overall single-pot functionalization process as it 
could be removed without reaction work up. 
5.4 Regioselective single-pot protection of carbohydrate derived 2,3-diols 
After establishing a reliable method for introducing and removing C2-acetals in hand, we 
explored the selective functionalization of these derivatives. The following discussions are based 
on single-pot functionalization of D-glucose substrate 5-1a. 
CPA-direct regioselective acetalization was performed, and the resultant C2-acetal 5-2a 
was successfully obtained in full conversion. At this point, the mixture was dried with a gentle N2 
flow and high vacuum before the next step. Initially compound 5-2a was subjected to free C3-
hydroxyl group protection without affecting the C2-acetal. Since mixed acetals are acid- and heat- 
labile, acidic conditions and high reaction temperatures were avoided. The regioselective 
protection of the C3-OH with an acetyl group was successful using pyridine as a base and acetic 
anhydride as an acetylating agent. However, both the benzoyl protection by benzoyl chloride and 
pivaloyl protection by pivaloyl chloride in the presence of pyridine were leading to unselective 
functionalization due to the competitive C2-acetal cleavage.  
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To explain this puzzling result, we hypothesized that acyl chloride and pyridine eventually 
provides pyridinium hydrochloride, which is acidic enough to cleave the acetal. This possibility 
was investigated by mixing C2-acetal 5-2a with pyridinium hydrochloride, which did indeed lead 
to the cleavage of acetal. Considering that the combination of acyl chloride with pyridine could 
generate pyridinium hydrochloride, these conditions were avoided for C2-functionalization. In 
contrast, other bases were well-tolerated and a selective protection of the C3-hydroxyl group with 
various protecting groups, such as acetyl, benzoyl, benzyl, para-methoxy benzyl, was achieved 
without inducing the C2-acetal cleavage.  
After the C3-OH protection, 0.05M HCl solution was added to the N2 stream/vacuum dried 
crude product obtained in the previous step. The HCl solution promoted selective cleavage of the 
C2-acetal, and the solution was cleanly removed in the subsequent drying step. The resulting free 
C2-OH was, then, protected in the same pot without isolation. At this point, a wide range of 
protecting conditions were employed as acids- and heat- labile mixed acetal was already removed. 
Diverse protecting groups were selectively installed with decent- to good yields in single-pot 
(Scheme 5.3a). Different combinations of selective protection of the C3- and C2-positions 
successfully provided various D-glucose-derived building blocks 5-4a-5-4q.  
In addition to the D-glucose-based substrate 5-1a, this method was also successfully 
applied to D-galactose-based substrate 5-1b and D-mannose-derived substrate 5-1c. Even though 
the D-galactose and D-mannose derivatives were generated with somewhat lower regioselectivity 
(C2:C3 = 18:1 and 1:12), the resulting carbohydrates were still selectively functionalized following 
the single-pot protocols (Scheme 5.3b and 5.3c). In particular, since D-mannose derivative 5-1c 
had reversed C3-selectivity for the acetalization, the functionalization was also performed in a 
reverse way (C2-protection, C3-acetal cleavage, and C3-protection) to afford compound 5-6a 
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Scheme 5. 3. Regioselective single-pot protection of a) D-glucose-based substrate 5-1a. b) D-




5.5 Single-pot synthesis of fully functionalized D-glucose  
After developing a strategy for the regioselective protection of C3- and C2-hydroxyls in 
derivatives 5-1a, 5-1b, and 5-1c, we investigated the possibility of further functionalization 
of the C4 and C6 hydroxyl groups. In our carbohydrate systems, the C4 and C6 hydroxyl 
groups were initially protected as a 4,6-benzylidene acetal. The regioselective cleavage of 
such acetals has been widely investigated.7 Among the variety of available methods, we 
selected the reagent based on the combination of triethyl silane and trifluoroacetic acid. 
These reagents are known to open the 4,6-benzylidene acetals to provide C6-benzyl 
protected product with the C4-free hydroxyl group. This condition was applied to 
unpurified compounds 5-4, and the corresponding crude products were successfully 
obtained (Scheme 5.4). 
 




The resultant C4-free hydroxyl containing intermediates were dried and subjected 
to the final protection to afford fully elaborated D-glucose derivatives. Various 
combinations of protecting groups were selectively introduced in different positions of D-
glucose, leading to a series of fully protected derivatives 5-7a to 5-7f in single-pot (Scheme 
5.4). 
5.6 Regioselective single-pot protection/glycosylation of monosaccahride 
With the regioselective single-pot protection protocol leading to functionalized 
monosaccharides developed, regioselective single-pot protection/glycosylation was also 
explored. Our initial attempts to accomplish the direct glycosylation of the free C3-OH 
after the C2-acetalization was not successful, as commonly used glycosylation promoters 
were not compatible with the acid-sensitive acetal. Even trace amounts of triflic acid 
(TfOH) or trimethylsilyl trifluoromethanesulfonate (TMSOTf), which likely generates 
TfOH, were enough to cleave the C2-acetal. As the C2-acetal was removed, glycosylation 
reaction took place in an unselective way leading to the mixture of the C2-and C3-
glycosides. Instead of the acidic promoters, basic catalyst, silver (II) carbonate, was 
introduced along with glucosyl bromide donor 5-S1 for the glycosylation of the C3-free 
hydroxyl group (Scheme 5.5). Unfortunately, even these conditions failed to provide the 
desired disaccharide 5-S2.  
 
Scheme 5. 5. Failed attempt of the direct C3-selective glycosylation of C2-acetal 5-2a with 




Compared to the direct C3-selective glycosylation, a C2-selective glycosylation 
followed by C3-selective protection was expected to be more feasible as common 
glycosylation promoters can be utilized in the absence of the acid-labile acetal. In order to 
perform C2-selective glycosylation, the strategically positioned free C2-hydroxyl group 
was prepared by modifying 5-1a via sequential CPA (R)-2K directed regioselective C2-
acetalization, C3-OH protection, and C2-acetal cleavage as described above.  
The free C2-OH with different protecting groups at the C3-position was then 
subjected to glycosylation reaction with a per-benzylated L-rhamnosyl trichloroacetimidate 
(TCA) donor 5-S4 (1.4 equiv) in single-pot (Scheme 5.6). With acetyl protection at the C2-
position, the yield of the C3-glycoside 5-8a was only 15 % after 4 steps in single-pot. The 
lower yield was explained by lower amount of the TCA donor participating in glycosylation 
reaction as it was acetylated with previous reagent before glycosylation. The yield was 
increased to 72% after increasing the amount of donor (2.5 equiv). A substrate with benzoyl 
protection at the C3-position also had a similar problem in single-pot C2-glycosylation as 
the TCA donor 5-S4 gets benzoylated before the glycosylation. However, after increasing 
the amount of donor, the single-pot glycosylation protocol provided C3-OBz-containing 
C2-glycoside 5-8b in 68% isolated yield. In contrast, glycosylation reaction of the free C2-
OH of the intermediate with C3-benzyl protection was efficiently carried out as 65% of the 
desired C2-glycoside 5-8c was afforded in a single-pot with only 1.4 equivalents of the L-
rhamnose-based donor 5-S4. The side reactions between the donor 5-S4 and prior reagents 
were not observed in this case. Similarly, C3-4-chloro-benzyl ether containing intermediate 
was also cleanly glycosylated with L-rhamnose donor 5-S4 to afford the C2-glycoside 5-8d 
in 69% (one-pot). At the same time,  
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Scheme 5. 6. Single-pot C3-selective protection/C2-selective glycosylation of monosaccharide 
derivative 5-1a and 5-1c.  
 
 
t-butyldimethylsilyl (TBS) protection at the C3-position was not compatible with 
glycosylation condition as the TBS group was cleaved faster than the glycosylation reaction 
happened. In addition to the C2-selective glycosylation, C3-selective glycosylation was 
also performed. Following the sequence comprised of C2-acetalization, C3-acetylation, 
C2-acetal cleavage, C2-benzylation, and C3-deacetylation, the C3-free hydroxyl group was 
obtained. The single-pot glycosylation was initially attempted with the L-rhamnose-based 
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TCA donor 5-S4, but the desired product was not obtained. After running a short column 
with the reaction mixture containing the free C3-OH-containing substrate, the glycosylation 
reaction was successfully performed and the desired disaccharide 5-8e was obtained in 39% 
overall yield. Lastly, the single-pot protection/glycosylation method was applied to the D-
mannose-based substrate 5-1c, and the desired C2-benzyl protected product, containing C3-
glycoside 5-8f was obtained in 63% yield in a single-pot. 
In order to observe the inherent regioselectivity exhibited by the diol 5-1a, the 
control glyocosylation reaction was performed by a direct glycosylation to the diol with 
TMSOTf promoter (Scheme 5.7). The direct glycosylation of benzylated L-rhamnose TCA 
donor 5-S4 to the diol 5-1a provided the regioselectivity favored in C3-glycoside 5-S5 over 
C2 glycoside 5-S6 (5-S5/5-S6 = 3:1). Perhaps, this is due to the higher nucleophilicity of 
the C3-hydroxyl groups in comparison to the C2-OH.8  
 
Scheme 5. 7. Control experiment for glycosylation of 5-1a and 5-S4. 
 
 
5.7 Single-pot glycosylation of regioselectively functionalized thioglycoside 
All of the carbohydrate substrates selectively functionalized using this protocol, were 
thioglycosides that contain an anomeric thioether moiety. Such thioglycosides are common 
glycosyl donors in various glycosylation reactions.8 The single-pot glycosylation of 
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thioglycoside 5-4q pre-generated in situ via the protocols described above and D-galactose 
derivative 5-S7 was investigated (Scheme 5.8). After the thioglycoside 5-4q was activated 
by NIS and TMSOTf, the glycosylation was successfully carried out and the desired 
disaccharide 5-9a was afforded with 35% overall yield (single-pot). 
 




In summary, we have described the versatile single-pot methods for the regioselective 
functionalization of carbohydrates. Using the CPA-catalyzed regioselective acetalization 
approach on carbohydrate-derived 2,3-diols, a strategically positioned free hydroxyl group 
was installed. The C2-OH and C3-OH of various D-glucose, D-galactose, and D-mannose 
derivatives, were then, selectively functionalized in a single-pot through subsequent 
protection, acetal cleavage, and re-protection protocol. The D-glucose-based substrate 5-1a 
was further functionalized to afford the derivatives with different protecting groups in all 
four positions in a single-pot. The regioselectivity was achieved by leaving one free 
hydroxyl group in a different position until the final protection was achieved. In addition 
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to the single-pot protection, the single-pot glycosylation was also performed on the C3-
protected/C2-OH in D-glucose derivatives. Various protecting groups and different sugar 
donors were well-tolerated in this single-pot glycosylation reaction. The functionalized 
carbohydrates from this single-pot protocol are even more valuable as they could be utilized 
as a thioglycoside donor in glycosylation reactions.  
 
 
5.9 Experimental information 
Methods and Reagents : 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used without 
further purification. Tetrahyrofuran (THF), dichloromethane (DCM) and diethyl ether (Et2O) were 
filtered through a column (Innovative Technology PS-MD-5) of activated alumina under nitrogen 
atmosphere. All reactions were carried out under an atmosphere of nitrogen in flame- or oven-
dried glassware with magnetic Fstirring. Reactions were cooled using Neslab Cryocool CB-80 
immersion cooler (0 to -60 °C) and Neslab Cryocool immersion cooler CC-100 II, or via external 
cooling baths: ice water (0 °C), sodium chloride/ ice water (-10 °C), or dry ice/acetone (- 78°C). 
Heating was achieved by use of a silicone bath with heating controlled by electronic contact 
thermometer. Deionized water was used in the preparation of all aqueous solutions and for all 
aqueous extractions. Solvents used for extraction and chromatography were ACS or HPLC grade. 
Purification of reactions mixtures was performed by flash column chromatography on SiO2 using 
SiliCycle SiliaFlash P60 (230-400 mesh). Diastereomeric ratios were determined by 1 H NMR 
analysis. Enantiomeric excess was determined by HPLC analysis using a Waters e2695 




All spectra were recorded on Varian vnmrs 700 (700 MHz), Varian vnmrs 500 (500 MHz), Varian 
MR400 (400 MHz), Varian Inova 500 (500 MHz) spectrometers and chemical shifts (δ) are 
reported in parts per million (ppm) and referenced to the 1H signal of the internal tetramethylsilane 
according to IUPAC recommendations. Data are reported as (br = broad, s = singlet, d = doublet, 
t = triplet, q = quartet, qn = quintet, sext = sextet, m = multiplet; coupling constant(S) in Hz; 
integration). High resolution mass spectra (HRMS) were recorded on MicromassAutoSpecUltima 
or VG (Micromass) 70-250-S Magnetic sector mass spectrometers in the University of Michigan 
mass spectrometry laboratory. Infrared (IR) spectra were recorded as thin films on NaCl plates on 
a Perkin Elmer Spectrum BX FT-IR spectrometer. Absorption peaks were reported in 
wavenumbers (cm-1).  
5.9.1 General procedure for the single-pot reaction 
All the reactions were performed in the same vial in single-pot. Nitrogen blow and high 
vacuum were used to dry the reaction mixture in between every reaction. DCM was used 
as a solvent throughout whole single-pot protocol because it is easily dried and also is 
compatible with most of conditions of protection/glycosylation reactions. Functionalization 
of D-glucose and D-galactose cases can be carried out as the same way (selective C2-
acetalization, C3-functionalization, C2-acetal cleavage, C2 functionalization), but 
functionalization of D-mannose is performed in a reversed way (selective C3-acetalization, 




Procedure for D-galactose and D-mannose substrate: 
A round bottom flask was flame dried and purged with nitrogen. Then 4,6-benzylidine 
acetal protected thioglycoside diol 5-1b (D-galactose) or 5-1c (D-mannose) (1.0 equivalent), 
(which was previously dried by azeotropic removal of moisture with toluene) and activated 
4A molecular sieves (powder) were charged in the flask. Anhydrous dichloromethane 
(0.04M) was added to the flask and the reaction mixture was sonicated for 5 mins to 
dissolve the diol completely in DCM. Then the reaction mixture was submerged in dry ice-
acetone (-78 oC) bath, and 2-methoxypropene (1.2 equivalent) was added, followed by (R)-
2K (2 mol%). The reaction mixture was transferred to Neslab CB 80 immersion cooler and 
stirred at -78 oC for 24 h. After the reaction completion, the reaction mixture was quenched 
with triethyl amine at -78 OC. (IMPORTANT!) THE REACTION MIXTURE WAS COMPLETELY 
DRIED BY PASSING A STREAM OF NITROGEN FOLLOWED BY APPLYING HIGH VACUUM AND 






Using diol 5-1a (20 mg, 0.056 mmol, 1.0 equiv.) as the starting material, preparation of 5-2a was 
accomplished by following general procedure. This product was purified by flash column 
chromatography on SiO2 (7/1 Hexanes/Ethyl acetate + 2% triethylamine ) to afford 5-2a  as a pale 
yellow oil (18.6 mg, 69%, C2:C3 = 25:1).  
1H NMR (500 MHz, CD3OD) δ 7.76 (s, 0.02H), 7.56 – 7.52 (m, 0.1H), 7.51 – 7.43 (m, 5H), 7.41 
– 7.30 (m, 6H), 7.29 – 7.23 (m, 1H), 5.59 (s, 1H), 5.54 (s, 0.02H), 4.85 (d, J = 8.5 Hz, 1H), 4.26 
(dd, J = 10.0, 5.0 Hz, 1H), 3.83 – 3.71 (m, 3H), 3.59 (at, J = 9.2 Hz, 1H), 3.56 – 3.48 (m, 1H), 3.34 
(s, 3H), 3.18 (s, 0.1H), 2.88 – 2.80 (m, 0.2H), 1.98 – 1.79 (m, 2H), 1.74 – 1.70 (m, 1H), 1.67 – 
1.60 (m, 2H), 1.55 – 1.45 (m, 2H), 1.43 – 1.35 (m, 2H), 1.29 – 1.25 (m, 1H), 1.14 (t, J = 7.3 Hz, 
1H). 13C NMR (125 MHz, CD3OD) δ 147.3, 146.5, 137.6, 134.0, 132.2, 131.3, 130.9, 128.6, 128.5, 
127.6, 127.6, 127.0, 126.1, 125.9, 101.6, 101.6, 101.5, 101.4, 87.9, 87.0, 79.7, 79.6, 74.9, 74.3, 
72.5, 70.2, 69.7, 68.2, 48.1, 47.9, 47.7, 47.6, 47.4, 47.2, 47.1, 45.9, 43.2, 36.6, 36.1, 33.8, 33.0, 
32.9, 31.0, 30.8, 29.2, 25.0, 24.9, 22.3, 22.2. IR (thin film, cm-1): 3380, 2931, 2857, 1581, 1557, 
1541, 1463, 1367, 1272, 1250, 1149, 1090, 1014, 917. HRMS (ESI+) Calcd. C26H32O6SNa [M + 






Using D-galactose diol 5-2a  (20 mg, 0.056 mmol, 1.0 equiv.) as the starting material, preparation 
of 5-2b was accomplished by following general procedure B. This product was purified by flash 
column chromatography on SiO2 (1/1 Hexanes/Ethyl acetate + 1% triethylamine ) to afford 5-2b 
as a pale yellow oil (22.2 mg, 93%, C2:C3 = 20:1).  
1H NMR (500 MHz, Chloroform-d) δ 7.70 – 7.62 (m, 2H), 7.54 (dd, J = 7.5, 1.6 Hz, 2H), 7.42 – 
7.33 (m, 3H), 7.25 – 7.18 (m, 3H), 5.58 (s, 1H), 5.16 (s, 1H), 4.60 (d, J = 9.3 Hz, 1H), 4.37 (dd, J 
= 12.3, 1.1 Hz, 1H), 4.31 (d, J = 3.2 Hz, 1H), 4.17 – 4.02 (m, 2H), 3.65 (dd, J = 8.6, 3.0 Hz, 1H), 
3.50 (s, 1H), 3.31 (s, 3H), 1.43 (s, 3H), 1.14 (d, J = 18.0 Hz, 3H). 13C NMR (125 MHz, 
Chloroform-d) δ 138.0, 133.4, 131.7, 129.0, 128.8, 128.1, 127.1, 126.6, 101.9, 101.4, 86.0, 77.3, 
77.0, 76.8, 75.4, 73.8, 70.9, 70.1, 69.3, 49.7, 25.0, 23.6. IR (thin film, cm-1): 3382, 2989, 2923, 
2857, 1471, 1456, 1439, 1375, 1156, 1099, 1044. HRMS (ESI+) Calcd. for C23H28O6SNa [M + 
Na]+ 455.1499, found 455.1509; [α]26D = – 5.4° (c 0.02, DCM). 
 (2R,4aR,6S,7S,8R,8aR)-8-((2-methoxypropan-2-yl)oxy)-2-phenyl-6-
(phenylthio)hexahydropyrano[3,2-d][1,3]dioxin-7-ol (5-3c). 
Using diol 5-3a (20 mg, 0.04 mmol, 1.0 equiv.) as the starting material, synthesis of  5-3c was 
accomplished by following general procedure B. This product was purified by flash column 
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chromatography on SiO2 (3/1 Hexanes/Ethyl acetate + 1% triethylamine) to afford 5-3c  as a pale 
yellow oil (16.2 mg, 78%, C2:C3 = 1:12.6).  
1H NMR (500 MHz, CD3OD) δ 7.54 – 7.43 (m, 4H), 7.39 – 7.25 (m, 6H), 5.58 (s, 1H), 5.48 (s, 
1H), 4.29 (td, J = 9.8, 4.8 Hz, 1H), 4.22 (d, J = 3.0 Hz, 1H), 4.19 (dd, J = 10.0, 3.1 Hz, 1H), 4.11 
(dd, J = 10.2, 4.8 Hz, 1H), 4.05 (at, J = 9.7 Hz, 1H), 3.82 (at, J = 10.3 Hz, 1H), 3.21 (s, 3H), 1.40 
(d, J = 12.0 Hz, 3H), 1.37 (s, 3H). 13C NMR (125 MHz, CD3OD) δ 137.9, 133.7, 131.6, 128.8, 
128.5, 127.6, 127.3, 126.0, 102.0, 101.5, 89.5, 77.3, 72.5, 68.1, 65.7, 48.6, 48.1, 47.1, 24.5, 24.2. 
IR (thin film, cm-1): 3433, 2985, 2923, 2853, 1456, 1373, 1211, 1169, 1095, 1031, 970. HRMS 





1H NMR (500 MHz, CD3OD) δ 7.54 – 7.32 (m, 9H), 5.60 (s, 1H), 4.82 – 4.78 (m, 1H), 4.29 (dd, 
J = 10.4, 4.9 Hz, 1H), 3.82 – 3.72 (m, 3H), 3.65 – 3.57 (m, 1H), 3.52 (td, J = 9.7, 5.0 Hz, 1H), 3.34 
(s, 3H), 1.91 – 1.42 (m, 10H), 1.32 (s, 9H). 13C NMR (126 MHz, CD3OD) δ 152.05, 139.03, 
132.76 (2C), 131.63 (2C), 129.95, 129.02 (2C), 127.53 (2C), 127.07 (2C), 103.01, 102.92, 88.71, 







1H NMR (500 MHz, CD3OD) δ 7.99 – 7.95 (m, 1H), 7.87 – 7.78 (m, 3H), 7.58 (dd, J = 8.6, 1.8 
Hz, 1H), 7.49 (pt, J = 6.8, 3.4 Hz, 4H), 7.34 (dtd, J = 6.1, 4.8, 3.8, 1.5 Hz, 3H), 5.61 (s, 1H), 4.99 
(d, J = 9.0 Hz, 1H), 4.30 (dd, J = 10.4, 4.8 Hz, 1H), 3.86 – 3.75 (m, 3H), 3.65 – 3.54 (m, 2H), 3.36 
(s, 3H), 1.92 – 1.68 (m, 5H), 1.62 – 1.39 (m, 5H). 13C NMR (126 MHz, CD3OD) δ 139.02, 135.08, 
133.86, 132.67, 131.05, 129.96, 129.85, 129.56, 129.03 (2C), 128.74, 128.46 (2C), 127.74, 127.53, 





1H NMR (700 MHz, CD3OD) δ 7.52 – 6.96 (m, 8H), 5.57 (s, 1H), 4.55 (d, J = 9.3 Hz, 1H), 4.11 
(dd, J = 10.4, 5.1 Hz, 1H), 3.82 (dd, J = 9.3, 7.5 Hz, 1H), 3.73 – 3.67 (m, 2H), 3.59 (t, J = 9.4 Hz, 
1H), 3.37 (s, 3H), 3.28 (td, J = 9.8, 5.1 Hz, 1H), 2.55 (s, 6H), 1.97 – 1.76 (m, 5H), 1.61 – 1.28 (m, 
5H). 13C NMR (176 MHz, CD3OD) δ 145.28 (2C), 139.02, 132.47, 130.18, 129.91, 129.19 (2C), 
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128.99 (2C), 127.49 (2C), 103.08, 102.88, 90.12, 81.24, 76.66, 75.74, 70.66, 69.54, 48.67, 34.60, 
26.38 (2C), 23.86, 23.77 (2C), 22.80 (2C). 
 
5.9.2 Regioselective single-pot protection of carbohydrate-derived 2,3-diols (Chapter 5.4) 
General procedure (D-glucose and D-galactose substrate): 
C2 acetalization → C3-OH protection → C2-acetal cleavage → C2-OH protection  
General scheme of regioselective protection of D-glucose 
 





1) CPA directed regioselective C2-acetalization 
- The procedure was described above (Section 5.9.1). 
 
2) C3-OH protection 
Instruction:  
Most of reaction conditions are tolerated to protect C3-OH selectively except the conditions 
that could cleave C2-acetal such as high temperature, acidic conditions, or a combination 
of acyl halide and pyridine. Acyl halide and pyridine forms a pyridinium halide salt, which 
is acidic enough remove the C2-acetal. The following procedure was written based on the 
functionalization of the D-glucose-derived substrate. 
 
Procedure:  
* The resulting dried C2-acetal protected substrate 5-2a was subjected to one of the 




Acetyl protection: Triethyl amine (5.0 equiv) and anhydrous dichloromethane (0.3M) 
were added to the reaction mixture. Then anhydrous acetic anhydride (1.1 equiv), and 4-
dimethyaminopyridine (DMAP) (0.1 equiv) were added to the mixture. The reaction was 
stirred at room temperature until the reaction completion, which was monitored by TLC. 
After the reaction was completed, the mixture was completely dried through N2 gas flow 
and high vacuum. 
 
Benzoyl protection:  Triethyl amine (5.0 equiv) and anhydrous dichloromethane (0.3M) 
were added to the reaction mixture. Then benzoyl chloride (1.2 equiv), and 4-
dimethyaminopyridine (DMAP) (0.10 equiv) were added to the mixture. The reaction was 
stirred at room temperature until the reaction completion, which was monitored by TLC. 
After the reaction was completed, the mixture was completely dried by passing a stream of 
N2 followed by applying high vacuum. 
(Typically, benzoyl chlorides were found to be more reactive than benzoic acid 
anhydrides.) 
 
Benzyl protection: Anhydrous dichloromethane (0.2M) was added to the reaction mixture. 
Then sodium hydride (60% dispersion in mineral oil) (1.2 equiv), and benzyl bromide (1.1 
equiv), tetrabutylammonium iodide (TBAI) (0.10 equiv) were subsequently added to the 
mixture. Then 3-5 drops of anhydrous dimethylformamide (DMF) was added to the 
solution to dissolve the NaH efficiently. The reaction mixture was stirred at room 
temperature until the reaction completion, as judged by TLC. After completion, the reaction 
was carefully quenched with methanol. The solution was then, filtered through a HPLC 
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filter to remove the slurry containing mineral oil from sodium hydride. The resulting 
filtered solution was completely dried by passing a stream of N2 followed by applying high 
vacuum. 
 
para-methoxy benzyl (PMB) protection: same as benzyl protection, except using PMB 
chloride instead of benzyl bromide. 
 
4-chlorobenzyl protection: same as benzyl protection, except using 4-chlorobenzyl 
bromide instead of benzyl bromide. 
 
* The crude reaction mixture was subjected to the next reaction step without purification.   
(*Common procedure) 
 
3) C2-acetal cleavage 
Instruction:  
When a clean C2-acetal product 5-2a was dissolved in CDCl3 for NMR, the acetal cleavage 
was observed. We hypothesized that even the trace amount of hydrochloric acid in the 
CDCl3 could cleave the mixed acetal. To test this idea, 0.05M HCl solution was prepared 
in chloroform, and this solution was indeed acidic enough to remove the C2-acetal. 
Therefore, CDCl3 should be avoided as the NMR solvent.  
0.05M HCl solution did not cleave 4,6-benzylidine acetal moiety, which was excellent for 





0.05 M HCl solution in dichloromethane was added to the resulting reaction mixture firstly 
to neutralize the basic reaction condition. While the HCl solution is added, the pH of 
solution was monitored by pH paper. The 0.05M HCl solution was added until the reaction 
medium became slightly acidic (around pH 5-6). This acidic solution was stirred until the 
reaction completion (C2-acetal cleavage), and the reaction can be monitored by TLC. Once 
the reaction is completed, the resulting reaction mixture was completely dried by passing a 
stream of N2 followed by applying high vacuum. 
 
4) C2-OH protection 
Instruction:  
The scope of the protecting groups for the C2-OH protection was significantly wider due 
to the absence of acid-labile mixed acetal (Combination of acyl chloride and pyridine was 
also available). In addition, more equivalents of reagents can be used to achieve higher 
reaction conversions since this is the last step of the single-pot protocol.  
Procedure: 
* The resulting dried compound with free C2-OH was subjected to one of the following 
conditions below.    
 
Acetyl protection: Triethyl amine (5.0 equiv) and anhydrous dichloromethane (0.3M) 
were added to the reaction mixture. Then anhydrous acetic anhydride (1.2 equiv), and 4-
dimethyaminopyridine (DMAP) (0.2 equiv) were added to the mixture. The reaction was 
stirred at room temperature until TLC analysis indicated reaction completion. After 
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completion, the reaction was slowly quenched with methanol. The solvent was then 
removed under vacuum and the residue was dissolved in DCM and washed with NH4Cl 
(x3). The resultant aqueous layers were extracted with DCM (x2), and the organic layers 
were combined and dried over MgSO4 solution. The dried crude solution was concentrated 
in vacuo and purified by a flash column chromatography on SiO2 (hexanes : ethyl acetate, 
15:1 → 10:1 → 4:1). 
 
Benzoyl protection:  Pyridine (10.0 equiv) and anhydrous dichloromethane (0.3M) were 
added to the reaction mixture. Then benzoyl chloride (1.2 equiv), and 4-
dimethyaminopyridine (DMAP) (0.2 equiv) were added to the mixture. The reaction was 
stirred at room temperature until TLC analysis indicated reaction completion. After 
completion, the reaction was slowly quenched with methanol. The solvent was then 
removed under vacuum and the residue was dissolved in DCM and washed with NH4Cl 
(x3). The resultant aqueous layers were extracted with DCM (x2), and the organic layers 
were combined and dried over MgSO4 solution. The dried crude solution was concentrated 
in vacuo and purified by a flash column chromatography on SiO2 (hexanes : ethyl acetate, 
15:1 → 10:1 → 4:1). 
(Benzoyl chloride was found to be more reactive than benzoic anhydrides.) 
 
4-bromobenzoyl protection: same as benzoyl protection, except using 4-bromobenzoyl 




Pivaloyl protection: Pyridine (10.0 equiv) and anhydrous dichloromethane (0.5M) were 
added to the reaction mixture. Then pivaloyl chloride (1.2 equiv), and 4-
dimethyaminopyridine (DMAP) (0.2 equiv) were added to the mixture. The reaction was 
stirred at room temperature until TLC analysis indicated reaction completion After 
completion, the reaction was slowly quenched with methanol. The solvent was then 
removed under vacuum and the residue was dissolved in DCM and washed with NH4Cl 
(x3). The resultant aqueous layers were extracted with DCM (x2), and the organic layers 
were combined and dried over MgSO4 solution. The dried crude solution was concentrated 
in vacuo and purified by a flash column chromatography on SiO2 (hexanes : ethyl acetate, 
15:1 → 10:1 → 4:1). 
 
Benzyl protection: Anhydrous dichloromethane (0.2M) was added to the reaction mixture. 
Then, sodium hydride (60% dispersion in mineral oil) (1.5 equiv), and benzyl bromide (1.2 
equiv), tetrabutylammonium iodide (TBAI) (0.2 equiv) were sequentially added to the 
mixture. This followed by the addition of 3-5 drops of anhydrous DMF to dissolve the NaH 
more efficiently. The reaction was stirred at room temperature until TLC analysis indicated 
reaction completion. After completion, the reaction was slowly quenched with methanol. 
The solvent was then removed under vacuum and the residue was dissolved in DCM and 
washed with NH4Cl (x3). The resultant aqueous layers were extracted with DCM (x2), and 
the organic layers were combined and dried over MgSO4 solution. The dried crude solution 
was concentrated in vacuo and purified by a flash column chromatography on SiO2 




para-methoxy benzyl (PMB) protection: same as benzyl protection, except using PMB 
chloride instead of benzyl bromide. 
 
4-chlorobenzyl protection: same as benzyl protection, except using 4-chlorobenzyl 
bromide instead of benzyl bromide. 
 
2-Naphthyl protection: same as benzyl protection, except using 2-naphthylmethyl 
bromide instead of benzyl bromide. 
 
Allyl protection: Anhydrous dimethylformamide (DMF) (0.2M) was added to the reaction 
mixture. Then sodium hydride (60% dispersion in mineral oil) (1.5 equiv) was added slowly 
and the solution was stirred for 30 min under the atmosphere of N2. Then allyl bromide (1.2 
equiv) was added slowly, and the resultant mixture was stirred at 50 oC until TLC analysis 
indicated reaction completion. The reaction was quenched with methanol carefully. The 
solvent was then removed under vacuum and the residue was dissolved in DCM  and 
washed with water (x3). After drying over MgSO4, the resulting crude product was purified 
by a flash column chromatography on SiO2 (hexanes : ethyl acetate, 15:1 → 10:1 → 4:1). 
 
Methyl protection: Anhydrous dimethylformamide (DMF) (0.2M) was added to the 
reaction mixture. Then sodium hydride (60% dispersion in mineral oil) (1.5 equiv) was 
added slowly and the solution was stirred at room temperature for 30 min under the 
atmosphere of N2. Then methyl iodide (1.5 equiv) was added slowly, and the reaction 
mixture was stirred at room temperature overnight. After reaction completion, the mixture 
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was poured into ice water and extracted with Et2O (x3). The combined organic layers were 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The 
resulting crude product was purified by a flash column chromatography on SiO2 (hexanes 
: ethyl acetate, 15:1 → 10:1 → 4:1 ). 
 
tert-Butyldimethylsilyl (TBS) protection: Anhydrous dimethylformamide (DMF) was 
added to the reaction mixture. Then imidazole, (5.0 equiv), and tert-butyldimethylsilyl 
chloride (TBS-Cl) (1.5 equiv) were sequentially added to the mixture. The reaction was 
stirred at room temperature until TLC analysis indicated reaction completion. After reaction 
completion, the mixture was poured into ice water and extracted with Et2O (x3). The 
combined organic layers were dried over MgSO4, filtered and the solvent was removed 
under reduced pressure. The resulting crude product was purified by a flash column 




d][1,3]dioxin-8-yl acetate (5-4a). 
(Followed by a general single-pot procedure 1, 2, 3, 4): 
1H NMR (700 MHz, Chloroform-d) δ 7.57 – 7.51 (m, 2H), 7.44 – 7.39 (m, 2H), 7.37 – 7.28 (m, 
11H), 5.48 (s, 1H), 5.39 (dd, J = 9.7, 8.8 Hz, 1H), 4.91 (d, J = 10.9 Hz, 1H), 4.83 (d, J = 9.7 Hz, 
1H), 4.63 (d, J = 10.9 Hz, 1H), 4.37 (dd, J = 10.5, 4.9 Hz, 1H), 3.78 (t, J = 10.2 Hz, 1H), 3.60 (t, 
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J = 9.5 Hz, 1H), 3.58 – 3.52 (m, 2H), 1.96 (s, 3H). 13C NMR (176 MHz, Chloroform-d) δ 
169.85, 137.70, 137.00, 133.03, 132.45 (2C), 129.26 (2C), 129.19, 128.60 (2C), 128.36 (2C), 
128.28 (2C), 128.17, 128.09, 126.26 (2C), 101.48, 88.58, 79.30, 78.68, 75.37, 74.42, 70.50, 
68.74, 21.05. HRMS (ESI+) (m/z): [M+Na]+ calcd for C28H28O6S 515.1504, found 515. 1496. 
 
(2R,4aR,6S,7R,8S,8aR)-8-acetoxy-2-phenyl-6-(phenylthio)hexahydropyrano[3,2-
d][1,3]dioxin-7-yl benzoate (5-4b). 
1H NMR 1H NMR (700 MHz, Chloroform-d) δ 8.06 – 8.03 (m, 2H), 7.62 – 7.58 (m, 1H), 7.49 – 
7.46 (m, 2H), 7.45 – 7.42 (m, 4H), 7.37 – 7.34 (m, 3H), 7.33 – 7.28 (m, 3H), 5.55 – 5.51 (m, 2H), 
5.28 (dd, J = 10.0, 9.1 Hz, 1H), 4.95 (d, J = 10.0 Hz, 1H), 4.43 (dd, J = 10.6, 4.9 Hz, 1H), 3.85 (t, 
J = 10.3 Hz, 1H), 3.76 (t, J = 9.6 Hz, 1H), 3.67 (td, J = 9.7, 4.9 Hz, 1H), 1.94 (s, 3H). 13C NMR 
13C NMR (176 MHz, Chloroform-d) δ 170.11, 165.36, 136.87, 133.65, 133.22 (2C), 131.92, 
130.09 (2C), 129.33, 129.30, 129.16 (2C), 128.70 (2C), 128.56, 128.41 (2C), 126.31 (2C), 101.71, 
87.10, 78.36, 72.86, 71.29, 71.02, 68.65, 20.87. HRMS (ESI+) (m/z): [M+Na]+ calcd for 
C28H26O7S 539.1900, found 539.1908.  
 
(2R,4aR,6S,7R,8S,8aR)-8-acetoxy-2-phenyl-6-(phenylthio)hexahydropyrano[3,2-
d][1,3]dioxin-7-yl pivalate (5-4c). 
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1H NMR(700 MHz, Chloroform-d) δ 7.49 – 7.45 (m, 2H), 7.43 – 7.41 (m, 2H), 7.37 – 7.31 (m, 
6H), 5.50 (s, 1H), 5.40 (t, J = 9.4 Hz, 1H), 5.02 (dd, J = 10.1, 9.1 Hz, 1H), 4.82 (d, J = 10.1 Hz, 
1H), 4.39 (dd, J = 10.6, 5.0 Hz, 1H), 3.81 (t, J = 10.3 Hz, 1H), 3.68 (t, J = 9.6 Hz, 1H), 3.59 (td, J 
= 9.7, 5.0 Hz, 1H), 2.01 (s, 3H), 1.23 (s, 9H). 13C NMR (176 MHz, Chloroform-d) δ 176.92, 
169.93, 136.94, 133.06 (2C), 132.25, 129.30, 129.20 (2C), 128.54, 128.39 (2C), 126.34 (2C), 
101.73, 87.27, 78.37, 72.75, 70.91, 70.26, 68.66, 38.95, 27.19 (3C), 20.87.HRMS (ESI+) (m/z): 




(phenylthio)hexahydropyrano[3,2-d][1,3]dioxin-8-yl acetate (5-4d). 
1H NMR (700 MHz, Chloroform-d) δ 7.56 – 7.51 (m, 2H), 7.45 – 7.40 (m, 2H), 7.37 – 7.28 (m, 
8H), 7.26 – 7.23 (m, 2H), 5.48 (s, 1H), 5.38 (dd, J = 9.7, 8.8 Hz, 1H), 4.86 (d, J = 11.1 Hz, 1H), 
4.81 (d, J = 9.7 Hz, 1H), 4.59 (d, J = 11.1 Hz, 1H), 4.37 (dd, J = 10.6, 4.9 Hz, 1H), 3.78 (t, J = 
10.2 Hz, 1H), 3.60 (t, J = 9.6 Hz, 1H), 3.56 – 3.51 (m, 2H), 1.98 (s, 3H). 13C NMR (176 MHz, 
Chloroform-d) δ 169.83, 136.96, 136.21, 133.86, 132.89, 132.42 (2C), 129.46 (2C), 129.31 (2C), 
129.23, 128.74 (2C), 128.38 (2C), 128.25, 126.26 (2C), 101.51, 88.46, 79.41, 78.63, 74.43, 74.40, 






(phenylthio)hexahydropyrano[3,2-d][1,3]dioxin-8-yl benzoate (5-4e). 
1H NMR (700 MHz, Chloroform-d) δ 8.06 (dt, J = 8.2, 1.4 Hz, 2H), 7.58 – 7.54 (m, 1H), 7.51 (dt, 
J = 6.9, 1.4 Hz, 2H), 7.44 (td, J = 7.8, 1.3 Hz, 2H), 7.34 (ddtd, J = 6.9, 3.9, 2.7, 1.5 Hz, 4H), 7.32 
– 7.26 (m, 4H), 5.55 (dd, J = 9.8, 8.3 Hz, 1H), 5.47 (s, 1H), 4.83 (dd, J = 9.5, 1.2 Hz, 1H), 4.38 
(dd, J = 10.6, 5.0 Hz, 1H), 3.95 (ddd, J = 9.3, 8.2, 1.2 Hz, 1H), 3.80 (t, J = 10.3 Hz, 1H), 3.74 (t, 
J = 9.5 Hz, 1H), 3.63 (td, J = 9.7, 5.0 Hz, 1H), 0.82 (s, 9H), 0.20 (s, 3H), -0.11 (s, 3H). 13C NMR 
(176 MHz, Chloroform-d) δ 165.61, 137.03, 134.07, 133.16, 131.61 (2C), 130.31, 129.95 (2C), 
129.22 (2C), 128.99, 128.49 (2C), 128.28 (2C), 127.80, 126.15 (2C), 101.34, 90.62, 79.05, 76.50, 
72.96, 70.22, 68.81, 26.04 (3C), 18.31, -3.71 (2C). HRMS (ESI+) (m/z): [M+Na]+ calcd for 
C32H38O6SSi 601.2056, found 601.2044.  
 
(2R,4aR,6S,7R,8S,8aR)-7-acetoxy-2-phenyl-6-(phenylthio)hexahydropyrano[3,2-
d][1,3]dioxin-8-yl benzoate (5-4f). 
1H NMR (700 MHz, Chloroform-d) δ 8.03 – 7.98 (m, 2H), 7.57 – 7.52 (m, 1H), 7.51 (dd, J = 6.5, 
3.0 Hz, 2H), 7.42 (t, J = 7.7 Hz, 2H), 7.38 (dt, J = 6.5, 4.0 Hz, 2H), 7.35 (dd, J = 5.0, 1.9 Hz, 3H), 
7.30 (p, J = 3.6 Hz, 3H), 5.62 (t, J = 9.4 Hz, 1H), 5.51 (s, 1H), 5.22 (t, J = 9.6 Hz, 1H), 4.90 (d, J 
= 10.0 Hz, 1H), 4.43 (dd, J = 10.6, 5.0 Hz, 1H), 3.83 (dt, J = 13.5, 9.9 Hz, 2H), 3.68 (td, J = 9.7, 
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5.0 Hz, 1H), 2.01 (s, 3H). 13C NMR (176 MHz, Chloroform-d) δ 169.56, 165.76, 136.79, 133.43, 
133.03 (2C), 132.04, 130.00 (2C), 129.47, 129.23 (2C), 129.20, 128.58 (2C), 128.54, 128.34 (2C), 
126.24 (2C), 101.60, 86.94, 78.58, 73.48, 70.94, 70.69, 68.64, 20.90. HRMS (ESI+) (m/z): 
[M+Na]+ calcd for C28H26O7S 529.1297, found 529.1286. 
 
(2R,4aR,6S,7R,8S,8aR)-7-(allyloxy)-2-phenyl-6-(phenylthio)hexahydropyrano[3,2-
d][1,3]dioxin-8-yl benzoate (5-4g). 
1H NMR (500 MHz, Chloroform-d) δ 8.10 – 8.04 (m, 2H), 7.59 – 7.53 (m, 3H), 7.45 (t, J = 7.8 
Hz, 2H), 7.40 – 7.27 (m, 9H), 5.79 – 5.68 (m, 1H), 5.61 (dd, J = 9.8, 8.7 Hz, 1H), 5.49 (s, 1H), 
5.11 (dq, J = 17.3, 1.6 Hz, 1H), 5.01 (dq, J = 10.3, 1.3 Hz, 1H), 4.84 (d, J = 9.7 Hz, 1H), 4.40 (dd, 
J = 10.6, 5.0 Hz, 1H), 4.32 (ddt, J = 12.1, 5.5, 1.3 Hz, 1H), 4.10 (ddt, J = 12.2, 6.4, 1.3 Hz, 1H), 
3.79 (dt, J = 24.9, 9.9 Hz, 2H), 3.65 – 3.56 (m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 165.48, 
136.96, 134.28, 133.26, 133.17, 132.40 (2C), 130.02, 129.93 (2C), 129.24 (2C), 129.11, 128.53 
(2C), 128.30 (2C), 128.12, 126.26 (2C), 118.01, 101.48, 88.65, 79.04, 78.76, 75.15, 74.37, 70.61, 
68.80. HRMS (ESI+) (m/z): [M+Na]+  calcd for C29H28O6S 527.1504, found 527.1493.  
 
(2R,4aR,6S,7R,8S,8aR)-8-(benzoyloxy)-2-phenyl-6-(phenylthio)hexahydropyrano[3,2-
d][1,3]dioxin-7-yl 4-bromobenzoate (5-4h). 
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1H NMR (700 MHz, Chloroform-d) δ 7.96 – 7.89 (m, 2H), 7.82 (dd, J = 8.1, 1.1 Hz, 1H), 7.56 – 
7.29 (m, 16H), 5.83 – 5.73 (m, 1H), 5.54 (s, 1H), 5.49 – 5.40 (m, 1H), 5.03 (ddd, J = 11.2, 10.0, 
1.0 Hz, 1H), 4.47 (dd, J = 10.6, 4.9 Hz, 1H), 3.90 (dt, J = 14.5, 10.1 Hz, 2H), 3.79 – 3.71 (m, 1H). 
13C NMR (176 MHz, Chloroform-d) δ 165.71, 164.64, 136.76, 133.35, 133.19 (2C), 131.95 (2C), 
131.52 (2C), 130.03, 129.93 (2C), 129.22 (2C), 129.17, 128.79, 128.63, 128.56, 128.47 (2C), 
128.35 (2C), 128.13, 126.25 (2C), 101.65, 87.12, 78.59, 73.33, 71.45, 71.14, 68.66.HRMS (ESI+) 
(m/z): [M+Na]+  calcd for C33H27BrO7S 669.0559, found 669.0545.  
 
(2R,4aR,6S,7R,8S,8aR)-7-(benzyloxy)-2-phenyl-6-(phenylthio)hexahydropyrano[3,2-
d][1,3]dioxin-8-yl benzoate (5-4i). 
1H NMR (700 MHz, Chloroform-d) δ 8.02 (dt, J = 8.4, 1.1 Hz, 2H), 7.60 – 7.54 (m, 3H), 7.43 
(ddd, J = 8.4, 7.4, 0.9 Hz, 2H), 7.40 – 7.33 (m, 5H), 7.30 – 7.27 (m, 3H), 7.20 – 7.12 (m, 5H), 5.67 
(ddd, J = 9.8, 8.7, 0.9 Hz, 1H), 5.50 (s, 1H), 4.90 (dd, J = 9.7, 0.9 Hz, 1H), 4.85 (d, J = 10.5 Hz, 
1H), 4.61 (d, J = 10.5 Hz, 1H), 4.41 (dd, J = 10.6, 5.0 Hz, 1H), 3.82 (t, J = 10.3 Hz, 1H), 3.80 – 
3.76 (m, 1H), 3.72 (ddd, J = 9.6, 8.6, 0.9 Hz, 1H), 3.62 (td, J = 9.6, 4.9 Hz, 1H). 13C NMR (176 
MHz, Chloroform-d) δ 165.49, 137.32, 136.96, 133.23, 133.16, 132.45 (2C), 129.99, 129.94 (2C), 
129.28 (2C), 129.10, 128.51 (2C), 128.45 (2C), 128.41 (2C), 128.30 (2C), 128.16, 128.00, 126.25 
(2C), 101.49, 88.71, 79.40, 78.83, 77.34, 75.18, 70.60, 68.80. HRMS (ESI+) (m/z): [M+Na]+  





(phenylthio)hexahydropyrano[3,2-d][1,3]dioxin-8-yl benzoate (5-4j). 
1H NMR (700 MHz, Chloroform-d) δ 7.99 – 7.95 (m, 2H), 7.60 – 7.53 (m, 3H), 7.45 – 7.42 (m, 
2H), 7.39 – 7.33 (m, 5H), 7.31 – 7.27 (m, 3H), 7.08 (s, 4H), 5.64 (dd, J = 9.8, 8.7 Hz, 1H), 5.49 (s, 
1H), 4.89 (d, J = 9.6 Hz, 1H), 4.82 (d, J = 11.0 Hz, 1H), 4.56 (d, J = 11.0 Hz, 1H), 4.41 (dd, J = 
10.6, 5.0 Hz, 1H), 3.82 (t, J = 10.3 Hz, 1H), 3.77 (t, J = 9.6 Hz, 1H), 3.68 (dd, J = 9.7, 8.7 Hz, 1H), 
3.62 (td, J = 9.7, 5.0 Hz, 1H). 13C NMR (176 MHz, Chloroform-d) δ 165.47, 136.91, 135.86, 
133.79, 133.36, 133.05, 132.37 (2C), 129.84 (2C), 129.82, 129.71 (2C), 129.33 (2C), 129.13, 
128.58 (2C), 128.55 (2C), 128.31 (2C), 128.23, 126.24 (2C), 101.51, 88.65, 79.47, 78.75, 75.01, 




d][1,3]dioxin-7-yl acetate (5-4k). 
1H NMR (700 MHz, Chloroform-d) δ 7.51 – 7.44 (m, 4H), 7.42 – 7.27 (m, 11H), 5.58 (s, 1H), 
5.06 – 5.00 (m, 1H), 4.86 (d, J = 12.0 Hz, 1H), 4.70 (d, J = 10.1 Hz, 1H), 4.66 (d, J = 12.0 Hz, 
1H), 4.39 (dd, J = 10.6, 5.0 Hz, 1H), 3.81 (t, J = 10.3 Hz, 1H), 3.77 – 3.73 (m, 2H), 3.51 (td, J = 
9.5, 4.8 Hz, 1H), 2.03 (d, J = 1.6 Hz, 3H). 13C NMR (176 MHz, Chloroform-d) δ 169.47, 
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138.18, 137.23, 132.80 (2C), 132.40, 129.21, 129.10 (2C), 128.48 (2C), 128.44 (2C), 128.29, 




1H NMR (700 MHz, Chloroform-d) δ 7.55 – 7.52 (m, 2H), 7.49 – 7.46 (m, 2H), 7.40 – 7.35 (m, 
5H), 7.33 – 7.27 (m, 6H), 5.57 (s, 1H), 4.92 (d, J = 11.2 Hz, 1H), 4.79 (d, J = 11.3 Hz, 1H), 4.64 
(d, J = 9.8 Hz, 1H), 4.37 (dd, J = 10.6, 5.1 Hz, 1H), 3.78 (t, J = 10.3 Hz, 1H), 3.73 (dd, J = 9.4, 
8.3 Hz, 1H), 3.65 (m, 1H, s, 3H), 3.45 (td, J = 9.8, 5.1 Hz, 1H), 3.21 (dd, J = 9.8, 8.3 Hz, 1H). 13C 
(176 MHz, Chloroform-d) δ 138.49, 137.41, 133.14, 132.50 (2C), 129.12 (2C), 128.55 (2C), 
128.50 (2C), 128.40 (2C), 128.19, 127.99, 127.89, 126.15 (2C), 101.29, 88.20, 83.06, 82.39, 81.38, 





1H NMR (500 MHz, Chloroform-d) δ 7.56 – 7.45 (m, 4H), 7.41 – 7.28 (m, 11H), 5.98 (ddt, J = 
16.4, 10.9, 5.8 Hz, 1H), 5.57 (s, 1H), 5.30 (d, J = 17.2 Hz, 1H), 5.19 (d, J = 10.4 Hz, 1H), 4.91 (d, 
J = 11.2 Hz, 1H), 4.78 (d, J = 11.1 Hz, 1H), 4.69 (d, J = 9.8 Hz, 1H), 4.40 – 4.28 (m, 3H), 3.78 (q, 
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J = 9.5, 8.5 Hz, 2H), 3.66 (t, J = 9.4 Hz, 1H), 3.46 (td, J = 9.6, 4.9 Hz, 1H), 3.38 (dd, J = 9.7, 8.3 
Hz, 1H). 13C NMR (126 MHz, Chloroform-d) δ 138.41, 137.39, 134.81, 133.26, 132.42 (2C), 
129.12 (2C), 128.56, 128.51 (2C), 128.40 (2C), 128.27 (2C), 127.96, 127.91, 126.13 (2C), 117.48, 
101.27, 88.40, 83.01, 81.43, 80.37, 75.45, 74.84, 70.43, 68.84. (m/z): [M+Na]+  calcd for 




1H NMR (500 MHz, Chloroform-d) δ 7.56 – 7.46 (m, 4H), 7.42 – 7.29 (m, 11H), 7.26 – 7.23 (m, 
2H), 6.85 – 6.78 (m, 2H), 5.59 (s, 1H), 4.88 – 4.78 (m, 3H), 4.73 (dd, J = 17.1, 10.3 Hz, 2H), 4.39 
(dd, J = 10.5, 5.0 Hz, 1H), 3.85 – 3.79 (m, 2H), 3.78 (s, 3H), 3.68 (t, J = 9.3 Hz, 1H), 3.52 – 3.44 
(m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 159.45, 138.20, 137.41, 133.20, 132.51 (2C), 
130.55, 129.97 (2C), 129.15 (2C), 129.13, 128.55 (2C), 128.41 (2C), 128.33 (2C), 128.01 (2C), 
126.13 (2C), 113.94 (2C), 101.27, 88.39, 82.78, 81.61, 80.54, 76.01, 75.14, 70.41, 68.86, 55.41. 
HRMS (ESI+) (m/z): [M+Na]+  calcd for C34H34O6S 593.1974, found 593.1963.  
 
(2R,4aR,6S,7R,8S,8aR)-8-((4-methoxybenzyl)oxy)-2-phenyl-6-(phenylthio)hexahydro-
pyrano[3,2-d][1,3]dioxin-7-yl benzoate (5-4o). 
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1H NMR (700 MHz, Chloroform-d) δ 8.04 – 7.98 (m, 2H), 7.61 (tt, J = 7.3, 1.3 Hz, 1H), 7.53 – 
7.35 (m, 10H), 7.30 – 7.27 (m, 3H), 7.04 – 7.00 (m, 2H), 6.60 – 6.55 (m, 2H), 5.61 (s, 1H), 5.25 
(ddd, J = 10.3, 8.8, 1.6 Hz, 1H), 4.84 (d, J = 10.0 Hz, 1H), 4.73 (d, J = 11.7 Hz, 1H), 4.60 (d, J = 
11.7 Hz, 1H), 4.42 (dd, J = 10.6, 5.0 Hz, 1H), 3.89 – 3.78 (m, 3H), 3.69 (s, 3H), 3.56 (td, J = 9.7, 
5.0 Hz, 1H). 13C NMR (176 MHz, Chloroform-d) δ 165.12, 159.25, 137.34, 133.32, 133.10 (2C), 
132.36, 130.08 (2C), 129.96, 129.93 (2C), 129.20, 129.04 (2C), 128.50 (2C), 128.44 (2C), 128.31, 
126.16 (2C), 113.81, 113.69 (2C), 101.43, 87.16, 81.61, 78.89, 74.01, 72.15, 70.78, 68.77, 55.24. 
HRMS (ESI+) (m/z): [M+Na]+  calcd for C34H32O7S 607.1766, found 607.1759.  
 
(2R,4aR,6S,7R,8S,8aR)-8-((4-methoxybenzyl)oxy)-2-phenyl-6-(phenylthio)hexahydro-
pyrano[3,2-d][1,3]dioxin-7-yl acetate (5-4p). 
1H NMR (700 MHz, Chloroform-d) δ 7.52 – 7.43 (m, 4H), 7.41 – 7.36 (m, 3H), 7.31 (dd, J = 5.1, 
2.0 Hz, 4H), 7.18 (d, J = 8.5 Hz, 2H), 6.85 – 6.82 (m, 2H), 5.57 (s, 1H), 5.00 (t, J = 9.4 Hz, 1H), 
4.78 (d, J = 11.6 Hz, 1H), 4.69 (d, J = 10.1 Hz, 1H), 4.60 (d, J = 11.6 Hz, 1H), 4.39 (dd, J = 10.6, 
5.0 Hz, 1H), 3.83 – 3.80 (m, 1H), 3.79 (s, 3H), 3.74 – 3.71 (m, 2H), 3.50 (dq, J = 9.6, 5.0 Hz, 1H), 
2.05 (s, 3H). 13C NMR (176 MHz, Chloroform-d) δ 169.44, 159.39, 137.26, 132.80 (2C), 132.41, 
130.26, 129.76 (2C), 129.20, 129.09 (2C), 128.43 (2C), 128.27, 126.13 (2C), 113.85 (2C), 101.37, 





[3,2-d][1,3]dioxin-7-yl acetate (5-4q). 
1H NMR (500 MHz, Chloroform-d) δ 7.46 (dtd, J = 9.0, 5.0, 4.2, 2.5 Hz, 4H), 7.41 – 7.36 (m, 3H), 
7.33 – 7.30 (m, 3H), 7.27 (d, J = 2.0 Hz, 1H), 7.25 (s, 1H), 7.21 – 7.16 (m, 2H), 5.56 (s, 1H), 5.05 
– 4.99 (m, 1H), 4.81 (d, J = 12.2 Hz, 1H), 4.70 (d, J = 10.1 Hz, 1H), 4.63 (d, J = 12.2 Hz, 1H), 
4.39 (dd, J = 10.6, 5.0 Hz, 1H), 3.80 (t, J = 10.3 Hz, 1H), 3.75 – 3.69 (m, 2H), 3.50 (dq, J = 9.5, 
4.7 Hz, 1H), 2.06 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 169.41, 137.16, 136.72, 133.60, 
132.84, 132.34, 129.27, 129.26, 129.12, 128.61, 128.46, 128.34, 126.12, 101.46, 86.97, 81.32, 




1H NMR (500 MHz, Chloroform-d) δ 7.78 – 7.67 (m, 2H), 7.56 – 7.51 (m, 2H), 7.42 – 7.27 (m, 
10H), 7.24 – 7.14 (m, 3H), 6.91 – 6.84 (m, 2H), 5.50 (s, 1H), 4.73 (d, J = 4.7 Hz, 2H), 4.65 – 4.58 
(m, 3H), 4.37 (dd, J = 12.3, 1.6 Hz, 1H), 4.15 (d, J = 4.1 Hz, 1H), 3.99 (dd, J = 12.3, 1.7 Hz, 1H), 
3.90 (t, J = 9.4 Hz, 1H), 3.81 (s, 3H), 3.62 (dd, J = 9.2, 3.4 Hz, 1H), 3.42 (s, 1H). 13C NMR (126 
MHz, Chloroform-d) δ 159.42, 138.32, 138.03, 132.96, 132.83 (2C), 130.84, 130.01 (2C), 129.19, 
129.00 (2C), 128.55 (2C), 128.31 (2C), 127.94 (2C), 127.55, 126.77, 126.76 (2C), 113.91 (2C), 





d][1,3]dioxin-7-yl pivalate (5-5b). 
1H NMR (500 MHz, Chloroform-d) δ 7.62 – 7.55 (m, 2H), 7.43 (dd, J = 6.7, 3.1 Hz, 2H), 7.38 – 
7.33 (m, 3H), 7.31 – 7.26 (m, 6H), 7.25 – 7.20 (m, 2H), 5.44 (s, 1H), 5.34 (t, J = 9.7 Hz, 1H), 4.70 
(d, J = 9.9 Hz, 1H), 4.67 – 4.59 (m, 2H), 4.35 (dd, J = 12.4, 1.6 Hz, 1H), 4.15 (dd, J = 3.4, 1.0 Hz, 
1H), 3.98 (dd, J = 12.4, 1.7 Hz, 1H), 3.69 (dd, J = 9.7, 3.4 Hz, 1H), 3.44 (s, 1H), 1.25 (s, 9H). 13C 
NMR (126 MHz, Chloroform-d) δ 176.59, 138.06, 137.76, 133.45 (2C), 132.22, 129.12, 128.85 
(2C), 128.47 (2C), 128.22  (2C), 127.98, 127.88, 127.68 (2C), 126.67 (2C), 101.26, 85.87, 78.86, 
73.51, 71.46, 70.10, 69.45, 68.08, 38.90, 27.37 (3C).  
 
General procedure (D-mannose-based substrates):  






d][1,3]dioxin-8-yl acetate (5-6a). 
1H NMR (700 MHz, Chloroform-d) δ 7.54 – 7.42 (m, 4H), 7.39 – 7.27 (m, 11H), 5.58 (s, 1H), 
5.54 (s, 1H), 5.28 (dd, J = 10.5, 3.4 Hz, 1H), 4.69 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 
4.40 (td, J = 9.8, 4.8 Hz, 1H), 4.27 – 4.20 (m, 3H), 3.88 (t, J = 10.3 Hz, 1H), 2.03 (s, 3H). 13C 
NMR (176 MHz, Chloroform-d) δ 170.31, 137.41, 137.39, 133.74, 131.96 (2C), 129.32 (2C), 
129.22, 128.69 (2C), 128.40 (2C), 128.27, 128.21 (2C), 127.90, 126.38 (2C), 101.99, 86.52, 77.75, 
76.37, 73.21, 70.66, 68.65, 65.44, 21.13. 
 
5.9.3 Single-pot synthesis of fully functionalized D-glucose-derivatives (Chapter 5.5) 
General procedure: 
C2 acetalization → C3-OH protection → C2-acetal cleavage → C2-OH protection 
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→ Benzylidine acetal selective opening → C4-OH protection 
 
 
1) C2 acetalization 
- The procedure was described above (Section 5.9.1). 
2) C3-OH protection 
- The procedure was described above (Section 5.9.2). 
3) C2-acetal cleavage 
- The procedure was described above (Section 5.9.2). 
4) C2-OH protection 
- The procedure was described above (Section 5.9.2). 
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- Instead of performing purification on compound 5-4, the crude mixture 5-4 was dried completely 
dried by passing a stream of N2 followed by applying high vacuum, and was directly advanced to 
the next step. 
5) 4-6-benzylidine acetal selective opening 
Instruction:   
The condition for this step may cleave some protecting groups like acetyl (Ac), tert-butyldimethyl 
silyl (TBS), para-methoxybenzyl (PMB) groups. We observed a side-reactions with substrates 
containing such protecting groups, and undesired C2-and C3-deprotection was observed under the 
condition. In particular, this happened when the reaction was stirred for more than 2 h at room 
temperature. To address the problem, the reaction was stirred at 0 oC for 2 h and was quenched 
with base after 2 h. Even though reaction might not be completed, the conversion was mostly 
higher than 70%. In addition, the unreacted benzylidine acetal containing compound 5-4 could be 
successfully recovered along with the final product 5-7 using the column purification after the final 
protection step (Compound 5-4 does not react with the reagents in the last step). 
Procedure: 
The crude C2, C3-protected glucose derivative 5-4 (1.0 equiv) was dissolved in DCM (0.2 M) and 
the mixture was cooled to 0 oC. Then triethyl-silane (5 equiv) was added to the mixture followed 
by the slow addition of trifluoroacetic acid (5 equiv) at 0 oC. The reaction mixture was stirred for 
2 h at 0 oC, before being quenched with triethyl-amine after 2 h period. The resulting crude 
compound 5-S5 was completely dried by passing a stream of N2 followed by applying high vacuum. 




At this point, various reagents still remained in the reaction pot from previous steps. However, the 
desired crude product is supposed to have only one free C4-OH. To avoid undesired side-reactions 
with previous reagents, a large excess of the protection step reagents was used. This would also 
ensure protecting reagents to be sufficiently reactive with the C4-OH. 
Procedure: 
* The resulting dried crude compound  5-4 was subjected to one of the following conditions below.    
Acetylation: Pyridine (20.0 equiv) and anhydrous dichloromethane (0.5M) were added to the 
reaction mixture. Then acetic anhydride (2.0 equiv), and 4-dimethyaminopyridine (DMAP) (0.3 
equiv) were added to the mixture. The reaction mixture was stirred at room temperature until TLC 
analysis indicated reaction completion. After completion, the reaction was slowly quenched with 
methanol. The solvent was then removed under vacuum and the residue was dissolved in DCM 
and washed with NH4Cl (x3). The resultant aqueous layers were extracted with DCM (x2), and 
the organic layers were combined and dried over MgSO4. The dried crude solution was 
concentrated in vacuo and purified by a flash column chromatography on SiO2 (hexanes : ethyl 
acetate, 15:1 → 10:1 → 4:1). 
Benzoylation:  Pyridine (20.0 equiv) and anhydrous dichloromethane (0.5M) were added to the 
reaction mixture. Then, benzoyl chloride (2.0 equiv), and 4-dimethyaminopyridine (DMAP) (0.3 
equiv) were added to the mixture. The reaction mixture was stirred at room temperature until TLC 
analysis indicated reaction completion. After completion, the reaction was slowly quenched with 
methanol. The solvent was then removed under vacuum and the residue was dissolved in DCM 
and washed with NH4Cl (x3). The resultant aqueous layers were extracted with DCM (x2), and 
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the organic layers were combined and dried over MgSO4. The dried crude solution was 
concentrated in vacuo and purified by a flash column chromatography on SiO2 (hexanes : ethyl 
acetate, 15:1 → 10:1 → 4:1). 
Pivaloylation: Pyridine (20.0 equiv) and anhydrous dichloromethane (0.5M) were added to the 
reaction mixture. Then pivaloyl chloride (2.0 equiv), and 4-dimethyaminopyridine (DMAP) (0.3 
equiv) were added to the mixture. The reaction was stirred at room temperature until TLC analysis 
indicated reaction completion. After completion, the reaction mixture was slowly quenched with 
methanol. The solvent was then removed under vacuum and the residue was dissolved in DCM 
and washed with NH4Cl (x3). The resultant aqueous layers were extracted with DCM (x2), and 
the organic layers were combined and dried over MgSO4. The dried crude solution was 
concentrated in vacuo and purified by a flash column chromatography on SiO2 (hexanes : ethyl 
acetate, 15:1 → 10:1 → 4:1). 
Para-methoxybenzylation: Anhydrous DMF (0.2M) was added to the reaction mixture. Then 
sodium hydride (60% dispersion in mineral oil) (2.5 equiv), and benzyl bromide (2.0 equiv), 
tetrabutylammonium iodide (TBAI) (0.3 equiv) were sequentially added. The resultant reaction 
was stirred at room temperature until TLC analysis indicated reaction completion. After 
completion, the reaction was slowly quenched with methanol. The solvent was then removed under 
vacuum and the residue was dissolved in DCM and washed with NH4Cl (x3). The resultant 
aqueous layers were extracted with DCM (x2), and the organic layers were combined and dried 
over MgSO4. The dried crude solution was concentrated in vacuo and purified by a flash column 





2H-pyran-3-yl benzoate (5-7b). 
1H NMR (700 MHz, Chloroform-d) δ 7.94 (d, J = 8.3 Hz, 2H), 7.63 – 7.58 (m, 2H), 7.58 – 7.54 
(m, 1H), 7.42 (t, J = 7.6 Hz, 2H), 7.37 – 7.26 (m, 8H), 7.25 – 7.19 (m, 5H), 5.43 (t, J = 9.4 Hz, 
1H), 5.24 (t, J = 9.8 Hz, 1H), 4.88 (d, J = 11.2 Hz, 1H), 4.81 (d, J = 9.7 Hz, 1H), 4.59 (d, J = 11.2 
Hz, 1H), 4.53 – 4.45 (m, 2H), 3.86 – 3.79 (m, 1H), 3.69 – 3.59 (m, 3H), 1.78 (s, 3H). 13C NMR 
(176 MHz, Chloroform-d) δ 170.06, 165.62, 137.97, 137.79, 133.57, 133.40, 132.20 (2C), 129.98 
(2C), 129.22, 129.18 (2C), 128.64 (2C), 128.58 (2C), 128.40 (2C), 128.20 (2C), 128.04, 127.91, 
127.79 (2C), 127.69, 87.76, 78.61, 77.81, 75.58, 75.18, 73.70, 69.97, 69.46, 20.80. HRMS (ESI+) 
(m/z): [M+Na]+ calcd for C35H34O7S 621.1923, found 621.1912. 
 
(2R,3R,4S,5R,6S)-3-acetoxy-2-((benzyloxy)methyl)-5-((4-chlorobenzyl)oxy)-6-
(phenylthio)tetrahydro-2H-pyran-4-yl benzoate (5-7c). 
1H NMR (500 MHz, Chloroform-d) δ 7.93 – 7.83 (m, 2H), 7.63 – 7.54 (m, 3H), 7.43 (t, J = 7.8 
Hz, 2H), 7.37 – 7.27 (m, 8H), 7.06 – 6.97 (m, 4H), 5.47 (t, J = 9.4 Hz, 1H), 5.19 (t, J = 9.8 Hz, 
1H), 4.83 – 4.72 (m, 2H), 4.57 (d, J = 11.9 Hz, 1H), 4.49 (dd, J = 17.0, 11.5 Hz, 2H), 3.74 (ddd, J 
= 9.9, 5.3, 2.9 Hz, 1H), 3.66 – 3.57 (m, 3H), 1.81 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 
169.81, 165.76, 137.96, 135.79, 133.76, 133.53, 133.28, 132.18, 129.82, 129.74, 129.40, 129.25, 
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2H-pyran-3-yl benzoate (5-7d). 
1H NMR (700 MHz, Chloroform-d) δ 5.85 (s, 1H), 2.16 (s, 2H), 2.14 (s, 2H), 1.91 (s, 3H), 1.00 
(s, 6H). 13C NMR (126 MHz, Chloroform-d) δ 169.69, 165.12, 138.08, 137.67, 133.43, 133.03, 
132.50 (2C), 130.03(2C), 129.88, 129.01(2C), 128.60 (2C), 128.51 (2C), 128.42 (2C), 128.00 (2C), 
127.95 (2C), 127.87, 127.85, 127.84, 86.46, 81.59, 78.10, 74.29, 73.82, 72.26, 70.88, 70.01, 
20.96.HRMS (ESI+) (m/z): [M+Na]+ calcd for C35H34O7S 621.1923, found 621.1911. 
 
(2R,3R,4S,5R,6S)-5-acetoxy-4-(benzyloxy)-2-((benzyloxy)methyl)-6-(phenylthio)tetrahydro-
2H-pyran-3-yl pivalate (5-7e). 
1H NMR (700 MHz, Chloroform-d) δ 7.51 (d, J = 7.7 Hz, 2H), 7.35 – 7.28 (m, 7H), 7.26 – 7.16 
(m, 6H), 5.14 – 5.05 (m, 2H), 4.71 (d, J = 10.0 Hz, 1H), 4.62 (d, J = 11.1 Hz, 1H), 4.59 – 4.54 (m, 
2H), 4.49 (d, J = 11.8 Hz, 1H), 3.78 (t, J = 9.2 Hz, 1H), 3.71 (t, J = 8.5 Hz, 1H), 3.60 – 3.55 (m, 
1H), 3.50 (d, J = 11.0 Hz, 1H), 1.99 (s, 3H), 1.12 (s, 9H). 13C NMR (176 MHz, Chloroform-d) δ 
176.97, 169.49, 138.02, 137.82, 133.45, 132.49, 131.90 (2C), 129.05 (2C), 128.53 (2C), 128.52 
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(2C), 127.93 (2C), 127.85, 127.82, 127.61 (2C), 86.45, 82.04, 78.45, 73.86, 73.77, 71.27, 69.89, 




1H NMR (700 MHz, Chloroform-d) δ 7.58 (dt, J = 7.0, 3.3 Hz, 2H), 7.47 – 7.27 (m, 11H), 7.24 – 
7.20 (m, 4H), 7.15 – 7.05 (m, 2H), 6.88 – 6.79 (m, 4H), 4.88 (d, J = 10.4 Hz, 1H), 4.84 – 4.70 (m, 
4H), 4.68 – 4.64 (m, 1H), 4.62 – 4.58 (m, 1H), 4.56 – 4.49 (m, 2H), 3.82 – 3.75 (m, 7H), 3.73 – 
3.65 (m, 2H), 3.60 (dd, J = 11.3, 8.1 Hz, 1H), 3.51 – 3.45 (m, 2H). 13C NMR (176 MHz, 
Chloroform-d) δ 159.46, 159.39, 138.48, 138.26, 133.97, 132.07 (2C), 130.77, 130.40, 129.75 
(2C), 129.61 (2C), 129.02 (2C), 128.56 (2C), 128.48 (2C), 128.31 (2C), 127.98, 127.78 (2C), 
127.67, 127.54, 114.02 (2C), 113.99 (2C), 87.56, 86.65, 80.99, 79.27, 77.70, 75.66, 75.54, 74.84, 
73.55, 69.20, 55.43 (2C). HRMS (ESI+) (m/z): [M+Na]+ calcd for C42H44O7S 715.2705, found 
715.2692. 
5.9.4 Regioselective single-pot protection/glycosylation of monosaccharide (Chapter 5.6). 
General procedure: 




1) C2 acetalization 
- The procedure was described above (Section 5.9.1). 
2) C3-OH protection 
- The procedure was described above (Section 5.9.2). 
3. C2-acetal cleavage 
- The procedure was described above (Section 5.9.2). 
4. C2-OH glycosylation 
Instruction:  
Some of the residual reagents used in prior steps could affect the yield of this step (especially 
acetyl, benzoyl protection in C3-position) We observed that trichloroacetimidate glycosyl donors 
may react with acetyl anhydride, benzoyl chloride, etc. As a result, acetylated and benzoylated 
glycosyl donor was obtained and the glycosylation yields were diminished. To address this 
problem, 2.5 equiv of donor (instead of 1.4 equiv) were used for the glycosylation reactions, and, 
indeed the yield increased substantially. Filtering on compound 5-S3 after 3 steps could also 
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improve final glycosylation yield. Besides acetyl and benzoyl glycosylation, we did not observe 
any side-reactions of trichloroacetimidate donors, and relatively high yields were achieved. 
Procedure: 
The resulting C3-OH protected substrate 5-S2 (1.0 equiv) was dried by azeotropic removal of 
moisture with toluene (x3). Then, trichloroacetimidate donor (1.4 equiv) and activated 4Å MS 
were added to the mixture. The reaction mixture was then dissolved in DCM (0.2M) and cooled 
down to 0 oC. Then trimethylsilyl trifluoromethanesulfonate (20 mol%) was added to the resultant 
mixture, and the solution was stirred for 1 h at 0 oC. After the reaction completion, the mixture 
was quenched with triethyl amine and the crude product was purified by a flash column 





1H NMR (700 MHz, Chloroform-d) δ 7.56 – 7.51 (m, 2H), 7.47 – 7.27 (m, 23H), 5.45 (s, 1H), 
5.35 (t, J = 8.7 Hz, 1H), 5.07 (d, J = 2.3 Hz, 1H), 4.87 (d, J = 11.0 Hz, 1H), 4.74 – 4.69 (m, 2H), 
4.67 – 4.60 (m, 4H), 4.34 (dd, J = 10.6, 4.5 Hz, 1H), 4.23 (dt, J = 12.3, 6.3 Hz, 1H), 3.84 (dd, J = 
8.8, 2.8 Hz, 1H), 3.80 (t, J = 8.9 Hz, 1H), 3.78 – 3.76 (m, 1H), 3.73 (t, J = 9.8 Hz, 1H), 3.64 (t, J 
= 9.1 Hz, 1H), 3.57 – 3.50 (m, 2H), 1.95 (s, 3H), 1.36 (d, J = 6.0 Hz, 3H). 13C NMR (176 MHz, 
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Chloroform-d) δ 169.88, 138.76, 138.71, 138.52, 137.01, 132.86 (2C), 132.67, 129.21, 129.15 
(2C), 128.50 (2C), 128.49 (2C), 128.45 (2C), 128.38 (2C), 128.17, 128.07 (2C), 127.75, 127.73 
(2C), 127.70 (2C), 127.64, 126.23 (2C), 101.49, 100.12, 87.13, 80.59, 79.78, 78.34, 76.47, 75.75, 
75.02, 73.28, 72.41 (2C), 70.15, 69.45, 68.69, 21.04, 18.03. (HRMS (ESI+) (m/z): [M+Na]+ calcd 






1H NMR (500 MHz, Chloroform-d) δ 8.14 – 8.05 (m, 2H), 7.58 – 7.53 (m, 3H), 7.44 – 7.28 (m, 
20H), 7.20 – 7.12 (m, 3H), 7.01 – 6.89 (m, 2H), 5.72 – 5.64 (m, 1H), 5.47 (s, 1H), 5.10 (d, J = 2.0 
Hz, 1H), 4.87 (d, J = 11.1 Hz, 1H), 4.80 (d, J = 9.5 Hz, 1H), 4.63 – 4.52 (m, 3H), 4.38 (dd, J = 
10.6, 4.9 Hz, 1H), 4.29 (dq, J = 9.6, 6.2 Hz, 1H), 4.14 (d, J = 11.6 Hz, 1H), 3.96 (t, J = 9.0 Hz, 
1H), 3.85 (d, J = 11.7 Hz, 1H), 3.82 – 3.76 (m, 2H), 3.72 (t, J = 9.6 Hz, 1H), 3.66 – 3.61 (m, 2H), 
3.58 (t, J = 9.4 Hz, 1H), 1.33 (d, J = 6.3 Hz, 3H) 13C NMR (126 MHz, Chloroform-d) δ 165.38, 
138.81, 138.76, 138.36, 136.91, 133.77, 132.93, 132.60, 130.10, 130.05, 129.50, 129.17, 129.14, 
128.85, 128.52, 128.46, 128.41, 128.35, 128.32, 128.20, 128.11, 127.67, 127.58, 127.51, 127.39, 
127.34, 126.23, 101.50, 100.34, 87.10, 80.18, 79.77, 78.41, 77.84, 77.41, 77.16, 76.91, 76.69, 
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76.25, 75.16, 72.98, 71.94, 70.32, 69.44, 68.71, 17.84. HRMS (ESI+) (m/z): [M+Na]+ calcd for 





1H NMR (700 MHz, Chloroform-d) δ 7.59 – 7.52 (m, 2H), 7.47 – 7.26 (m, 20H), 7.26 – 7.17 (m, 
8H), 5.54 (s, 1H), 5.30 (s, 1H), 4.99 (d, J = 11.4 Hz, 1H), 4.91 (d, J = 11.0 Hz, 1H), 4.70 – 4.56 
(m, 5H), 4.40 – 4.34 (m, 2H), 4.33 – 4.25 (m, 2H), 3.86 (dd, J = 9.2, 2.8 Hz, 1H), 3.79 – 3.63 (m, 
6H), 3.48 (td, J = 9.6, 5.0 Hz, 1H), 1.36 (d, J = 6.2 Hz, 3H). 13C NMR (176 MHz, Chloroform-d) 
δ 138.94, 138.90, 138.80, 138.30, 137.27, 132.91, 132.84 (2C), 129.15, 129.05 (2C), 128.56 (2C), 
128.46 (2C), 128.43 (2C), 128.41 (2C), 128.22 (2C), 128.10 (2C), 127.98, 127.85, 127.73 (2C), 
127.67, 127.63, 127.60 (2C), 127.45 (2C), 127.38, 126.08 (2C), 101.27, 100.36, 87.01, 83.56, 
81.67, 80.66, 79.98, 78.41, 76.81, 75.21, 74.76, 72.60, 72.40, 70.04, 69.19, 68.79, 17.92. δ HRMS 
(ESI+) (m/z): [M+NH4]







1H NMR (700 MHz, Chloroform-d) δ 7.56 – 7.49 (m, 2H), 7.39 – 7.28 (m, 18H), 7.25 – 7.12 (m, 
9H), 5.50 (s, 1H), 5.28 (d, J = 2.1 Hz, 1H), 4.88 (dd, J = 19.0, 11.3 Hz, 2H), 4.70 (d, J = 11.8 Hz, 
1H), 4.66 – 4.61 (m, 3H), 4.51 (d, J = 11.7 Hz, 1H), 4.45 (d, J = 12.1 Hz, 1H), 4.35 (dd, J = 10.7, 
5.1 Hz, 1H), 4.32 – 4.26 (m, 2H), 3.85 (dd, J = 9.0, 2.9 Hz, 1H), 3.76 – 3.64 (m, 6H), 3.46 (td, J = 
9.6, 5.0 Hz, 1H), 1.36 (d, J = 6.2 Hz, 3H).. 13C NMR (176 MHz, Chloroform-d) δ 138.89, 138.83, 
138.62, 137.19, 136.79, 133.55, 132.91, 132.81 (2C), 129.23, 129.07 (2C), 128.84 (2C), 128.66 
(2C), 128.50 (2C), 128.46 (2C), 128.43 (2C), 128.35 (2C), 128.11 (2C), 128.01, 127.75 (2C), 
127.71, 127.68, 127.51, 127.39 (2C), 126.07 (2C), 101.36, 100.30, 87.04, 83.66, 81.55, 80.74, 
79.91, 78.12, 76.88, 75.16, 73.86, 72.70, 72.58, 70.02, 69.25, 68.77, 17.96.. HRMS (ESI+) (m/z): 





1H NMR (700 MHz, Chloroform-d) δ 7.51 – 7.48 (m, 2H), 7.48 – 7.45 (m, 2H), 7.35 – 7.27 (m, 
20H), 7.25 – 7.22 (m, 3H), 7.18 – 7.17 (m, 2H), 7.14 – 7.13 (m, 1H), 5.50 (s, 1H), 5.21 (d, J = 1.8 
Hz, 1H), 5.02 (d, J = 11.0 Hz, 1H), 4.84 (d, J = 11.0 Hz, 1H), 4.76 (d, J = 9.8 Hz, 1H), 4.65 (d, J 
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= 11.8 Hz, 1H), 4.59 – 4.56 (m, 2H), 4.53 (d, J = 11.0 Hz, 1H), 4.38 – 4.34 (m, 2H), 4.30 (d, J = 
12.2 Hz, 1H), 4.03 – 3.96 (m, 2H), 3.85 (dd, J = 9.5, 3.0 Hz, 1H), 3.77 (t, J = 10.1 Hz, 1H), 3.70 
– 3.68 (m, 1H), 3.55 – 3.44 (m, 4H), 0.85 (d, J = 6.2 Hz, 3H). 13C NMR (176 MHz, Chloroform-
d) δ 139.04, 138.98, 138.60, 137.93, 137.12, 133.46, 132.14 (2C), 129.23 (2C), 129.14, 128.61 
(2C), 128.42 (2C), 128.37 (2C), 128.28 (2C), 128.23 (2C), 128.01, 127.94 (2C), 127.92, 127.68 
(2C), 127.60, 127.57, 127.47 (2C), 127.40, 127.18 (2C), 126.54 (2C), 101.98, 98.98, 88.63, 81.97, 
80.77, 80.13, 79.47, 79.21, 76.39, 75.18 (2C), 72.61, 72.44, 70.86, 68.82, 68.27, 17.54 HRMS 





1H NMR (700 MHz, Chloroform-d) δ 7.47 (d, J = 7.7 Hz, 2H), 7.44 – 7.39 (m, 2H), 7.36 – 7.26 
(m, 20H), 7.26 – 7.23 (m, 4H), 7.20 (t, J = 7.6 Hz, 2H), 5.58 (s, 1H), 5.52 (s, 1H), 4.89 (d, J = 11.0 
Hz, 1H), 4.81 – 4.75 (m, 2H), 4.67 (d, J = 11.7 Hz, 1H), 4.61 (dd, J = 11.5, 4.5 Hz, 3H), 4.47 (d, 
J = 11.9 Hz, 1H), 4.39 (d, J = 11.8 Hz, 1H), 4.29 (td, J = 9.7, 4.8 Hz, 1H), 4.20 (dd, J = 10.3, 4.8 
Hz, 1H), 4.14 (dd, J = 10.2, 3.1 Hz, 1H), 4.12 – 4.04 (m, 2H), 3.94 (dd, J = 9.4, 3.1 Hz, 1H), 3.90 
(dd, J = 3.1, 1.4 Hz, 1H), 3.84 (t, J = 10.3 Hz, 1H), 3.75 – 3.71 (m, 1H), 3.59 (t, J = 9.5 Hz, 1H), 
1.13 (d, J = 6.2 Hz, 3H). 13C NMR (176 MHz, Chloroform-d) δ 139.16, 138.88, 138.48, 137.67, 
137.50, 133.89, 131.78 (2C), 129.31 (2C), 128.82, 128.63 (2C), 128.56 (2C), 128.48 (2C), 128.34 
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(2C), 128.24 (2C), 128.17 (3C), 127.98 (2C), 127.91, 127.83, 127.80 (2C), 127.65 (2C), 127.62, 
127.51, 126.20 (2C), 101.59, 95.77, 87.07, 80.84, 80.27, 77.25,  77.10, 75.09, 75.01, 73.62, 73.21, 
72.65, 72.38, 68.60, 68.25, 65.68, 17.83. HRMS (ESI+) (m/z): [M+Na]+ calcd for C53H54O9S 
889.3386, found 889.3369. 
 





hexahydropyrano[3,2-d][1,3]dioxin-7-yl acetate (5-9a).  
1H NMR (500 MHz, Chloroform-d) δ 7.50 – 7.44 (m, 2H), 7.43 – 7.36 (m, 3H), 7.26 – 7.24 (m, 
2H), 7.22 – 7.18 (m, 2H), 5.56 (s, 1H), 5.50 (d, J = 4.9 Hz, 1H), 5.02 (t, J = 8.3 Hz, 1H), 4.81 (d, 
J = 12.3 Hz, 1H), 4.64 (d, J = 12.3 Hz, 1H), 4.61 – 4.53 (m, 2H), 4.35 (dd, J = 10.5, 5.0 Hz, 1H), 
4.29 (dd, J = 5.0, 2.4 Hz, 1H), 4.17 (dd, J = 7.9, 1.9 Hz, 1H), 4.00 (dd, J = 11.3, 3.5 Hz, 1H), 3.91 
(ddd, J = 7.5, 3.5, 1.8 Hz, 1H), 3.83 – 3.61 (m, 4H), 3.43 (td, J = 9.6, 5.0 Hz, 1H), 2.06 (s, 3H), 
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1.51 (s, 3H), 1.44 (s, 3H), 1.32 (s, 6H). 13C NMR (126 MHz, Chloroform-d) δ 169.72, 137.27, 
136.92, 133.49, 129.22 (3C), 128.56 (2C), 128.44 (2C), 126.14 (2C), 109.53, 108.82, 102.53, 
101.46, 96.35, 81.60, 78.68, 73.39, 72.80, 71.38, 70.77, 70.62, 69.74, 68.84, 67.88, 66.33, 26.22, 
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